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Abstract 
Metal nanomaterials, such as gold nanoparticles (Au NPs), exhibit unique localised surface 
plasmon resonance, which can be exploited for probing biochemical and biophysical phenomena 
at the nanoscale and molecular level. Furthermore, the ability to control the synthesis and growth 
of such nanomaterials using organic and biomimetic molecules, such as nucleic acids and small 
molecules, facilitates deeper understanding of the interactions between biomolecules and 
nanomaterials. This thesis described the development of various highly sensitive and novel 
diagnostic platforms for detecting micro-RNA (miRNA), small molecule and protein biomarkers, 
by utilising the unique plasmonic properties of Au NPs, as well as modulating the morphology and 
size of various gold nanostructures. 
Au NP-conjugated nucleic acid probes, together with a poly(ethylene glycol)-functionalised 
microarray, enabled highly sensitive and multiplexed detection of miRNAs, conveniently under 
an optical microscope. Also, colorimetric detection of small molecules using the naked eye was 
achieved via the controlled growth of aptamer-functionalised Au NPs into various distinct 
nanostructures, which were dependent on aptamer–target interactions and aptamer-mediated NP 
growth. Lastly, the interactions between small molecules and Au seeds, and the effect on the size 
and aspect ratios of grown gold nanorods were investigated and elucidated. The size-modulating 
mechanism was further incorporated in an immunoassay for the sensitive detection of a protein 
biomarker, enabling its application in clinical diagnostics. The platforms developed in this thesis 
could serve as a basis for future development of new biosensing strategies that utilise plasmonic 
nanomaterials. 
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Chapter 1 : Introduction 
Nanotechnology and its biomedical applications represent a multi-disciplinary field involving 
material science, biochemistry, molecular biology, and medicine. Conceptualised by Richard 
Feynman in his speech “There’s Plenty of Room at the Bottom”, new ideas and thinking regarding 
nano-sized materials, and methods of scaling down bulk materials into the nanoscale (< 100 nm) 
have emerged over the past two decades. At the nanoscale, metals exhibit unique and useful 
optical, electronic, magnetic and mechanical properties. In particular, gold nanoparticles (Au NPs) 
possess high molar extinction coefficient and localised surface plasmon resonance, which can be 
used to probe physical, chemical and biological phenomena at the molecular level, and enable 
researchers to better understand the underlying fundamental sciences. Increased knowledge and 
expertise in synthesis methods have enabled the synthesis of Au NPs with better defined and 
controlled size, shape and structure, allowing further tailoring of the plasmonic properties of gold 
nanostructures. Furthermore, the ease of functionalising Au nanostructures and their tunable 
surface chemistry provide many routes to the preparation of complexes with biomolecules, such 
as nucleic acids, peptides and antibodies. Intelligently designed complexes can be versatile and 
adaptable to various chemical and biological systems, and be employed in many biomedical 
applications, such as bioimaging, drug delivery, therapy, biosensing and diagnostics. The aberrant 
expression of serum proteins may be associated with specific disease states. Interaction of 
biomolecule–Au NP complexes with such proteins may lead to changes in Au NP’s optical or 
plasmonic properties, which can then be transduced to quantify the amount of proteins. The results 
can be used in the detection of specific diseases, assess treatment outcome, and help in making 
vital medical decisions. Compared to the more conventional methods of biomolecule detection, 
such as fluorescence, chromatographic and radioactive methods, Au NPs do not experience 
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photobleaching, their absorbance can be tuned towards the near-infrared spectrum, which is the 
biological transparent window not affected by biological auto-fluorescence, and there is no need 
to deal with hazardous radioactive materials. Furthermore, the plasmonic properties of Au NPs can 
be utilised for naked eye detection of targets, without the need of equipment. This greatly facilitates 
their use in resource-limited areas and for point-of-care applications. In view of the many 
advantages of incorporating Au NPs in biomedical applications, this thesis aims to develop novel 
biosensing and diagnostic platforms using gold nanoparticle complexes. 
1.1 Gold Nanoparticles 
1.1.1 Synthesis, surface chemistry and biological functionalisation 
The methods for the synthesis of nanomaterials can be broadly categorised into top-down 
(preparation by physical manipulations) and bottom-up (synthesis by chemical means in solution 
phase) approaches. Top-down approaches usually involve lithographic methods such as, electron 
beam lithography, focused ion beam lithography, nanosphere lithography, colloidal lithography 
and soft lithography [1]. Lithographic methods are used to synthesise arrays of nanostructures on 
a physical substrate such as, nanoholes, nanodisks, nanorings or nanovoids, while the synthesis of 
colloidal Au NPs typically relies on bottom-up approaches. Much of the work on bottom-up 
approaches has so far focused on tuning the shape, size, stability and functionality of Au NPs. 
One of the most popular method for the synthesis of Au NPs is the Turkevich method [2], which 
involved a single-phase reduction of HAuCl4 in water using a boiling solution of trisodium citrate. 
In addition, the surface bound citrate acted as an electrostatic stabilising agent, preventing the 
aggregation of the Au NPs, allowing well-dispersed Au NPs of ~ 20 nm to be prepared. 
Furthermore, the size of the Au NPs could be controlled by varying the ratio of citrate to HAuCl4, 
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temperature, and the rate at which reagents were added. In a more recent study, an inverse method 
to the Turkevich method was developed [3], where HAuCl4 was added to boiling trisodium citrate 
instead of the more conventional method of adding boiling citrate to gold precursor. This inverse 
addition of reagents promoted thermal oxidation of citrate, causing faster nucleation of gold 
particles and resulted in improved monodispersity of the Au NPs synthesised. 
The Brust–Schiffrin method [4] is another popular and groundbreaking Au NP synthesis pathway 
(Figure 1.1). In this method, HAuCl4 was transferred from the aqueous phase to organic phase 
(toluene), using tetra-octylammonium bromide (TOAB) as the phase transfer agent, and HAuCl4 
was then reduced using sodium borohydride (NaBH4) in the presence of dodecanethiol. The thiol 
ligands that binded strongly to gold acted as superior capping and stabilising agent. As such, 
synthesised Au NPs could be dried/isolated and redispersed in organic solvents repeatedly, without 
signs of aggregation or decomposition. This was the first report for the synthesis of thermal- and 
air-stable Au NPs via a facile method. Highly monodispersed particles of 1.5–5.2 nm could be 
synthesised using this method. By varying the ratio of thiol ligand to HAuCl4, temperature, and 
concentration of sodium borohydride to control the reduction rate, the size of synthesised Au NP 
could be modulated. 
 
Figure 1.1. Schematic illustrating the Brust–Schiffrin method for the synthesis of Au NPs, using a 
two-phase system and using thiol ligands as capping agents. Figure adapted from reference [5]. 
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Polymers were also used as capping/stabilising agents in Au NP synthesis. Common polymers 
included: poly(N-vinylpyrrolidone) (PVP), poly(ethylene glycol) (PEG), poly(vinyl alcohol) 
(PVA), polyethyleneimine (PEI), poly(methyl methacrylate) (PMMA), poly(N-
isopropylacrylamide) (poly-NIPAM) and chitosan [6-10]. Au NP size was generally controlled 
through varying the molar ratio of HAuCl4 precursor to polymer ligands. A few main approaches 
for the synthesis of polymer-stabilised Au NPs included: (i) utilising thiol-containing polymer for 
capping via Au-thiol interaction (‘grafting to’ approach) (ii) growing initiators bonded to the 
surface of Au NPs (‘grafting from’ approach), and (iii) physical adsorption of polymers. Other 
stabilising agents included: primary and aromatic amines, quaternary ammonium, carboxyls and 
hydroquinone. 
The type of surface ligands present on the surface of Au NPs would affect their physicochemical 
properties, hydrophilicity, surface charge, zeta potential, solubility and dispersibility. The suitable 
tailoring of such properties would have a great impact on their utility in biomedical applications, 
such as biosensing, drug delivery, cell targeting, as well as in vivo and in vitro bioimaging. For 
example, surface passivation of Au NPs using PEG would prevent and/or reduce non-specific 
protein adsorption and enhance retention in the body. This would prolong the use of Au NPs in in 
vivo imaging, and enhance the stability of Au NPs in complex matrices. In addition, the surface 
chemistry and ligands present would determine how biomolecules, such as nucleic acids, 
antibodies, peptides and carbohydrates, and other probes were further attached to Au NPs. Many 
approaches could be employed to functionalise Au NPs with biomolecules. As the thiol–Au bond 
is one of the most robust and facile chemical bonds, the use of thiol-containing biomolecules, such 
as thiol-conjugated nucleic acid or cysteine-containing peptides, for bioconjugation has been 
common. Other methods included utilising amine–Au binding, physical and electrostatic 
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adsorption, and hydrophobic interactions. In addition, the use of bi-functional stabilising agents, 
such as an alkanethiol or thiol–polymer containing carboxylic, amine or azide groups, would 
introduce chemical functionalities and allow subsequent Au NP functionalisation with 
biomolecules. Due to the many available means for functionalisation, Au NPs could be attached 
with a plethora of biomolecules or probes (Figure 1.2) that was specific to individual needs in 
various applications. 
 
Figure 1.2. Schematic illustrating the types of biomolecules available for functionalisation on Au 
NPs for various biomedical applications. Figure adapted from reference [11]. 
1.1.2 Localised surface plasmon resonance and its application in biosensing 
A biosensor is typically made up of a recognition component for probe–target binding or 
interaction, and a transducing element to convert such binding or interactions into quantifiable and 
identifiable signals [12]. Au NPs and other metal NPs have emerged as principal materials in 
biosensing and other biomedical applications due to their unique properties, such as tunable 
physical attributes, large surface-to-volume ratio, facile functionalisation procedures, high 
reactivity, multivalent targeting and multiplexing abilities, and high cargo capacity [13]. As such, 
Au NPs have been used as transduction materials in a wide range of applications, such as 
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biosensing and diagnostics, in vivo and in vitro bioimaging, and medical therapies. Additionally, 
their nanoscale dimensions allow Au NPs to overcome biological barriers and prevent their 
removal by the reticuloendothelial system, thus enabling their utility in point-of-care in vivo 
diagnostics [14]. Furthermore, other Au nanostructures, in particular gold nanorods (Au NRs), 
have also been employed for biosensing purposes due to facile synthesis methods, high 
monodispersity, and controllable aspect ratios, which were vital in determining their optical 
properties [15, 16]. 
Noble Au NPs and other Au nanostructures display localised surface plasmon resonance (LSPR), 
which results from incident photons on the NP surface inducing conduction electrons, known as 
plasmons, which oscillate at a resonant frequency [17]. This enables NPs to scatter and adsorb 
light with high intensity, giving rise to unique intense absorption peaks known as LSPR peaks. 
The LSPR peak was first resolved and elucidated by Mie’s solution to Maxwell’s equations 
describing spherical particles: 
𝜎𝑒𝑥 =  
24𝜋2𝑅3(ε𝑚)
2/3
𝜆
 ⋅  
ε2
[ε1 + 2ε𝑚]2 +  (ε2)2
 
where σex is the extinction cross section, R is the radius of particles (R ≪ λ, where λ is the 
wavelength of light), εm is the surrounding medium’s dielectric constant, and ε1 and ε2 are the real 
and imaginary parts of the metal’s dielectric constant, respectively. Compared to silver (Ag) and 
copper (Cu), the LSPR peaks are present in the visible spectrum and extend into the near-infrared 
(NIR) spectrum for spherical Au NPs and Au NRs, respectively. As such, Au NPs demonstrating 
LSPR are widely used as sensitive labels for biosensing [18-20], surface-enhanced Raman 
spectroscopy (SERS), and other diagnostic assays [21].  
(1.1) 
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Au NP-based LSPR biosensing is utilised ubiquitously as Au scatters light with a cross section 
that is 106 times that of a fluorescein dye and 103 times that of nanospheres of an assembly of 
fluorescein dyes of a similar size. In addition, Au NPs do not undergo photobleaching, enabling 
monitoring and visualisation over prolonged time frames. Biosensing based on the LSPR 
phenomenon generally relies on the aggregation or changes in the refractive index of Au NPs [12]. 
For aggregation-based techniques, aggregation is induced by NP–target interaction, charge 
screening by the addition of salt, or cross-linking of NPs due to natural phenomena, such as DNA 
hybridisation, chemical coupling and antigen–antibody interaction. When inter-particle separation 
decreases below the diameter of the NP, near-field electromagnetic coupling results in a red shift 
in their LSPR peaks (from ~ 520 nm towards 650 nm), thereby inducing a colour change from red 
to blue for Au NPs (Figure 1.3).  
 
Figure 1.3. (a) Colour change of Au NPs as they began to aggregate in the presence of an increasing 
concentration of Pb2+, from 0 to 1 µM (1 to 10), and (b) the corresponding spectral red shift from 
Au NP aggregation. Figure adapted from reference [22]. 
Colourimetric target detection based on aggregation has a potent impact on diagnostics, especially 
at the point-of-care (POC), since colourimetric changes based on the LSPR phenomenon are easily 
detected by the naked eye, without the need for specialised equipment. Both modified and non-
modified Au NPs can be used. Mirkin pioneered the use of cross-linking DNA-modified Au NPs 
in the detection of DNA [23]. In their seminal work (Figure 1.4), two different sets of Au NPs 
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were covalently modified, via Au-thiol interaction, with a different nucleic acid sequence 
conjugated on each set. Both sets of sequences were non-complementary. However, the target 
oligonucleotide served as a cross-linker for the two nucleic acid sequences, and in the presence of 
target strands, both sets of modified Au NPs aggregated reversibly, inducing a red to purple colour 
change. In addition, raising the temperature above the melting temperature of the probe–target 
hybrid allowed the cross-linked NPs to dissociate. 
 
Figure 1.4. Schematic illustrating the target-mediated cross-linking of covalently modified Au NP 
probes. Two sets of Au NPs were individually modified with oligonucleotides that were non-
complementary to each other. The target strand formed a sandwich, cross-linking the two 
oligonucleotide probes, and led to the reversible aggregation and a red-to-purple colour change. 
Figure adapted from reference [23].  
Colourimetric aggregation of Au NPs can also be used to transduce biological activities and events, 
such as the degradation of liposomes with phospholipase A2 (PLA2), via novel design of biosensing 
systems [24]. Figure 1.5a shows one such system where target PLA2 degraded liposomes that 
encapsulated a bifunctional polypeptide. The bifunctional polypeptide subsequently caused the 
9 
 
aggregation of Au NPs, which were conjugated with a synthetic peptide that hetero-associated with 
the bifunctional polypeptide. The aggregation was visible to the naked eye and the limit of 
detection (LOD) achieved was 0.7 nM. This system was later adapted for the development of a 
lateral flow device (LFD) (Figure 1.5c) [25], in which PLA2-degraded liposomes released multi-
arm biotinylated PEG linkers, which when mixed with polystreptavidin-conjugated Au NPs, 
formed a distinct red colour on a streptavidin-coated test line due to the plasmonic properties of 
the Au NPs. The LFD was able to detect serum human PLA2 down to a concentration of 1 nM. 
 
Figure 1.5. (a) Schematic illustrating the colourimetric detection of PLA2 using PLA2-mediated 
degradation of liposomes, leading to the release of encapsulated bifunctional complementary 
polypeptide. The bifunctional polypeptide subsequently hetero-associated with synthetic peptide 
on Au NPs surface, causing Au NP aggregation and (b) a spectral red shift. Figure adapted from 
reference [24]. (c) Schematic illustrating a lateral flow assay, where PLA2-degraded liposomes 
released encapsulated biotinylated-PEG linkers. The linkers subsequently cross-linked 
polystreptavidin-coated Au NPs, forming a multivalent NP network on the test line, generating a 
distinct red band that was visible to the naked eye. (d) Application of the LFD in the detection of 
serum human PLA2 (hPLA2). Figure adapted from reference [25]. 
Due to their ease of functionalisation, Au NPs can be chemically functionalised (most frequently 
using thiol-Au interaction) with appropriate ligands for biosensing applications, via specific 
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chemical reactions to elicit colourimetric responses. For example, the Griess reaction (Figure 1.4a) 
was utilized in the detection of nitrite (NO2
-) [26]. In that study, two populations of Au NPs, each 
conjugated with a different thiol ligand, were prepared (Figure 1.6c). One type of Au NP probes 
was modified to contain an aniline amide end group, while the other contained a naphthalene end 
group. The NO2
- target converted the anilamide into a diazonium salt, which was then able to 
couple with naphthalene, forming a covalently-linked aggregated network of Au NPs. This 
resulted in a colour change from red to blue (Figure 1.6b), and a drop in absorbance at 520 nm 
(Figure 1.6d) due to the red shift of the LSPR peak of Au NPs, which was originally at 520 nm. 
 
Figure 1.6. (a) The Griess reaction where a nitrite ion (NO2
–) was used to covalently link a 
sulfanilamide molecule and a naphthylethylenediamine molecule, yielding an azo dye. (b) 
Colourimetric changes of Au NPs upon the addition of increasing amount (clockwise) of NO2
– (in 
µM). (c) Schematic illustrating the conjugation of two populations of Au NP probes; one 
containing an anilamide end group and another containing a naphthalene, which could be cross-
linked covalently with a NO2
–. (d) Reduction in the absorbance at 520 nm with an increase in the 
concentration of NO2
–. The red dotted line indicates the maximum contaminant limit for NO2
–. 
Figure adapted from reference [26]. 
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In another study, the Cu+-catalysed alkyne-azide click chemistry (Figure 1.7a) was adopted to 
induce a colourimetric change of Au NP probes [27]. Similarly, two populations of Au NPs were 
prepared via thiol–Au interaction. One population contained an azide end group, while the other 
contained an alkyne end group (Figure 1.7a). In the presence of Cu2+ and the ascorbic acid target 
molecules, the ascorbic acid reduced Cu2+ to Cu+, which could then catalyse the 1,3-dipolar 
cycloaddition between the azide and alkyne groups. This cycloaddition reaction subsequently led 
to the cross-linking and aggregation of the two Au NP populations, producing a rapid red-to-purple 
colour change and a spectral red shift in the LSPR peak of the Au NPs (Figure 1.7b). 
 
Figure 1.7. (a, top) Cu+-catalysed 1,3-dipolar cycloaddition between azides and alkynes in a click 
reaction. (a, bottom) Schematic showing the two populations of Au NP probes where one 
population contained an azide end group while the other contained an alkyne end group. In the 
presence of the ascorbic acid target, Cu2+ in the solution was reduced, generating Cu+, which then 
catalysed the cycloaddition reaction, causing the aggregation of the two Au NP probes. (b) The 
aggregation yielded a colour change (red to purple) and a red shift in the LSPR peaks of the Au 
NP probes. Figure adapted from reference [27]. 
As a result of LSPR, Au NPs and other nanostructures, such as Au NRs, scatter light intensely, 
enabling single NPs to be observed by various optical methods, such as dark- and bright- field, 
and photothermal and differential interference contrast microscopies [17, 28]. In addition, due to 
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their ease of synthesis and size control, Au NPs that scatter light at different wavelengths can be 
easily prepared simply by tuning the size of the as-synthesised Au NPs (Figure 1.8a). Single NPs 
can be easily observed at relatively low magnification (100×) using dark-field microscopy and 
appropriate white light illumination (Figure 1.8b, c) [29]. Furthermore, unlike their fluorophore 
counterpart, Au NPs do not undergo photobleaching, and compared to semiconductor quantum 
dots (QDs), Au NPs are less cytotoxic [30]. As such, Au NPs have been readily utilised in 
bioimaging, biosensing and diagnostics applications. 
 
Figure 1.8. (a) Light scattering of Au NPs (40–160 nm, left to right) under a white light 
illumination. Dark-field microscopy imaging of (b) 58- and (c) 78-nm Au NPs, which appear 
greenish and yellowish, respectively, under 100× magnification. Figure adapted from reference 
[29]. 
Dark-field microscopy has been used to detect and distinguished cancerous cells from non-
cancerous ones [31]. Spherical Au NPs and anisotropic Au NRs were synthesised and conjugated 
with anti-epidermal growth factor receptor (EGFR) antibodies, and then incubated with both 
cancerous and non-cancerous cells. As cancerous cells overexpressed EGFR on the cell surface, 
the conjugated Au nanostructures should bind more readily with the cancerous cells. Figure 1.9 
shows the light scattering images of Au NPs (35 nm) and Au NRs (aspect ratio of 3.9) after 
incubation with both cancerous and non-cancerous cells. As non-cancerous cells have significantly 
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less EGFR expressed on their cell membrane, they did not interact specifically with the conjugated 
Au nanostructures, and were therefore indistinguishable (Figures 1.9a and c). On the contrary, due 
to the overexpression of EGFR, anti-EGFR antibody-conjugated Au nanostructures could bind 
easily to the cell surface of cancerous cells, and individual cancerous cells were easily identified 
(Figures 1.9b and d). Furthermore, as the Au NPs scattered light strongly at ~ 550 nm, they 
appeared yellowish, while Au NRs appeared reddish due to their intense longitudinal surface 
plasmon resonance in the NIR region (~ 900 nm). Also, the extinction coefficients at the LSPR 
peaks of both Au NPs and Au NRs were more than 2× that for cancerous cells, as compared to 
non-cancerous cells, confirming that Au nanostructures could be used for in vitro bioimaging and 
detection of cancerous cells. 
 
Figure 1.9. Dark-field light scattering images of Au NPs after incubation with (a) non-cancerous 
(human keratinocytes, HaCaT) and (b) cancerous cells (human oral squamous cell carcinoma, 
HSC) with corresponding extinction spectra on the right, as well as images of Au NRs after 
incubation with (c) non-cancerous and (d) cancerous cells with corresponding extinction spectra 
on the right. As Au NPs possessed LSPR peak in the visible region (~ 550 nm), they appeared 
yellowish. As Au NRs possessed longitudinal surface plasmon resonance at the NIR region (~ 900 
nm), they appeared reddish. Figure adapted from reference [31]. 
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Differential interference contrast (DIC) microscopy also provides high signal strength, contrast 
and spatial resolution for the imaging of Au NPs. This has allowed the location of individual NPs 
during in vitro and in vivo bioimaging. However, compared to dark-field imaging, which is based 
on light scattering, DIC imaging of Au NP is less susceptible to intense light scattering from large 
vesicles and the nucleus edge, which has allowed for the imaging of small Au NPs (5–10 nm) [28]. 
DIC microscopy uses two-beam interferometry to provide information on the sample optical 
density, and the use of interference allows sensitive enhancements of small features that have 
different refractive indices as compared to the surrounding media, while being insensitive to 
scattered light from environmental components [32]. Figure 1.10a shows a schematic for the 
working principle of DIC microscopy [33]. Transmitted light from a light source passes through a 
standard polariser below the condenser to produce plane-polarised light. The polarised light then 
enters a modified Wollaston prism, which consists of two cemented quartz pieces, where the light 
is split into two beams, ordinary and extraordinary beams. The split beams travel in slightly 
different directions and vibrate perpendicularly to each other, and therefore do not cause 
interference. The distance between the beams is the shear difference, and is less than the resolution 
of the objective lens to prevent double images. The beams then passes through the specimen, where 
differences in slopes, thickness and refractive indices cause a change in their wave paths. After 
passing through the objective lens, the beams are focused on the rear focus plane in a second 
modified Wollaston prism, which combines the beams. Due to transmittance through the specimen, 
the beams have differing path lengths for different regions of the specimen. Finally, the analyser 
brings the vibrations of the beams of differing path lengths into the same axis and plane, where 
interference occurs and the path differences due to different refractive indices within the specimen 
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are converted to different intensities. One side of the specimen is usually bright, and the other in 
shadow, giving a pseudo-3D image.  
The full width half maximum (FWHM) defines the optical resolution. The axial and lateral 
resolutions (FWHMaxial and FWHMlateral, respectively) are defined by the equations below [32]:  
𝐹𝑊𝐻𝑀𝑎𝑥𝑖𝑎𝑙 =  
0.88𝜆
𝑛 − (𝑛2 − 𝑁𝐴2)0.5
  
𝐹𝑊𝐻𝑀𝑙𝑎𝑡𝑒𝑟𝑎𝑙 =  
0.51𝜆
𝑁𝐴
 
where λ is the wavelength, n is the refractive index of the immersion oil and NA is the numerical 
aperture of the objective lens. Since DIC imaging makes use of the full objective lens and 
condenser NA, whereas dark-field imaging requires that the NA of the objective lens be smaller 
than that of the condenser in order to reject the transmitted illumination light, the optical resolution 
of DIC is smaller than that of dark-field microscopy. DIC microscopy for the imaging of Au NPs 
was used for the tracking of TAT-coated Au NP (40 nm) and its interaction with a live HeLa cell 
(Figure 1.10a), and for visualisation of DNA hybridization on a glass slide surface (Figure 1.10b) 
[28]. The ability to image single particles potentially allows DIC imaging of Au NPs to be used in 
highly sensitive biosensing applications. 
(1.2) 
(1.3) 
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Figure 1.10. (a) Schematic for the working principle of DIC microscopy [33]. (b) Tracking the 
endocytosis of a TAT-coated 40-nm Au NP (circle) by a live HeLa cell. Endocytosis began at t = 
10 min, and moved inside the cell over time as indicated by the changing z position, which was 
estimated by the movement of the vertical stage needed to keep the NP in focus. (b) DIC imaging 
of thiol-DNA functionalised Au NPs (30 nm), which were hybridised to its capture probe on the 
surface on an aminosilane-functionalised glass slide. Figure adapted from reference [28]. 
1.2 Diagnostics and Biomarkers 
1.2.1 Background 
Diagnostic tests are a crucial component of the healthcare system, giving patients and healthcare 
providers crucial information to make the correct medical decisions, enabling successful health 
and disease management. Diagnostics give us unbiased, quantitative measurements, usually of 
disease biomarkers, which are vital for monitoring and assessing each stage of healthcare, from 
prevention, early detection, and diagnosis to treatment. Specifically, molecular diagnostics detect 
and quantify the presence of biomarkers, which include genetic materials such as the genome, 
proteins, and pathogens such as bacteria and viruses, which are specific to a particular disease. In 
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addition, molecular diagnostics enable the study of disease mechanics at the genetic, protein or 
metabolite level, allowing healthcare providers and clinicians to optimise the efficacies of 
treatments and to provide personalised medicine for individual patients. Biomarkers refer to any 
biological molecules or characteristics that can be quantified so as to reflect a particular 
physiological or disease state. 
The glucose meter and home pregnancy test kit are some of the most ubiquitous diagnostic tools 
currently available as they are easy to operate and can be used virtually anywhere. The urine test 
strip is another facile platform for healthcare workers to detect proteins, glucose, bilirubin, 
hemoglobin, leucocytes and pathogens [34]. These straightforward and easy-to-use kits help 
provide important health statistics. More sophisticated diagnostic tests include immunoassays for 
the multiplexed detection of cancer biomarkers, such as prostate-specific antigen, 
carcinoembryonic antigen and cancer antigen-125. However, such tests are complicated to 
conduct, and require sophisticated instrumentation and skilled personnel [35]. 
The utility and availability of biosensors at the POC or developing nations for diagnostics offer 
tremendous help in disease management and save lives. However, lowering costs, and getting 
access to equipment and trained personnel are some of the major problems currently faced by 
health and humanitarian organisations [36]. The World Health Organization (WHO) have 
recommended that diagnostics for the developing nations should be affordable, sensitive, specific, 
user-friendly, rapid and robust, equipment-free and delivered (ASSURED). To this end, the use of 
nanotechnology in molecular diagnostics has propelled the development of novel and highly-
sensitive biosensors, and led to improvements in existing diagnostic devices. This has in part been 
aided by the unique plasmonic properties of nanomaterials, such as Au NPs. Their ease of synthesis 
and functionalisation, tailorable surface chemistry and optical properties, and large surface-to-
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volume ratio make Au NPs highly adaptable, enabling them to be manipulated in a myriad of 
different ways, giving rise to numerous novel biosensing systems. In addition, through intelligent 
design, the signal generated by gold nanostructures can be modulated via target interaction and for 
the detection of multiple analytes/pathogens. Also, minute amounts of Au NPs are able to generate 
strong optical, plasmonic or electronic signals, enabling facile integration into miniaturised devices 
[37]. Hence, Au NPs have been used as signal transducers (in both solution- and substrate-based 
systems) in biosensors aimed at the early detection and diagnosis of diseases. Some of the hurdles 
that need to be overcome for the use of diagnostic tools, especially at the POC, include generally 
low abundance of biomarkers, background noise, and non-specific binding of interferences in 
complex biological fluids and matrices. 
1.2.2 Micro-RNA 
Significant efforts have been made to developing novel, sensitive and inexpensive strategies for 
the detection of nucleic acids. This is due to the high impact and widespread applications that such 
technologies can have towards the diagnosis of infectious and genetic diseases, genome analyses 
and pharmacogenomics [38-40]. In addition, as genomic databases are rapidly expanding, there is 
an increasing need for the multiplexed detection of nucleic acids in order to realise efficient high-
throughput gene analysis. 
Traditionally, radio-labelled probes were employed to detection DNA hybridisation. In one such 
study, Whitney et al. demonstrated the use of 33P-dCTP-labelled cDNA probes, which were 
immobilised on a glass slide, for the low-noise and sensitive detection of trace RNA [41]. 
However, the use of radioactive material imposed additional sample preparation, as well as 
disposal problems and health risks, and required skilled personnel for handling. Since then, 
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numerous other nucleic acid detection assays utilising fluorophores [42], chemiluminescence [43], 
quantum dots (QDs) [44] and enzymes [45] were developed.  
Micro-RNAs (miRNAs) are single-stranded, non-coding RNA molecules (~ 22 nt in length) that 
regulate gene expression by binding to the 3’ untranslated region of target messenger RNAs 
(mRNAs), and then silencing their translation into functional proteins. In addition, miRNAs have 
vital roles in various biological pathways, such as cell proliferation, differentiation, apoptosis, and 
stress response [46]. Although miRNAs were first considered as cell-based biomarkers, recent 
studies have demonstrated that they also exist in extra-cellular forms, such as in the plasma, serum, 
saliva and urine [47, 48]. Of particular note, such circulating miRNAs were found to be resistant 
to RNase digestion; their expression levels were consistent and they could exist stably in body 
fluids [49]. Given such properties, miRNAs show great potential as novel and non-invasive 
biomarkers. 
The abnormal expression of miRNAs has been associated with various cardiovascular diseases 
such as hypertrophy, fibrosis and arrhythmias [50, 51], as well as cancers [48, 52]. Corsten et al. 
were one of the first to establish the potential of using human plasma miRNA as biomarkers for 
diagnostic applications [53]. They discovered that patients with acute myocardial infarction (AMI) 
had a 1600-fold increase in the expression of plasma miR-208b, a 100-fold increase of miR-499 
and a 4-fold increase of miR-133a (Figure 1.11). 
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Figure 1.11. Comparison of plasma miR-208b, miR-499 and miR-133a expression levels between 
patients with AMI and healthy people. Figure adapted from reference [53]. 
However, the detection of miRNA, especially directly from body fluids, may prove difficult due 
to their low abundance and short length, which gives rise to specificity issues. Yang et al. reported 
a simple sandwich assay for the detection of miRNAs using Au NPs, followed by Ag amplification 
for signal enhancement [54]. However, the authors may encounter difficulties in quantifying target 
miRNAs reliably as they utilised extremely short capture and detection probes, which may 
compromise specificity due to cross-hybridisation since short probes are unable to hybridise 
efficiently to their targets. Therefore, the type and design of capture probes can significantly affect 
the sensitivity, specificity and robustness of miRNA detection assays. 
To overcome the problem of low abundance of circulating miRNAs, Johnson et al. developed a 
Au-coated piezoelectric cantilever sensor for the sensitive, selective and sample preparation-free 
detection of serum miRNA [55]. The flow-based system used immobilised capture probes on the 
cantilever to capture target miRNA strands. Probe–target hybridization was then detected by a 
reduction in the resonant frequency of the cantilever (Figure 1.12a). Additionally, by subsequently 
hybridising a Au NP-tagged target verification probe to the initial target–probe complex in a 
second hybridisation reaction, signal amplification (~ 130%) was achieved across the entire 
dynamic range in the mass-based sensing system with a LOD of 4 fM. Furthermore, the continuous 
vibration of the cantilever reduced non-specific binding of background materials in the serum, 
enabling the sensor to perform equally for the detection of targets in buffer and serum (Figures 
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1.12b and c). Although a very low LOD was achieved, the system suffered from low target 
throughput, and the fabrication of cantilevers would require extra resources and skilled personnel, 
hampering the practical use of the sensor in resource-limited areas and at the POC. 
 
Figure 1.12. (a) Schematic illustration of the piezoelectric cantilever-based biosensing system for 
the detection of serum miRNA. Thiolated DNA capture probes were immobilised on the cantilever 
through thiol–Au binding. Capture probes subsequently hybridised with target miRNAs in the flow 
system. The hybridisation of target strands could be transduced via a reduction in the resonant 
frequency of the cantilever. Au NP-tagged verification probes could then be hybridised for signal 
amplification. (b) Comparison of the detection of 100 fM of target miRNA in serum and buffer. 
(c) Curve of the detection of miRNA let-7a. Figure adapted from reference [55]. 
1.2.3 Small molecules 
Small molecules, such as toxins, carcinogens, hormones, drugs of abuse, pharmaceutical drugs, 
antibiotics and nutrients, have significant effects on biological processes due to their ability to 
cross cell membranes [56]. They also have wide-ranging applications. In biology, they are used as 
signalling molecules or pigments in cells. In addition, they can be used as biomarkers in 
diagnostics for monitoring the level of antibiotics, as well as for tracking hormonal expressions in 
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the detection of diseases and physiological disorders. For example, an increase in the salivary 
concentration of cortisol by ~ 10-fold has been associated with Cushing’s syndrome [57, 58]. 
Blood cortisol levels are also used to determine the health of the pituitary or adrenal glands, and 
are affected by emotional stress, infection, or strenuous physical activities. In addition, the 
quantification of 17β-estradiol (estradiol), a type of steroid hormone, can be used to assess ovarian 
function [59] and the risk of breast cancer [60].  
Monitoring the level of pharmaceutical and therapeutic drugs in the plasma or serum can be used 
to assess treatment efficacy and for diagnostics. With such information, clinicians can personalise 
drug dosage to prevent adverse side effects, such as avoiding graft rejection or toxicity [61]. Also, 
the majority of pharmaceuticals, such as antibiotics, used for human therapy is often excreted 
unmodified, or as decomposed or converted side products. Combined with the disposal and 
incomplete removal of antibiotics, antibiotics often find their way into drinking water and also into 
the food and beverage industry. This antibiotic contamination promotes antibiotic resistance for 
bacteria and may pose threats to human health. For example, kanamycins, which are 
aminoglycosidic antibiotics used to treat bacterial infections, are also extremely ototoxic and 
nephrotoxic [62], hence it is vital to monitor residues of kanamycins in water or food sources for 
the proper management of public health. 
Conventionally, small molecules can be detected by several methods, such as radioactive and 
enzymatic immunoassays, and fluorescence polarisation [63]. However, due to specificity and 
false-positive issues, immunological methods typically only serve as screening assays for small 
molecules, such as cocaine, while a confirmation detection by chromatography and/or 
spectrometry are subsequently conducted [64]. High-performance liquid chromatography (HPLC) 
and gas chromatography coupled with mass spectrometry (GC-MS) have achieved specific and 
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sensitive detection of small molecules and are considered the gold standards, with LOD in the 
range of 1–50 ng/ml. When coupled with other spectroscopic methods, such as surface-enhanced 
Raman scattering (SERS) [65] and ion mobility increment spectroscopy (IMIS), detection 
sensitivity can be lowered [66]. However, such chromatographic and spectroscopic methods are 
usually complex, with slow results turnover, and require trained personnel as well as expensive 
instrumentation. As such, alternative methods have been developed, especially those incorporating 
nanotechnology, which are easier to conduct and equally sensitive. 
Evtugyn et al. developed a sensitive aptamer-based electrochemical sensor for the detection of 
ochratoxin A (OTA) [67]. Gold electrodes were first modified with poly-neutral red (Figure 1.13). 
Au NPs conjugated with thiolated OTA aptamers that specifically capture OTA molecules were 
embedded into the polymer matrix through drop casting. Au NPs enabled the direct electron 
transfer between the analyte and electrodes, without the need for electron mediators. In the 
presence of target OTA, binding between OTA and its aptamer caused an increase in the charge 
transfer resistance due to a conformation change of the aptamer, and target detection was measured 
by the increase in impedance. The impedimetric sensor was able to achieve a LOD of 0.02 nM, 
and was able to detect the presence of 5 nM of OTA that was spiked into beer samples. 
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Figure 1.13. (a) Schematic illustrating the sensing mechanism of the impedimetric sensor. OTA 
aptamer-conjugated Au NPs that are embedded into poly-neutral red-modified gold electrodes 
capture target OTA molecules, resulting in an increase in charge transfer resistance. (b) Nyquist 
plots demonstrating the increase in impedance with increasing concentrations of OTA, and the 
corresponding increase in charge transfer resistance with log OTA concentrations (inset). Figure 
adapted from reference [67]. 
Although the use of electrochemical methods has proven to be very sensitive and effective, specific 
instruments are required for such techniques. In contrast, colourimetric detection using the naked 
eye is very useful, especially in resource-limited areas and at the POC, due to its simplicity and 
equipment-free nature. Zhu et al. developed an interesting colourimetric method for the detection 
of cocaine via the release of Au NPs that were previously encapsulated in a DNA-polymer 
hydrogel matrix [68]. In their study, two DNA strands were conjugated to polyacrylamide 
polymers. In the presence of Au NPs and an aptamer linker strand, the three DNA strands were 
able to hybridise with each other, forming a cross-linked network of polyacrylamide, which 
eventually formed a gel (Figure 1.14) that encapsulated Au NPs. Subsequently, when target 
cocaine molecules were introduced to the hydrogel, aptamer-target binding resulted in the 
dissolution of the cross-linked network, causing the release of encapsulated Au NPs. However, the 
study only investigated the detection of 1 mM of cocaine, and the sensitivity of the assay could 
not be assessed. 
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Figure 1.14. (a) Schematic illustrating the working mechanism of the hydrogel sensor. The 
hydrogel network was formed when an aptamer linker hybridised with two DNA strands, each 
conjugated to polyacrylamide, in the presence of Au NPs. Upon addition of target molecules, 
aptamer–target interaction resulted in the dissolution of the hydrogel, causing the release of 
encapsulated Au NPs. (b) Photograph of the hydrogel before (left) and after (right) adding 1 mM 
of cocaine. The hydrogel was initially under a layer of Tris buffer, and after the release of Au NPs, 
formed a uniform red solution. Figure adapted from reference [68]. 
1.2.4 Protein antigens 
Proteins are the functional unit in biology and their expression can be used as biomarkers to reflect 
biological activities in cells and tissues. Aberrant protein expression is usually associated with 
disease states; hence, highly sensitive and specific detection of protein levels are crucial for clinical 
and molecular diagnostics. First utilised in 1983, CA-125 levels in the serum were used to 
distinguish patients with ovarian cancer from normal donors, whereby normal donors had serum 
CA-125 levels of ~ 35 U/ml, whereas patients with ovarian cancer had serum levels of 1–8000 
U/ml [69]. In addition, the prostate-specific antigen (PSA), which is a glycoprotein secreted by the 
prostate and bulbourethral glands, and the urethra lining, is used as a biomarker in the diagnosis 
of prostate cancer. Furthermore, β-amyloid levels in the cerebrospinal fluid are also used to 
diagnose patients with Alzheimer disease [70]. 
Besides the abnormal expression of plasma/serum proteins, specific autoantibodies produced by 
the humoral immune response (Figure 1.15), in response to their corresponding cancers, tumours 
or viruses, can also be used as biomarkers for disease detection, and studies have described the 
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production of autoantibodies in response to oncoproteins, and other mutated proteins such as p53 
[71, 72]. During humoral immune response, antigens produced by tumour cells stimulate antigen-
presenting cells (APC) to activate T-helper cells, which then proliferate, and in turn activate the 
B-cells. Through antigen-specific binding, the B-cells are localised to the tumour site, where they 
differentiate into plasma cells, which produce specific autoantibodies directed against the tumour 
antigens. Such autoantibodies serve as disease-specific biomarkers if the tumour antigens 
recognised are only produced in that specific type of tumour [73]. In addition, autoantibody 
production has also been observed for patients infected with human immunodeficiency virus 
(HIV), Epstein-Barr virus (EBV), cytomegalovirus (CMV) and hepatitis A, B and C viruses [74].  
 
Figure 1.15. Schematic illustrating the mechanism of the humoral immune response. Figure 
adapted from reference [73]. 
The enzyme-linked immunosorbent assay (ELISA) is currently one of the most commonly used 
technique for protein detection. However, its detection sensitivity may allow the detection of 
targets only after the protein biomarker has reached critical levels, by which time the diseases, 
such as cancer, may have reached their terminal stages, and any medical intervention then would 
be deemed too late. Although traditional radioactive immunoassays can achieve femtomolar 
detection limits, such assays are tedious and the need to isolate radioactive materials adds 
unnecessary complexities [75]. Au NPs, with their unique LSPR properties, can be used to amplify 
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detection signal, which alleviates the low sensitivity issues associated with conventional ELISA 
and enables early detection of diseases and timely medical treatment. 
The biobarcode technique [76] developed by Stoeva and Mirkin et al. was able to achieve 
multiplexed and highly sensitive (sub-femtomolar) detection of three protein biomarkers; PSA, 
human chorionic gonadotropin (HCG), and α-fetoprotein (AFP). In their study, three populations 
of 30-nm Au NP probes were prepared. Each population of Au NPs was dual-functionalised with 
an antibody, which recognised its specific target (PSA, HCG or AFP), and also a barcoded 
oligonucleotide strands (Figure 1.16a). Half of the barcoded oligonucleotide was unique for each 
Au NP population, while the other half was identical, serving as a universal sequence. In the 
capture phase of the assay (Figure 1.16b), three populations of magnetic microparticle (MMP) 
probes, which were each functionalised with a monoclonal antibody that recognised a different 
epitope from those on the Au NP probes, captured their respective target proteins and formed a 
sandwich with their corresponding Au NP probes. After magnetic isolation and washing of probes, 
the barcoded oligonucleotides were released via addition of an alkanethiol. In the detection phase 
(Figure 1.16c), the released barcoded oligonucleotides were added to a glass chip, where the 
unique portion was captured by their respective complementary strands that were immobilised on 
a specific region of the chip. The identical portion could then hybridise with 13-nm Au NPs, which 
were conjugated with the complementary sequence. With the use of the identical/universal 
sequence, only one population of 13-nm Au NP needed to be prepared. Capture of 13-nm Au NPs 
enabled visual readout; if target concentrations were too low, signal amplification could be further 
carried out by hydroquinone-mediated reduction of Ag+ ions on the surface of the Au NPs, and 
subsequently read by the scanometric method [77]. The assay was highly sensitive (low-pM 
detection of targets in undiluted serum) and highly selective, where signal was detected at the 
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intended region in various combinations of target mixture, with virtually no cross-contamination 
(Figure 1.16d). Nonetheless, the assay involved relatively complex procedures compared to 
standard ELISAs, and required specific equipment, especially for the scanometric detection, 
limiting its application at the POC. 
 
Figure 1.16. (a–c) Schematic illustrating the mechanism of the biobarcode assay in the detection 
of protein biomarkers for cancer diagnosis. (d) Scanometric detection of 13-nm Au NP on a glass 
chip. In the various combinations of target mixtures, positive signals are detected only when the 
target was present in the mixture. There was virtually no cross-contamination. Figure adapted from 
reference [76]. 
To eliminate the use of equipment, Qu et al. developed a colourimetric immunoassay, which 
incorporated the use of Cu+-catalysed cycloaddition between azides and alkynes (or click reaction) 
for the detection of target using the naked eye [78]. In their assay (Figure 1.17a), two populations 
of Au NPs were prepared, one was functionalised with an azide-presenting group, while the other 
was functionalised with an alkyne-presenting group. The model target antigen, HIV gp41 antigen, 
was immobilised on a solid substrate, followed by the binding of the primary antibody and copper 
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monoxide (CuO) NP-conjugated secondary antibody. Upon addition of HCl, the CuO NPs 
dissolved to release Cu2+ ions, which were then reduced by sodium ascorbate to Cu+. The Cu+ ions 
subsequently catalysed the cross-linking of the Au NPs, inducing a red-to-blue colour change after 
10 min of incubation. The detection system was assayed with a fixed concentration of gp41 
immobilised, while the CuO-conjugated secondary antibody was serially diluted. A colour change 
that was detectable by the naked eye was visible down to a 6400× dilution (~ 150 ng/ml) of the 
secondary antibody (Figure 1.17b). Although the assay could sensitively detect the diluted 
secondary antibody, it was done with a fixed concentration of gp41, which might have been in 
excess. As such, the binding kinetics of the primary and secondary antibodies would be higher as 
compared to when trace amounts of target were present. Therefore, the detection limit of the assay 
might not be as low or accurate as suggested. Nonetheless, the dissolution of the CuO NPs, which 
released a magnified amount of Cu2+ ions, contributed to signal amplification. Coupled with the 
intense LSPR generated by Au NPs, the assay could be more sensitive as compared to conventional 
ELISAs utilising horse radish peroxidase (HRP)-catalysed colourimetric changes. 
 
Figure 1.17. (a) Schematic illustrating the naked eye detection of target antigen. After 
immobilisation of the antigen, followed by the binding of the primary antibody and CuO NP-
conjugated secondary antibody, the CuO NPs were dissolved by HCl, releasing Cu2+ ions. Sodium 
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ascorbate in the solution reduced Cu2+ to Cu+, which then catalysed the cross-linking of azide- and 
alkyne-presenting Au NPs, resulting in a red-to-blue colour change. (b) Photographs showing the 
colour change with decreasing dilutions of the CuO NP-conjugated secondary antibody, in the 
presence of a fixed amount of target gp41 antigen. Figure adapted from reference [78]. 
1.2.5 Biomarkers studied in this thesis 
This thesis examined novel methods for the detection of various target biomolecules: micro-RNA-
208b, which can be used to detect acute myocardial infarction (upregulation by 1,600×) [53]; 
ochratoxin A, which is a mycotoxin found in red wine; cocaine, which is a drug of abuse typically 
tested for law enforcement purposes; 17β-estradiol, which is detected for the assessment of ovarian 
function and breast cancer; and prostate specific antigen, which is used for the diagnosis of prostate 
cancer. Table 1.1 below highlights the detection capabilities of current gold standard tests for these 
analytes. 
Currently, the measure of blood cardiac troponin, which is an important cardiac marker, is vital in 
assessing patients with acute myocardial infarction [79]. Troponin I and troponin T are the 
clinically relevant markers measured; an increased blood troponins level indicates damage to the 
myocardium. In particular, the use of POC tests for the quantification of cardiac troponins is able 
to significantly reduce assay turnaround duration, as compared to centralised laboratory testing, 
and is more able to meet the recommended time, between drawing of blood and test results, of ≤ 
60 min [80]. Nonetheless, POC tests are less sensitive compared to laboratory testing, and may be 
less reliable in ruling out the onset of acute myocardial infarction [81]. 
For the detection of small molecules, such as ochratoxin A, cocaine and estradiol, gold standard 
detection techniques include HPLC and GC-MS [62]. Ochratoxin A detection are usually 
chromatography-based, utilising the natural fluorescent of the analyte for detection [82]. Lateral 
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flow devices based on immunoassays have been developed for more rapid analyte detection [83]. 
Similarly, the detection of cocaine from patient urine or blood samples in toxicology laboratories 
has generally relied on GC-MS as the gold standard detection technique, whereas immunoassay-
based lateral flow devices have been developed for rapid on-site screening purposes [84]. Toxic 
endocrine disrupting compounds, such as estradiol, are typically detected using HPLC-MS [85], 
while rapid immunoassays have also been developed for fast detection of estradiol.  
The detection of protein targets, such as PSA, are usually detected using immunoassays, such as 
the enzyme linked immunosorbent assay (ELISA), to take advantage of the specific interaction 
between antigen and antibodies. In addition, lateral flow chromatographic immunoassays, for rapid 
and semi-quantitative detection of PSA, have also been developed. 
Table 1.1. Standard diagnostic tests for the analytes studied in this thesis. 
Test Analyte 
Limit of 
Detection 
Time to 
Result 
POC – Fluorescent Immunoassay 
(Alere Triage® troponin I) 
Troponin I 20 pg/mL 15 min 
Lab – Immunochemiluminescent 
(Siemens ADVIA Centaur® TnI-Ultra®) 
Troponin I 6 pg/ml 20 min 
POC – Lateral Flow 
Ochratoxin 
A 
1–10 ng/ml 
10–15 
min 
Lab – HPLC 
Ochratoxin 
A 
10 pg/ml 
(0.02 nM) 
2 h 
POC – Lateral Flow 
(Cozart® Rapid Urine Cocaine Test) 
Cocaine 
300 ng/ml 
(1 µM) 
5–10 min 
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Lab – GC-MS Cocaine 
1 ng/ml 
(3 nM) 
1.5–2 h 
POC – 1-Step Chemiluminescent Immunoassay 
(DiaSorin LIAISON® Estradiol Assay) 
17β-
estradiol 
12 pg/ml 
(0.04 nM) 
0.5 h 
Lab – Ultra-HPLC 
17β-
estradiol 
5 pg/ml 
(0.02 nM) 
1.5–2 h 
POC – Lateral Flow 
(Instant-View PSA Whole Blood Test) 
PSA 4 ng/ml 4–7 min 
Lab – ELISA  
(PSA AccuBind® ELISA Kit) 
PSA 0.5 ng/ml 45 min 
 
1.3 Overview of the Thesis and Scientific Contributions 
In this thesis, three novel biosensing and diagnostic platforms were developed using biomolecule-
conjugated Au NP complexes, as well as via the controlled growth and synthesis of anisotropic 
gold nanostructures (branched Au NPs and Au NRs); the detection mechanisms are further 
elucidated. The platform and assays developed were used to detect several major classes of 
biomarkers, namely nucleic acid (micro-RNA), small molecules (ochratoxin A, cocaine and 17β-
estradiol) and protein antigen (prostate specific antigen), where the quantification of their levels 
in biological and complex fluids could be used for diagnostic purposes. 
Circulating miRNAs are increasingly used as biomarkers in disease diagnostics and screening. 
However, their short length has given rise to specificity issues in their detection. In addition, 
although the polymerase chain reaction (PCR) has allowed for the very sensitive detection of trace 
nucleic acid targets, it would be more beneficial for POC applications if biological samples could 
be assayed directly with minimal sample preparation. However, researchers also face non-specific 
binding issues when directly probing biological fluids, such as serum or plasma. Chapter 2 
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describes the development of a nucleic acid-based microarray, which used designer hairpin capture 
probes to improve the specificity in the detection of disease-specific miRNA. Additionally, surface 
functionalisation of the microarray platform using carboxyl-polyethylene glycol minimised non-
specific adsorption of biological materials in complex body fluids, allowing highly sensitive and 
specific detection of target miRNA directly from unprocessed human serum. Furthermore, the use 
of Au NP-conjugated signalling probe allowed direct imaging of the Au NPs using DIC 
microscopy under a basic laboratory optical microscope, without the need for highly sophisticated 
equipment. 
Aptamers are single-stranded nucleic acid strands that can bind to various targets, such as cells, 
proteins and small molecules. They are seen as a good alternative to antibodies in target detection 
due to their lower cost of synthesis and greater stability against denaturation. Highly sensitive 
colourimetric biosensors based on aptamer–Au NPs have been reported previously; however, a 
vast majority of them were based on Au NP aggregation, which might be affected by electrolytes 
present in complex matrices. Chapter 3 introduces a new concept of target detection via the 
controlled growth of aptamer-functionalised Au NP probes. 5-nm Au NP probes either grew into 
Au NP with a branched morphology (blue-coloured solution) in the presence of low target 
concentration, or into spherical Au NP (red-coloured solution) when target concentration was high. 
The assay was rapid and versatile, and the changes in morphology could be detected by the naked 
eye. Furthermore, the assay readily detected target small molecules from complex matrices, i.e. 
OTA from red wine, cocaine from synthetic urine, and estradiol from synthetic saliva, after simple 
sample preparation. 
The controlled isotropic/anisotropic synthesis of Au nanostructures to tailor their physical 
properties presents an effective avenue to harness their plasmonic properties in biosensing 
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applications. In particular, the seed-mediated synthesis of Au NRs has been widely studied and 
utilised due to the ease of control over the NR dispersity, size and shape, and the ability to tune 
the longitudinal LSPR peaks of NRs across a broad spectral range (visible to NIR) by controlling 
the aspect ratio of the Au NRs. Chapter 4 demonstrates the use of small molecules to control the 
growth of Au NRs, where NRs of different aspect ratios could be produced. Depending on the 
small molecule and its interaction with the seed particle, the aspect ratio of grown Au NRs either 
decreased or increased. Small molecules, such as 4-aminophenyl phosphate, which acted as 
capping agents for the Au seed particles via NH2–Au interaction, would prevent the anisotropic 
growth of Au NRs, hence Au NRs with decreasing aspect ratios were obtained. 4-aminophenol, 
which served as a reducing agent on the Au seeds, would promote the anisotropic growth of Au 
NRs via increasing the concentration of the seed particles, and Au NRs with increasing aspect 
ratios were obtained. In addition, the small molecules could be generated from enzymatic activity 
from their precursors; 4-aminophenol could be generated from the dephosphorylation of 4-
aminophenyl phosphate by alkaline phosphatase. The use of 4-aminophenol as a modulator of Au 
NR growth was novel and has not been previously described in the literature. Alkaline phosphatase 
was incorporated into an ELISA assay for the detection of PSA, which was a biomarker for prostate 
cancer. Due to the sensitive change of the longitudinal LSPR peaks in response to changes in the 
aspect ratio of Au NRs, highly sensitive detection of PSA was achieved. Validation of the assay 
using serum samples of known PSA levels was conducted, whereby proportionate changes in the 
longitudinal LSPR peaks of grown Au NRs in relation to PSA levels were obtained. 
Chapter 5 summarises the findings of this thesis, and proposes future work to improve upon the 
presented biosensing platforms, along with future research directions. 
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Chapter 2 : A Microarray Platform for Detecting Disease-
Specific Circulating miRNA in Human Serum 
The majority of the data described in this chapter has been published in S. Roy, J.H. Soh, and J. 
Y. Ying, A Microarray Platform for Detecting Disease-Specific Circulating miRNA in Human 
Serum. Biosens. Bioelectron., 2016. 75: p. 238-246 [86]. 
2.1 Introduction 
The rapid and sensitive detection of sequence-specific nucleic acid sequences is important for 
timely and accurate molecular diagnostics. The advent of the PCR has brought about tremendous 
improvements in diagnostics due to its ability to amplify target nucleic acid strands, thus achieving 
sensitivity levels of 5–10 copies [87]. However, PCR is complex, labour-intensive and time-
consuming, therefore, it is unlikely to find widespread application outside of a research or clinical 
laboratory, especially at a POC setting. In addition, due to the inherent competition among 
different primers [88] and lengthy optimisations required to detect several targets simultaneously 
[14], the ability of PCR to carry out rapid, multiplexed target detection is severely hampered. This 
can be detrimental as the diagnosis of certain diseases, such as cancer [89], which may require the 
simultaneous detection or tracking of multiple targets.  
To enable rapid and multiplexed target detection, much effort has been devoted to the development 
of nucleic acid-based microarrays. Due to their highly parallel nature, such microarrays are 
routinely employed for genome analysis, and discovery and detection of biomarkers, and analysis 
of genetic mutations, such as single nucleotide polymorphism (SNP) and chromosomal anomalies 
[90]. Briefly, for target detection on microarrays, a library of short (20–70 nt) [91] nucleic acid 
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probes or primers are immobilised on microfabricated arrays on solid substrates, to achieve highly 
parallel detection of diverse targets. Subsequently, target nucleic acid strands can be extracted 
from samples and labelled with fluorescence or radioactive labels for signal transduction, before 
being added to the probes for target-probe hybridisation. However, extraction and labelling of 
target strands would constitute additional sample preparation, which may increase turnaround time 
and hamper the timely detection of diseases. If no extraction or labelling is needed, an additional 
signalling or reporting probe, containing a signal transduction element, such as fluorescent dyes 
or Au NPs, is usually used to form a sandwich with the target–probe hybrid.  
Fluorescence is commonly used for signal generation on nucleic acid-based microarrays; however, 
these are usually limited by their sensitivities, with detection limits in the picomolar range [92-
94]. Various strategies were developed to increase the fluorescence signal, for instance, using SiO2 
substrate to enhance the fluorescence from Cy3 dyes after positioning the dyes at an optimised 
distance from the substrate surface [95]. Also, the introduction of cationic surfactant, such as 
cetyltrimethylammonium bromide (CTAB), to FAM-labelled targets was found to enhance the 
fluorescence intensity by 26×, and increased the contrast for SNP detection from 1.3–15× [96]. 
Despite significant efforts, fluorescent-based detection may prove difficult for the direct detection 
of nucleic acid targets from biological fluids, which is usually in the femto to sub-femtomolar 
range. The use of plasmonic Au NPs can help improve the limit of detection. Nam and Mirkin et 
al. developed an assay using bio-bar-code DNA-mediated amplification, followed by the 
immobilisation of Au NP-tagged reporting probe and silver enhancement on a solid platform, and 
achieved attomolar detection limit [87], which could rival that of PCR. However, the assay 
contained multiple steps, which may be complicated to perform, and required specialised 
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equipment to image the silver-enhanced Au NPs. A balance between assay complexity and 
detection sensitivity must therefore be reached.  
As mentioned in Section 1.2.2, circulating miRNAs (18–24 nt) present in plasma, serum, saliva, 
and urine have emerged as potential disease biomarkers due to their resistance to RNase and stable 
expression in such body fluids. In addition, aberrant expression of circulating miRNAs is linked 
to cancer, cardiovascular diseases, abnormal pregnancies, and diabetes. However, reliable 
detection of such short nucleic acid may be challenging since the annealing temperature is low, 
which reduces the hybridisation stringency and increases the rate of false positive. In addition, 
selective and specific target detection is further challenged as members within a miRNA family 
have high sequence homology, with as few as a single base difference in sequence. From 
thermodynamic analysis, a structurally constrained nucleic acid probe, i.e. probes having a 
secondary structure as opposed to being linear, can increase the specificity of target–probe 
recognition [97], and the use of probes containing a stem-loop (hairpin) structure can mediate the 
recognition of SNP among various DNA targets [98]. 
Through RNA profiling of plasma from patients with acute myocardial infarction (AMI), Corsten 
et al. discovered that patients with AMI demonstrated a 1,600-fold and 100-fold increase in the 
expression of plasma miR-208b and miR-499, respectively. Furthermore, the expression of these 
cardiomyocyte-specific miRNAs correlated well with that of circulating troponin T, demonstrating 
a potential role of these miRNAs as biomarkers for the diagnosis of AMI [53]. Typically, miRNAs 
are transcribed in a same manner as pre-messenger RNAs, during which miRNAs undergo 
endonucleolytic cleavage, nuclear export and strand selection to form single-stranded mature 
miRNAs. Mature miRNAs may then be transferred and bound to Argonaute proteins for RNA 
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silencing processes [99]. Conversely, mature miRNAs may also circulate freely and stably, 
resistant to RNase degradation, in the blood stream where they serve as important biomarkers [53]. 
Differential interference contrast (DIC) microscopy is an imaging technique that relies on 
differences in refractive indices within the media to create high-resolution, pseudo-3D images, and 
provides a relatively convenient mean for NP imaging using a standard optical microscope. The 
use of plasmonic Au NPs as imaging probes is particularly advantageous since they have a large 
apparent refractive index, enabling high DIC contrast [100]. Furthermore, background noise is 
reduced since homogeneous media do not induce a significant difference in optical path length and 
refractive index. In addition, Au NP-based imaging is less susceptible to photobleaching and 
spectral crosstalk compared to fluorescence-based detection. 
For POC applications, it is preferable that target detection is conducted without tedious sample 
preparation, such as RNA extraction, PCR amplification and target labelling. In addition, sample 
collection should be minimally invasive, in contrast to tissue biopsies. Human serum is a good 
matrix in this regard. However, non-specific adsorption is a critical issue when applying such 
biological fluids directly to microarrays due to the presence of over 20,000 proteins [101], over a 
large concentration range, from 50 mg/ml (albumin) [102] to < 1 pg/ml (troponin) [103]. The 
presence of even a small amount of protein can lead to adhesion and propagation of unwanted 
biofouling. Traditional methods for preventing non-specific protein binding include the use of 
bovine serum albumin (BSA) or non-fat milk to block the surfaces of microarrays. However, these 
methods are not the most effective, and noise from the adsorption of low amounts of proteins may 
affect detection sensitivity. Furthermore, the huge size of BSA may hinder probe–target 
interactions [104]. More recently, the use of polymer coatings have been employed as anti-
biofouling materials. In particular, poly(ethylene glycol) (PEG) has been widely used as it has high 
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protein-resistant properties, and minimises non-specific protein adsorption due to its low 
interfacial energy, non-adhesive property and high mobility [105]. The non-specific binding of 
IgG to PEG coating is about 28 ng/cm2 compared to 500 ng/cm2 on fluorinated silane [106], and 
that of albumin and fibrinogen is 50 to 100 ng/cm2 on PEG compared to 600–700 ng/cm2 on bare 
silicon surface [107]. 
In this chapter, a highly sensitive and selective microarray platform is described. The platform was 
functionalised with a PEG-passivated layer, and utilised hairpin capture probes (CPs), for the direct 
detection of disease-specific miRNA from unprocessed human serum, via DIC imaging of Au NP-
tagged signalling probes. Our model target was miR-208b, which can be quantified to detect 
patients with acute myocardial infarction, in which circulating miR-208b in the serum is 
upregulated by 1600× [53]. In addition, the multiplexing capability of the microarray was 
demonstrated, and compared to linear CPs, hairpin CPs was shown to be better at discriminating 
single-base mismatches within members of the let-7 miRNA family. 
2.2 Experimental Section 
2.2.1 Materials 
Plain microscope glass slides purchased from VWR International (West Chester, PA) with 
dimensions of 25 mm × 75 mm × 1 mm were used for surface functionalization and fabrication of 
microarrays. Synthetic miRNA targets, aminated oligonucleotide CPs, and thiolated 
oligonucleotide SPs (Table 1) were custom-made by Sigma-Aldrich (Singapore). 3-aminopropyl 
triethoxysilane (APTES), N-ethyl-N’-(3-dimethylaminopropyl) carbodiimide (EDC), 
N-hydroxysulfosuccinimide sodium salt (sulfo-NHS), Zonyl® FSN fluorosurfactant, 5 M sodium 
cyanoborohydride (NaBH3CN) solution and sterile-filtered human serum were purchased from 
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Sigma-Aldrich (St. Louis, MO). Human serum was obtained from healthy human male type AB 
plasma in the USA, sterile-filtered by the manufacturer, and used in this study without further 
processing. Glutaraldehyde (25%) and toluidine Blue O (TBO) dye were purchased from Merck 
KGaA (Darmstadt, Germany). Carboxyl–PEG–amine, COOH-(C2H4O)24-C2H4-NH2 (MW = 1 
kDa) was purchased from Nanocs Inc. (New York, NY). 5-nm Au nanoparticles (NPs) were 
obtained from BB International (Cardiff, UK). Dithiothreitol (DTT) was purchased from Gold 
Biotechnology, Inc.® (St. Louis, MO). All solutions were prepared with nuclease-free water, 20× 
saline sodium citrate (SSC) and 1× phosphate buffered saline (PBS), purchased from 1st Base Pte. 
Ltd. (Singapore).  
The glass slides were treated with oxygen plasma using a CD300 gas plasma system from 
Europlasma NV (Oudenaarde, Belgium). Thermal curing of the glass slides was conducted in a 
RTP-6 infrared lamp heating system from Ulvac-Riko, Inc. (Methuen, MA). Microarrays were 
printed on functionalised glass slides using the SpotBot® 3 Personal Microarrayers (Sunnyvale, 
CA). Absorbance was measured with an Infinite® M200 microplate reader (Tecan Group Ltd.). X-
ray photoelectron spectroscopy (XPS) measurement and data processing were performed by June 
Ong from the Institute of Materials Research and Engineering (IMRE), Singapore. 
Table 2.1. Sequence information of the oligonucleotides used in this study. Bolded sequences are 
complementary to their respective target miRNAs, and sequences in italics are complementary to 
the Au NP- or Cy3-conjugated SPs. 
Annotation Sequence 
Hairpin (HPN) CP for 
miR-208b 
5’–NH2-(CH2)6-TTT TTC CGC GCA CAA ACC TTT TGT 
TCG TCT TAT TTA ATA TAT GCG CGG GCG–3’ 
has-miR-208b 5’–AUA AGA CGA ACA AAA GGU UUG U–3’ 
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HPN CP for miR-335 5’–NH2-(CH2)6-TTT TTC CGC GCA CAT TTT TCG TTA 
TTG CTC TTG ATT AAT ATA TGC GCG GGC G–3’ 
has-miR-335 5’–UCA AGA GCA AUA ACG AAA AAU GU–3’ 
SP HPN–thiol 5’–RS-S-(CH2)6-TTT TTT CGC CCG CGC A–3’ 
SP HPN–Cy3 5’–Cy3-TTT TTT CGC CCG CGC A–3’ 
HPN CP for let-7a 5’–NH2-(CH2)6-TTT TTC CGC GCA ACT ATA CAA CCT 
ACT ACC TCA TTA ATA TAT GCG CGG GCG–3’ 
Linear CP for let-7a 5’– NH2-(CH2)6-TTT TTT AAC TAT ACA ACC–3’ 
has-let-7a 5’–UGA GGU AGU AGG UUG UAU AGU U–3’ 
has-let-7b 5’–UGA GGU AGU AGG UUG UGU GGU U–3’ 
has-let-7f 5’–UGA GGU AGU AGA UUG UAU AGU U–3’ 
has-let-7g 5’–UGA GGU AGU AGU UUG UAC AGU U–3’ 
SP linear let-7a–thiol 5’–TAC TAC CTC ATT TTT T-(CH2)3-S-SR–3’ 
 
2.2.2 Functionalisation of glass slides 
The procedure for functionalizing glass slides is outlined in Fig. 2. Before functionalization, the 
glass slides were cleaned in Piranha solution (H2SO4:H2O2 = 3:1) at 120°C for 2 h. Caution: 
Piranha solution is highly oxidizing, corrosive, reactive and potentially explosive, therefore, 
appropriate personal protective equipment (i.e. neoprene apron and face shield) should be worn at 
all times when handling it. Following Piranha treatment, the glass slides were rinsed thoroughly 
with deionized (DI) water and dried in nitrogen gas. The glass slides were then treated with oxygen 
plasma at 200 W for 10 min. 
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Subsequently, to introduce primary amine groups on the surface, the glass slides were immersed 
in 5% (v/v) APTES (in ethanol) solution for 2 h at room temperature with gentle shaking. They 
were then rinsed thoroughly with pure ethanol and dried with nitrogen. Next, the glass slides were 
thermally cured at 110°C for 16 h. For the addition of surface aldehyde groups, the glass slides 
were immersed in 4% glutaraldehyde (diluted in 1× PBS) solution containing 50 mM NaBH3CN 
at room temperature for 2 h with gentle shaking. The slides were cleaned with 1× PBS and dried 
with nitrogen. Finally, to introduce a PEG layer containing surface carboxyl groups, the glass 
slides were immersed in 500 mM of carboxyl–PEG–amine (dissolved in 1× PBS) solution 
containing 50 mM NaBH3CN at room temperature overnight with gentle shaking. After treatment 
with carboxyl–PEG solution, the slides were washed with 1× PBS, and dried with nitrogen. 
2.2.3 Quantification of surface carboxyl group 
Surface density of carboxyl groups on the glass slides was determined through evaluating the 
staining of basic TBO, following published procedure [108]. TBO is a cationic blue dye derivative 
of phenothiazine (C12H9NS), which binds electrostatically to the negatively charged carboxyl 
group on the surface of the glass slides. The glass slides were immersed in 0.5 mM TBO solution 
(pH 10, adjusted with NaOH). Complexation between TBO and the carboxyl groups was 
conducted at room temperature for 5 h with mild shaking. During complexation, a calibration curve 
was constructed, where the absorbance of TBO solutions (in 50% acetic acid) at varying 
concentrations were measured. The maximum absorbance of the TBO molecules was determined 
to be 633 nm, and all absorbance values were taken at 633 nm. 
2.2.4 Immobilisation of CPs on functionalised glass slide for microarray production  
In order to facilitate reaction between primary amine and carboxyl groups for the immobilization 
of aminated CPs, the glass slides were immersed in a solution containing 5 mM EDC and 10 mM 
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sulfo-NHS (in 0.1 M 2-(N-morpholino)ethanesulfonic acid (MES) buffer, pH 5). This activated 
the surface carboxyl groups for the spontaneous reaction with primary amines, as EDC and sulfo-
NHS would react with the carboxyl groups to form amine-reactive sulfo-NHS esters. The 
activation reaction was conducted at room temperature for 6 h with gentle shaking. Next, the glass 
slides were briefly washed with nuclease-free water and dried with nitrogen. 10 μM of aminated 
hairpin or linear CPs was then dissolved in 5× SSC (pH 7), and spotted in a microarray format 
using the SpotBot 3 microarrayer. Immobilization of the CPs was performed at room temperature 
overnight. Subsequently, the glass slides were washed in 5× SSC buffer, and then briefly in 
nuclease-free water to remove unbound CPs. 
2.2.5 SP–Au NP conjugation 
Conjugation of the single-stranded thiolated SP to Au NP was conducted following a published 
procedure [109]. Briefly, 100 μM thiolated SPs were treated with 0.1 M DTT (dissolved in 
nuclease-free water) at room temperature for 2 h, and then purified using a NAP-5 column (GE 
Healthcare). Stock Au NP solution was first incubated with 0.05% FSN for 15 min at room 
temperature. Next, NaCl solution was added to achieve a final concentration of 1 M. The solution 
retained its red color as the non-ionic FSN was able to stabilize the Au NPs against aggregation 
induced by the addition of salt (NaCl). 2 μM thiolated SPs were then added, and the conjugation 
reaction was conducted at room temperature for 2 h. Thereafter, non-conjugated thiolated SPs were 
removed by centrifugation at 16,000 g for 45–60 min. The SP‒Au NP conjugates were 
resuspended in 0.1 M of PBS (pH 7). This process was repeated 3‒5 times for complete removal 
of non-conjugated thiolated SPs. 
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2.2.6 Hybridisation of target miRNA and SP on the microarray 
miRNA targets of varying concentrations (1 fM–100 nM), dissolved either in 20 µl of 5× SSC 
buffer or in commercially obtained human serum, were applied to the immobilized CPs for CP‒
target hybridization. Hybridization was allowed to occur at room temperature over 6 h. The glass 
slides were then washed 3 times with 1× SSC buffer (1 min each) at 40°C, and with 5% ethanol 
(in nuclease-free water) for 30 s, with moderate shaking. After washing, the glass slides were dried 
with nitrogen. 
Next, thiolated or Cy3-labelled SPs were added to the CP‒target hybrid, and hybridization was 
allowed to occur at room temperature over 6 h. Lastly, the same washing steps were performed, 
except that they were conducted at room temperature. 
2.2.7 Detection of miRNA targets using DIC imaging of Au NPs 
miRNA targets were quantified through DIC imaging of Au NPs using an Olympus IX 81 
microscope, which was equipped with Nomarski prisms and a computerized stage control. 
Visualization of the Au NPs was done under 60× magnification with 100 ms of exposure. 
Estimation of the surface coverage of Au NPs was conducted using the Metamorph® software 
(Molecular Devices, Inc., Sunnyvale, CA). 
2.2.8 Detection of target sequence mismatch 
Hairpin or linear CPs for the hsa-let-7a target (Table 2.1) were immobilized onto carboxyl–PEG 
functionalised glass slides following the procedures described earlier. Next, 100 nM of each of 
hsa-let-7a, hsa-let-7b, hsa-let-7f and hsa-let-7g targets (dissolved in 5× SSC buffer) was spotted 
onto a microarray with hairpin CPs, and on another microarray with linear CPs. Subsequent SP 
hybridization and DIC imaging steps were conducted as described earlier. The signal intensities 
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for the above set of miRNAs with high sequence homology were analyzed to substantiate the 
efficacy of the hairpin CPs in discriminating sequence mismatch over their linear counterparts. 
2.3 Results and Discussion 
2.3.1 Mechanism for the detection of miRNA targets 
The principal steps for the detection of miRNA on the microarray is shown in Figure 2.1 below. 
Hairpin-structured CPs (amine-modified) were immobilised on carboxyl–PEG functionalised 
glass slides via EDC/sulfo-NHS coupling (Figure 2.1a). The region complementary to the target 
miRNA was contained within the loop region (highlighted). When target miRNA strands were 
present, the hairpin structure would unfold, forming a probe–target hybrid (Figure 2.1b). In 
addition, the unfolding of the hairpin structure would expose the stem region, which was 
complementary to the SPs. Subsequently, Au NP-tagged SPs could then hybridise with the exposed 
stem (Figure 2.1c). The Au NPs represented a target–probe hybrid and could be imaged using DIC 
microscopy, where the amount of Au NPs correlated with the target concentration. 
However, in the presence of a non-complementary or mismatched strands, the CPs would retain 
their hairpin structure (Figure 2.1b, green) since these strands were less likely to hybridise with 
the CPs and cause a structural change. Consequently, the CPs would remain folded and the Au 
NP-conjugated SPs would be unable to hybridise with the stem region (Figure 2.1c, green), thus 
reducing false-positives and increasing specificity of the platform.  
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Figure 2.1. Schematic illustration of the miRNA detection assay on a microarray, which is 
produced on a carboxyl–PEG functionalised glass slide. (a) Immobilization of hairpin CPs. (b) 
CP‒target hybridization at the loop region. (c) CP‒SP hybridization at the stem region. 
2.3.2 Surface functionalisation of glass slides 
The process for the surface functionalisation of glass slides are illustrated in Figure 2.2. O2 plasma 
treatment would activate silanol groups on the surface of the glass slides (Figure 2.2a), enabling 
silanization with APTES (Figure 2.2b). Subsequent thermal curing for 16 h at 110°C would 
promote condensation and cross-linking of siloxane linkages, forming a monolayer of APTES 
(Figure 2.2c). The cross-linked siloxane prevents the hydrolysis of the APTES monolayer [110], 
enabling a more stable APTES functionalisation. Glutaraldehyde acts as a cross-linker for the 
covalent attachment of carboxyl–PEG–amine to the APTES layer, by first forming a Schiff base 
(R3N=C R1R2) with the amine group of APTES (Figure 2.2d), and another Schiff base with the 
amine group of the carboxyl–PEG–amine (Figure 2.2e). The formation of Schiff base is 
spontaneous at RT, however, it is labile and unstable. Therefore, reduction of the Schiff base to a 
secondary or tertiary amine using NaBH4 or NaBH3CN is preferred since these amines are much 
more stable and not as susceptible to hydrolysis in aqueous solution. NaBH3CN is used in our 
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study since it is a milder reducing agent compared to NaBH4, and would leave reactive aldehyde 
groups at the other end of the glutaraldehyde free, after the initial reaction with APTES, to react 
with the carboxyl–PEG–amine. 
X-ray photoelectron spectroscopy (XPS) was used for elemental surface characterisation of the 
glass slides after each functionalisation step. An area of analysis of 400 × 400 µm2 and depth of 
5–10 nm was employed. Figure 2.2f depicts the different types of elements found on a plain glass 
slide after washing with Piranha and O2 plasma. The elemental peaks detected were oxygen (533 
eV, 57%), carbon (285 eV, 8.6%) and silicon (103 eV, 34.4%). As glass is mostly SiO2, most of 
the elements present were indeed Si and O. The small percentage of carbon may be due to traces 
of impurities on the glass. Comparing the nitrogen 1s (N1s) scan of plain (Figure 2.2g) and 
APTES-treated (Figure 2.2h) glass slides, there was a distinct nitrogen peak for the APTES-treated 
glass slide whereas no peak was detected for the plain glass slide. This demonstrated successful 
APTES functionalisation, with available amine groups for subsequent functionalisation reactions. 
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Figure 2.2. (a–e) Schematic illustration of the procedure for the surface functionalization of glass 
slides. (f) XPS elemental peaks on the surface of Piranha-washed plain glass slide. XPS N1s 
spectra of (g) Piranha-washed plain glass slide and (h) after APTES functionalisation. (i–l) XPS 
C1s spectra of the surface functional groups on the glass slides after (i) washing with Piranha 
solution, (j) APTES coating, (k) glutaraldehyde coating, and (l) carboxyl–PEG functionalization. 
Figure 2.2i depicts the XPS C1s spectrum of plain glass slide, and compares it to that of APTES-
treated glass slide (Figure 2.2j). APTES treatment and thermal curing produced a peak at 285.8 
eV, which is attributed to amino carbon, signifying APTES functionalisation. Subsequently, a peak 
at 288.1 eV was produced after addition of glutaraldehyde (Figure 2.2k), which was associated to 
the carbonyl carbon of the aldehyde group. Finally, after treatment with the carboxylic–PEG–
amine, a peak at 288.4 eV emerged (Figure 2.2l), which was attributed to carboxyl carbon.  
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The concentration of available surface carboxylic groups were critical for high density attachment 
of amine-modified capture probes, and consequently, the sensitivity of target miRNA detection. 
In addition, signal intensities highly correlated with the concentration of surface functional groups 
[111]. Therefore, the quantification of carboxylic groups on the surface of the glass slides was 
important in ensuring high-quality miRNA detection assay. TBO staining was employed as a 
recognised dye adsorption technique for quantifying carboxylic groups [112]. Using the TBO 
assay, the density of carboxylic groups on the surface of the glass slides was determined as 1.10 ± 
0.05 × 1015 molecules/cm2. This density was associated with a dense monolayer of carboxylic 
groups [113, 114]. 
2.3.3 Proof-of-concept study using fluorescence-based detection 
Nucleic acid detection on microarrays using fluorescent probes has been widely adopted and is 
considered the gold standard [115, 116], therefore, fluorescence-based detection was first used as 
a proof-of-concept study to validate the detection scheme illustrated in Figure 2.1, before 
proceeding with using Au NPs as signal transduction elements. The same procedure was employed 
as outlined in Section 2.2.6, however, a Cy3-modified SP was used instead of the Au NP-
conjugated one. The fluorescence micrographs for the detection of a decreasing concentration of 
miR-208b targets were depicted in Figures 2.3a–d, where there was a corresponding decrease in 
fluorescence intensity. The associated calibration curve (Figure 2.3e) over a range of 1 pM to 10 
µM showed a linear range from 10–100 nM and a limit of detection (LOD) of 10 nM (3σ). The 
LOD was determined as the lowest concentration of target that produced a signal greater than 3× 
the standard deviation of the blank (3σ). 
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Figure 2.3. Proof-of-concept demonstrated by fluorescence-based miRNA detection. Fluorescence 
images of on-chip hybridization between immobilized CPs and (a) 1 μM, (b) 10 nM, (c) 10 pM 
and (d) 100 fM of miR-208b targets. (e) Calibration curve for the fluorescence detection of miR-
208b. Error bars represent the SD of the mean, n = 3. Fluorescence images of Cy3-labelled SPs (f) 
immediately after spotting and (g) after stringent wash. Fluorescence images for the hybridization 
of Cy3-labelled SPs to immobilized hairpin CPs (h) with prior target–CP hybridization and (i) 
without target. Scale bars = 100 μm. 
Nonetheless, two issues remained to be addressed: (i) whether there is non-specific adsorption of 
SPs to the glass slide surface, and/or (ii) hybridisation of the SPs with the stem region of the CPs 
in the absence of target. Such occurrences would result in false-positives and reduce the accuracy 
of the assay.  
In order to investigate the presence of non-specific SP adsorption on the microarray, Cy3-modified 
SPs (1 µM) were spotted on carboxyl–PEG–amine functionalised glass slides, and incubated for 6 
h at RT, before the washing steps described in Section 2.2.6 were conducted. Immediately after 
spotting the Cy3-modified SPs (Figure 2.3f), strong fluorescence intensity from the Cy3 dye was 
observed, whereas after washing, there was negligible fluorescence (Figure 2.3g). This indicated 
that there were no significant non-specific adsorption of the Cy3-modified SPs. The carboxylic 
groups would be deprotonated at a neutral pH (under 5× SSC conditions, pH = 7, Section 2.2.4), 
resulting in a negatively charged surface, which would repel negatively charged nucleotide 
molecules, thereby minimising non-specific adsorption of random (non-target) nucleic acid 
strands. 
Subsequently, to determine if there is hybridisation between the SPs and the CPs in the absence of 
prior CP–target hybridisation, we first immobilised the hairpin CPs. Cy3-modified SPs (1 µM) 
were then added and incubated for 6 h at RT. After washing and drying using N2, negligible 
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fluorescence was observed (Figure 2.3i). In contrast, bright fluorescence was observed (Figure 
2.3h) when there was prior CP–target hybridisation using 1 µM of perfectly complement target 
(miR-208b), which functioned as the positive control. From these control experiments, we 
concluded that the surface functionalisation and detection mechanism were able to minimise non-
specific adsorption and false-positives, enabling our microarray platform to be target-specific and 
robust. 
2.3.4 Detection of miRNA targets in buffer and human serum 
A hairpin CP (Figure 2.4), with a stem-loop structure, was designed for the detection of miR-208b. 
The stem-loop structure forms spontaneously at 20°C (∆G = -7.43 kcal/mol), with > 10 mM of 
Na+. 
 
Figure 2.4. Schematic showing the stem-loop structure of the CP. Structure was generated using 
the UNAFold application provided online by Integrated DNA Technologies (IDT) Inc. 
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The sequence complementary to miR-208b was located within the loop region (base 12–33), while 
the sequence complementary to the Au NP-conjugated SP was located along the stem region (base 
42–51).  
After establishing the proof-of-concept using fluorescently modified SPs, Au NP-conjugated SPs 
were used in their place. The same assay procedures were employed, and the Au NPs were 
quantified via DIC microscopy. 
 
Figure 2.5. Quantification of miRNAs via DIC imaging of Au NPs. Surface coverage of Au NPs 
corresponding to miR-208b target concentrations of (a) 1 nM, (b) 1 pM, (c) 1 fM and (d) blank, 
and (e) the associated calibration curve. Scale bars = 50 μm. (f) Comparison of miRNA target 
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detection in buffer and human serum on carboxyl–PEG functionalised glass slides and commercial 
aldehyde glass slides. Error bars represent the SD of the mean, n = 3. 
Figures 2.5a–d depict the DIC images associated with a decreasing concentration of miR-208b 
targets in 5× SSC buffer. DIC microscopy created a pseudo-3D morphology for individual Au 
NPs, enabling facile visualisation and quantification of miR-208b. The LOD was 100 fM (based 
on 3× blank SD, Figure 2.5e), which was lower than that using fluorescence detection, and the 
linear range was 100 fM to 100 nM. In order to investigate the viability of the detection of 
circulating miRNA targets directly from physiologically relevant samples, synthetic miR-208b 
was spiked into unprocessed human serum and quantified on microarray. Comparing the detection 
of miR-208b in 5× SSC buffer and in serum (Figure 2.5f), there was a decrease in signal intensity 
(22 ± 7%) for the detection of targets in serum, and the LOD was 100 fM. For referencing purpose, 
Mitchell et al. determined the level of various miRNAs, namely miR-15b, miR-16 and miR-24, in 
the plasma of healthy donors as ranging from 15 fM to 222 fM [52]. As our microarray offered a 
superior LOD, the platform is capable of handling low levels of miRNA targets in biological 
samples. In addition, since many miRNAs are up-regulated, e.g. miR-208b (1,600×) and miR-499 
(100×) for myocardial infarction [53] and miR-223 (55×) for metastatic prostate cancer [117], our 
microarray can potentially be applied for disease screening and diagnostics. In addition, we 
compared the performance of the carboxyl–PEG–amine functionalised glass to a commercial 
aldehyde functionalised glass slide (Figure 2.5f). The aldehyde functionalised slide was chosen as 
aldehyde is a common platform used for printing nucleic acid-based microarrays. For the detection 
of miR-208b in serum on the aldehyde slide, the LOD was 1 pM, which was 1 order of magnitude 
higher than the carboxyl–PEG–amine glass slide. Also, signal intensities were greatly reduced, 
particularly at lower target concentrations (100 fM to 1 nM). Hence, the carboxyl–PEG–amine 
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glass slide was superior as compared to the aldehyde functionalised one for miRNA detection in 
human serum. 
Differences in results for the screening of miRNA among various studies and/or different 
techniques could stem from a few factors. (i) Levels of miRNAs in serum or plasma might not 
correlate directly with the amount of miRNAs found in tissues; the low expression levels of 
miRNAs in serum might render microarray-based detection of miRNA more suitable for up-
regulation studies, instead of for down-regulation [118]. (ii) Also, different target labelling and/or 
amplification techniques employed could lead to different expression profiles of target miRNA 
[118]. 
Figure 2.6 demonstrates the multiplexing capabilities of the carboxyl–PEG–amine functionalised 
microarray. Rows 1 and 3 were immobilised with hairpin CPs for miR-208b targets, while rows 2 
and 4 were immobilised with hairpin CPs for miR-335 targets. A solution containing a 1:1 mixture 
of the targets, 100 nM (Figures 2.6a–c) and 10 nM (Figures 2.6d–f) of Cy3-modified miR-208b 
and FAM-modified miR-335, was then added to the array of CPs and incubated for 6 h at room 
temperature (RT). After washing, fluorescence images were obtained, and we observed that the 
targets only hybridised to their respective CPs for both target concentrations, where Cy3 
fluorescence was only observed on rows 1 and 3 while FAM fluorescence was only observed on 
rows 2 and 4 (Figures 2.6c and f). There was negligible cross-contamination even in the presence 
of a high concentration (100 nM) of non-complementary targets, hence, showing the high 
selectivity of hairpin CPs for their respective targets. Through spatial mapping of CPs and 
computerised image analysis, the throughput of DIC imaging of Au NPs could be scaled up for 
high-throughput detection and profiling of miRNA targets. 
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Figure 2.6. Multiplexed detection study showing the hybridization of a mix of 100 nM of (a) miR-
208b and (b) miR-335 targets to their respective hairpin CPs, and (c) the overlaid image. 
Multiplexed detection of 10 nM of (d) miR-208b and (e) miR-335 targets. (f) Overlaid image of 
(d) and (e). Scale bar = 200 µm. 
2.3.5 Discriminating sequence mismatches using hairpin CPs 
Often, the members in a family of miRNAs differ from each other by only a single base. Therefore, 
it is imperative for assays to be able to discriminate single-base mismatches with high accuracy in 
order to ensure highly accurate screening of miRNAs. In addition, the onset of many diseases, e.g. 
cancer, are due to point mutations in one or more genes [119]. Therefore, the detection of such 
single-base mismatch could be utilised as molecular markers for diagnosing early-stage 
tumorigenesis [120]. Discrimination of sequence mismatches between let-7a and let-7b, let-7f, and 
let-7g, which have high sequence homology within the let-7 family, was conducted as a 
demonstration. As such, hairpin and linear CPs were designed for let-7a, which was the perfect-
match (PM) target, while let-7f contained a single-base mismatch (1MM), and let-7b and let-7g 
both contained dual-base mismatches (2MM). From Figure 2.7, when hairpin CPs for let-7a was 
employed, we observed a 74% decrease in signal when let-7f (1MM) was added, while there was 
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an even greater drop for let-7b (80%) and let-7g (84%), which both contained 2MM, as compared 
to let-7a (PM). In the case of let-7b, the 2MM involved 2 A–U base pairs (Table 2.1), while for 
let-7g, 1 C–G and 1 A–U base pairs were involved. As a C–G base pair consists of 3 hydrogen 
bonds whereas an A–U base pair consists only of 2 hydrogen bonds, the reduction in melting 
temperature for sequence mismatches is greater for let-7g than for let-7b. Therefore, a greater 
reduction in signal was seen for let-7g although both miRNAs had 2MM as compared to let-7a. 
Conversely, the same trend was observed when linear CPs for let-7a was utilised, but with a 
smaller reduction in signal intensities. From Figure 2.7, we observed a 31% decrease in signal for 
let-7f (1MM), and a drop of 57% and 67% for let-7b (2MM) and let-7g (2MM), respectively. 
   
 Sequence 
has-let-7a 5’–UGA GGU AGU AGG UUG UAU AGU U–3’ 
has-let-7b 5’–UGA GGU AGU AGG UUG UGU GGU U–3’ 
has-let-7f 5’–UGA GGU AGU AGA UUG UAU AGU U–3’ 
has-let-7g 5’–UGA GGU AGU AGU UUG UAC AGU U–3’ 
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Figure 2.7. Selectivity and sequence mismatch discrimination study among members of the hsa-
let-7 family, using hairpin and linear CPs for let-7a. Error bars represent the SD of the mean, n = 
3. Base mismatches for members of the let-7 family with respect to let-7a have been indicated in 
red in the table. 
As a result of their stem-loop structure, hairpin CPs are considered structurally-constrained 
molecules, which undergo a greater structural reorganisation, during hybridisation or dissociation 
of probe–target hybrid, as compared to linear CPs [97]. This has enhanced the ability of hairpin 
probes to discriminate sequence mismatches. In addition, a study has reported faster hybridisation 
and more stable hybrids between hairpin probes to their targets, as compared to linear probes [121]. 
Such properties would confer significant advantages, especially in POC settings, which often 
require rapid and sensitive quantification of targets for diagnoses of diseases. 
Hairpin-structured probes, such as a molecular beacon, are thought to transit through three 
conformational states in response to increasing temperature (Figure 2.8a) [97]. As the probe–target 
hybrid is more stable than the stem of a hairpin probe, the hairpin probe hybridises with its target 
spontaneously when the temperature is low, below the melting temperature (Tm) of the probe–
target hybrid, forming a double-stranded complex (1st state). When the temperature increases, the 
probe–target hybrid dissociates, and the hairpin probe regains its stem-loop structure (2nd state). 
The hairpin probe then becomes a randomly coiled oligonucleotide (3rd state) when temperature 
increases above the stem Tm.  
In the study, thermodynamic parameters (enthalpy, ∆H and entropy, ∆S) were determined for the 
transition of one state to the other. For the transition from the 2nd to 3rd state, the fluorescence 
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increase due to denaturation of the stem was measured, and ∆H23 and ∆S23 were determined 
using the following equation: 
                                                𝑅 ln (
𝐹 –𝛽
𝛾 –𝐹
) = – ∆𝐻2→3
1
𝜃
 + ∆𝑆2→3                                              (2.1) 
where R is the gas constant, F is the intensity of fluorescence at a given temperature, β and γ are 
the fluorescence intensities for the 2nd and 3rd state, respectively, and θ is the temperature (K). 
For the transition from the 1st to 2nd state, the decrease in fluorescence intensity due to the 
dehybridisation of probe–target complex (both perfect matched and mismatched strands), and 
subsequent Förster resonant energy transfer (FRET) after the formation of the stem-loop structure 
(2nd state), were measured and ∆H12 and ∆S12 were determined using the following equation: 
                                            𝑅 ln(𝑇0 – 0.5𝑃0) = – ∆𝐻1→2
1
𝜃𝑚
 +  ∆𝑆1→2                                       (2.2) 
where T0 is the total concentration of targets present, P0 is the total concentration of hairpin probes, 
and θm is the melting temperature of the probe–target hybrid. 
After obtaining the thermodynamic parameters, a free energy phase diagram (Figure 2.8b), which 
is in the form of ∆G = ∆H – θ∆S (for the 1st and 2nd state), was constructed. The 3rd state serves as 
the reference, where ∆G = 0, since both hairpin probe and target strands are in a randomly coiled 
state. The free energy diagram attempts to demonstrate how hairpin probes are better at 
discriminating mismatches in target sequences compared to linear probes, and illustrates the free 
energy of the three conformational states of a hairpin probe, when in equilibrium with its perfect 
matched and mismatched target. For linear probes, during probe–target hybrid dissociation, the 
probes change from the 1st state directly to the 3rd state since it does not form a stem-loop structure 
(2nd state), and the difference in Tm between perfect and mismatched target is ~ 8°C (∆θ’). The 
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difference in Tm is greater for hairpin probes, as the probes transit from the 1
st state to the 2nd state 
instead, and the Tm difference increases to ~ 14°C (∆θ). Therefore, hairpin probes are better at 
detecting mismatches in target sequence. 
 
Figure 2.8. (a) Schematic illustrating hairpin probe transitioning between various states. In the 1st 
state, the molecular beacon probe is hybridised with its perfectly matched target. Probe–target 
hybridisation produces a rigid double-stranded oligonucleotide; hence, the fluorescence donor and 
acceptor are far apart, and fluorescence can be detected. As the temperature increases (∆), the 
probe–target complex dissociates. The molecular beacon then regains its single-stranded stem-
loop structure (2nd state), which is non-fluorescent as the fluorescence donor and acceptor are in 
close proximity for FRET. As the temperature further increases, beyond the stem melting 
temperature (Tm), the molecular beacon becomes a fluorescent single-stranded oligonucleotide, 
without any secondary structure. (b) Free energy diagram of the three states of the molecular 
beacon with target nucleic acid. The positions of the traces are representative of all hairpin probes 
in general. The change in Tm, between perfect match (1p) probe–target hybrid and mismatch (1m) 
hybrid, is larger when probes can form a secondary structure (∆θ) after probe–target hybrid 
dissociation than if the probe cannot (∆θ’). Figure adapted from reference [97]. 
Table 2.2 presents a summary of how our microarray platform compares with existing miRNA 
detection techniques. 
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Table 2.2. Comparing the microarray platform with other miRNA detection techniques. 
Platform Mechanism of Detection 
 
(+) Advantages 
(–) Disadvantages 
 
Limit of 
Detection 
Selectivity 
No. of 
Steps & 
Time to 
Result 
Reference 
Microarray miRNA probes are immobilised 
on CombiMatrix 4×2K arrays. 
Target miRNAs, extracted from 
human serum and labelled with 
biotin are then added for probe–
target hybridisation. The 
formation of probe–target 
complex is subsequently detected 
using Cy5 fluorescence or via an 
electrochemical system. 
 (+) Highly sensitive 
(+) High-throughput 
(+) Does not require amplification 
(–) Extraction and labeling of miRNA 
targets from human serum needed 
(–) Specialised equipment needed for 
target detection 
 6.6 fM in 
human 
serum 
Discrimination 
of 2-base 
mismatch of 
target 
sequence 
21 steps 
20 h 
[118] 
Piezo-
electric 
Cantilever 
A flow system in which CPs are 
first immobilised on the 
cantilever. Probe–target 
hybridization is subsequently 
detected by a measuring the 
decrease in the resonant frequency 
of the cantilever. 
 (+) Highly sensitive 
(+) Highly selective – Ability to 
discriminate SNP 
(+) Non-specific binding from blood 
interferences can be minimised via 
continuous sensor vibration 
(+) Target detection is near real-time 
(+) Target extraction and/or labelling 
are not needed, minimising sample 
preparation 
 4 fM in 
human 
serum 
Discrimination 
of 1-base 
mismatch 
between let-7a 
and let-7c 
5 steps 
4–6 h 
[55] 
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(–) Relatively low-throughput 
detection of targets – 1 target per 
cantilever 
(–) Skilled personnel required for the 
fabrication of the cantilevers 
Protein-
Nanopore 
Sensor 
Sensor element based on the 
α-haemolysin protein pore. 
Programmable probe–target 
hybridisation creates unique 
current events, where the 
frequency of such events can be 
used to quantify miRNA targets. 
 (+) Highly sensitive 
(+) Highly selective – Able to 
discriminate SNP 
(+) High-throughput where 
multiplexed detection can be achieved 
by chemically modifying probes with 
specific barcodes 
(–) Extraction of RNAs from human 
plasma is needed 
 100 fM in 
human 
plasma 
Discrimination 
of 1- and 2-
base mismatch 
between let-7a 
and let-7c and 
let-7b, 
respectively 
5 steps 
1.5 h 
[122] 
Electro-
chemical 
Sensor 
Screen-printed gold electrodes 
serve as a platform for the 
immobilisation of hairpin CPs. 
Formation of probe–target 
complexes allows two auxiliary 
probes to self-assemble into a 
network of DNA concatamers, 
which act as transducers for signal 
amplification. Finally, redox 
indicators are added for binding 
 (+) Highly sensitive 
(+) Highly selective – Able to 
discriminate SNP 
(+) Target extraction and/or labelling 
are not needed, minimising sample 
preparation 
(+) Ability to amplify target signal 
(–) Relatively low-throughput target 
detection 
 100 aM in 
human 
serum 
Discrimination 
of 1- and 2-
base mismatch 
of target 
sequence 
3 steps 
4 h 
[123] 
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with the concatamers in order to 
generate electrochemical signals. 
Microarray Hairpin CPs are immobilised on 
carboxyl–PEG–amine 
functionalised glass slides. 
Subsequent probe–target 
complexation exposes binding 
region in the stem for the binding 
of Au NP-tagged signalling 
probes. These probes can be 
imaged using DIC microscopy for 
facile target quantification. 
 (+) Highly sensitive 
(+) Highly selective – Able to 
discriminate SNP 
(+)Target extraction and/or labelling 
are not needed, which minimises 
sample preparation 
(+) Multiplexed detection 
(+) Prevents non-specific binding 
(–) Target signal amplification 
mechanism is absent 
(–) Relatively low-throughput with 
regards to genome-wide analysis and 
profiling of miRNAs 
 100 fM in 
human 
serum 
Discrimination 
of 1-base 
mismatch 
between let-7a 
and let-7f, and 
2-base 
mismatch 
between let-7a 
and let-7b and 
let-7f 
4 steps 
12.5 h 
This thesis 
Lateral 
Flow 
Lateral flow strips of the Roche 
Troponin T (TnT) test are 
immobilised with anti-TnT 
antibodies. Gold particles labelled 
with antibodies for another epitope 
of TnT forms a sandwich with 
immobilised TnT, giving a red 
colour band for qualitative TnT 
detection from blood samples. 
 (+) Highly sensitive 
(+) Highly portable, easy to use 
(+) Direct use of blood sample, 
minimal sample preparation 
(+) Rapid time to result 
(–) Target detection is non-
quantitative without a strip reader 
(–) Relatively low-throughput 
compared to microarrays 
 50 pg/ml 
in human 
blood 
Not measured 2 steps 
12 min 
[124] 
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2.4 Conclusions and Future Work 
Major efforts have been devoted towards creating specific, sensitive and rapid assays for the 
detection of nucleic acid targets in POC settings. The potential applications for such technologies 
include the diagnosis of infectious and genetic diseases, as well as genome analysis and 
pharmacogenomics. In this chapter, a carboxyl–PEG–amine functionalised microarray platform 
was developed for the highly sensitive and selective detection of miR-208b in buffer and human 
serum, where miR-208b acted as a model target for the detection of acute myocardial infarction 
(AMI). This study demonstrated a platform for the direct profiling of miRNA from unprocessed 
human serum, and could detect as low as 100 fM of miR-208b in serum without requiring tedious 
target extraction, labelling and PCR amplification. Functionalising the glass slides with carboxyl–
PEG–amine and employing hairpin CPs enabled the high detection sensitivity. In addition, our 
platform proved to be better at detecting miR-208b targets in human serum than commercial 
aldehyde functionalised glass slides. This demonstrated that anti-fouling treatment was essential 
in minimising interference associated with many different proteins (> 20,000) and circulating 
nucleic acids, from biological fluids, which could significantly affect detection sensitivity. 
Moreover, multiplexed target detection was demonstrated, with virtually no cross-contamination. 
In addition, the platform was able to discriminate between members of the let-7 family, which 
contained as little as a single-base mismatch. Finally, Au NPs were chosen as the signal 
transduction agent for our platform due to the ease of functionalisation with oligonucleotides and 
their large apparent refractive index, which would enhance contrast in DIC microscopy to achieve 
distinct visualisation of the Au NPs conveniently under an optical microscope. As such, our 
platform is well poised to be employed in minimally invasive profiling and detection of circulating 
miRNA in biological samples for diagnostic purposes. Since the proof-of-concept has been 
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established via detection of spiked miRNA target in human serum, the next step would be the 
testing of real patient sample for further validation of the platform. 
In this study, three surface functionalisation steps (APTES, glutaraldehyde and carboxyl–PEG–
amine) and an EDC/sulfo-NHS activation step were required to produce the functionalised 
microarray platform. Conducting all these reactions could be technically tedious and inefficient as 
any error in one of these steps could result in poor functionalisation of the carboxyl–PEG–amine 
and affect hairpin probe immobilisation and subsequent target detection. In addition, more 
reactions would equate to rising production cost for the platform. Hence, the use of aldehyde– or 
NHS–PEG could be explored to reduce the functionalisation steps required. 
In addition, currently the hybridisation between capture probe–target and capture probe–signalling 
probe were conducted under static conditions, which required a long duration, particularly so when 
the concentration of target was low, as the diffusion of nucleic acid molecules was generally slow 
[125]. In order to increase the hybridisation rate and efficiency, microfluidic channels could be 
integrated onto the microarray platform for flow-enhanced probe–target hybridisation. Adopting a 
recirculating flow using microfluidics has reduced hybridisation time to 2.5 h [91], and in another 
study where oscillating flow was employed, hybridisation duration was further reduced to 0.5 h 
[126]. Integration of such microfluidic systems would greatly reduce the result turnaround time 
and enhance the utility of our platform in a POC setting. Integration of such microfluidic systems 
would greatly reduce the result turnaround time in order to compete with lateral flow or portable 
electrochemical devices, and enhance the practical utility of our platform in a POC setting. 
Furthermore, as an optical microscope with DIC functionality is current required for target 
detection and quantification, the platform is not readily viable for use in the field; further 
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miniaturisation of the DIC detection or alternative signal transduction mechanism, such as 
colourimetric detection, is required. 
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Chapter 3 : Colorimetric Detection of Small Molecules Using 
Aptamer-Functionalised Gold Nanoparticle Probes 
The majority of the data in this chapter has been published in J.H. Soh et al., Colorimetric 
Detection of Small Molecules in Complex Matrices via Target-Mediated Growth of Aptamer-
Functionalised Gold Nanoparticles. Anal. Chem., 2015. 87 (15): p. 7644-7652 [127].  
3.1 Introduction 
Small molecules, such as toxins, carcinogens, nutrients, hormones, pharmaceutical drugs, 
antibiotics and drugs of abuse, are important to detect. Their sensitive and selective detection from 
food and water sources, environment and biological fluids, such as blood, urine and saliva, have a 
great impact on food, drug and environmental screening, as well as clinical diagnostics. For 
example, tetracycline-based antibiotics, such as oxytetracycline, which is used to treat infectious 
disease in livestock are often excreted from the animal body and enter dairy and food products as 
contaminants [128], and the detection of such contaminants and mycotoxins are required to 
maintain high quality of food products. On the other hand, the detection of neurotransmitter 
dopamine levels in the brain could be used to evaluate neurological disorders, where deficient 
dopamine levels is associated with Alzheimer’s, Parkinson’s and Huntington’s disease, and 
schizophrenia [129]. In addition, carefully-monitored plasma levels of theophylline, which is a 
common drug used in treating asthma, is required as levels above 100 µM is toxic, causing death 
or irreversible damage to the brain [130]. However, the selective detection of theophylline is 
confounded by the presence of structurally-related caffeine and theobromine, leading to 
overestimation of true theophylline levels, further highlighting the need for selective target 
detection. 
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To confer nanomaterials, such as Au NP probes, with the ability to detect specific targets, such 
probes must be imbued with a target recognition agent, which include biomolecules such as protein 
antibodies or nucleic acids [131], via physical or chemical modifications. Functional nucleic acids, 
such as aptamers, have emerged as a new class of recognition element that can be used in tandem 
with various nanostructures for biomedical applications and serves as an excellent alternative to 
the traditional antibodies. Aptamers are single-stranded nucleic acid strands that can bind readily 
and selectively to wide-ranging targets, such as cells, peptides, proteins, ions and small molecules. 
They are produced through the systematic evolution of ligands by exponential enrichment 
(SELEX) process, where single-stranded DNAs or RNAs against a target are identified and 
isolated from a library of ~ 1015 nucleic acid sequences. In general, DNA aptamers are less 
susceptible towards enzymatic degradation compared to RNA aptamers. Their target recognition 
ability is derived from the formation of 3D structures, such as hairpin, quadruplex and pseudo-
knot that these single-stranded nucleic acids form, allowing them to interact specifically with their 
target by adopting a unique conformation, and binding to their targets via aromatic ring stacking 
as well as hydrogen, electrostatic and van der Waals bonding [132, 133]. In addition, aptamers 
bind to their targets with high affinity, with a dissociation constant (Kd) that is in the µM–pM 
range, which is comparable to antibody-antigen affinity. Also, due to the induced fit binding with 
their targets, aptamers are able to discriminate their targets against very similarly structured 
molecules, which can differ by as little as an –OH group [128]. 
Compared to antibodies, aptamers exhibit greater stability against enzymatic and thermal 
denaturation due to their structural robustness afforded by their phosphodiester backbone. 
Aptamers are able to denature reversibly and regenerate their 3D structures after denaturation in 
various temperature, pH and ionic concentrations [134]. In addition, aptamers are virtually non-
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immunogenic in in vivo systems and are easily utilised in biological systems. Lastly, and most 
importantly, the synthesis of aptamers do not require animals and in vivo immunization, enabling 
facile and inexpensive chemical synthesis in vitro, where aptamer products can be obtained with 
higher yields and purity. As such, nucleic acid-based aptamers can be easily modified with various 
molecules for labelling or signal transduction, making it a versatile probe in many different 
applications [135, 136]. 
Small molecules have conventionally been detected using spectrometry and chromatography, 
including HPLC and GC-MS. However, these methods can be complex, requiring complicated 
sample preparation steps, expensive equipment and qualified personnel to operate, resulting in 
repetitive testing cycles and long result turnover. Although spectrometry and chromatography 
methods have achieved sensitive detection [65] of small molecules and are the gold standards for 
laboratory-based screening of small molecules, alternative techniques are required for the facile 
and sensitive detection of small molecules. In recent years, novel studies utilising aptamer-Au NP 
complexes, which leverage the excellent optical properties and high absorbance of plasmonic NPs 
for the development of colorimetric detection systems, have begun to emerge [137, 138]. However, 
these detection systems usually rely on the aggregation of Au NPs as their signal transduction 
mechanism, and therefore may not be applicable in biofluids and complex media as the presence 
of other salts, nucleic acids and peptides may interfere with the aggregation of Au NPs. 
Although the most common biological matrix used for the detection of disease biomarkers is blood 
(including serum and plasma), the collection of blood is invasive. For readily accessible, less 
invasive sample collection, urine and saliva are good alternatives and they allow for ease of 
multiple sample collections in a day. 
71 
 
The use of urine as a diagnostic medium spares patients from invasive procedures, such as 
cystoscopy for the detection of bladder cancer and biopsies for tumour detection. Recently, urinary 
circulating miRNA levels have been associated with various diseases. For example, the down-
regulation of urinary miR-99a and miR-125b has been detected in patients with urothelial 
carcinoma of the bladder [139], whereas the down-regulation of urinary miR-451 and miR-21, 
together with a significant up-regulation of miR-155, have been detected in patients with breast 
cancer [140]. Urinalysis is commonly performed with a urine dipstick, which tests for analytes, 
such as glucose, bilirubin, blood, ketones, protein, pH, nitrite, leukocyte esterase and nitrite, and 
can be used to reflect the state of an individual’s metabolism, proper functioning of the liver and 
kidneys, as well as detect the presence of urinary tract infection or acid-base imbalance. Another 
commonly used urinalysis device is the pregnancy test kit, which measures HCG levels in the urine 
to indicate whether a woman is pregnant. Results from such urine dipsticks can be read visually 
and conveniently, without the need for equipment. In addition, urine is routinely used for the 
detection of drugs of abuse, as most drugs are detectable up to 1.5–4 days, for a single dosage, and 
up to ~ 7 days, for chronic abusers, in the urine, as compared to 1–2 days in blood [141]. The 
detection time depends on the dosage taken, route of drug administration, source of sample (e.g. 
hair, urine, sweat, saliva or blood), analytical method employed, the drug of interest and inter-
individual variations in metabolism. Due to heightening demands for its detection for law 
enforcement and toxicology screening, there is a need for rapid and sensitive detection of cocaine. 
After an intranasal administration of cocaine (20–100 mg), urinary cocaine is detectable up to 3 
days, with a LOD of 0.3 µg/ml (~ 0.88 µM) using fluorescence polarisation immunoassay and a 
LOD of 0.05 µg/ml (~ 147 nM) using GC-MS [142]. More sensitive detection techniques would 
enable trace amounts of drugs to be detectable more reliably and even longer after administration. 
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Saliva functions as a lubricant, buffering and protective agent for maintaining the integrity of our 
teeth, contains anti-bacterial ability, and helps in tasting and food digestion [143]. It is produced 
primarily by the sublingual, submandibular and parotid glands, which are the major saliva-
producing glands, as well as by many other minor glands. It is composed of mainly water, enzymes 
(including lipase and amylase), proteins (such as mucin and statherin), anti-bacterial agents 
(including lysozyme, IgA and defensin) and electrolytes (such as sodium, potassium, carbonate 
and phosphate ions) [144]. Many of the biomarkers, metabolites and drugs that are found in the 
blood are also present in saliva, and the expression levels correlate closely to one another. Such 
analytes enter saliva via passive diffusion (intracellular route) or by ultrafiltration through tight 
junctions between cells (extracellular route) [145]. Commercialised diagnostic assays have been 
developed for detecting pathogens, such as dengue and rubeola, and salivary antibodies against 
human immunodeficiency virus (HIV), and hepatitis (Hep) B and C [144]. In addition, saliva can 
be used to monitor the levels of therapeutic drugs, drugs of abuse and hormones for clinical 
screening and diagnostics application. For instance, levels of anti-epileptic drugs (AEDs), such as 
carbamazepine, can be monitored from the saliva, which contains ~ 38% of serum carbamazepine, 
and there is a high correlation, r = 0.89, between salivary and serum levels [146]. Also, salivary 
steroid hormones, such as cortisol, show high correlation (r = 0.97) with active serum cortisol 
levels, and can be used to detect Cushing’s and Addison’s syndrome [147, 148]. Furthermore, the 
measure of salivary hormones is preferred over serum as salivary hormones exist in their active 
form, whereas in serum, such hormones are protein-bound, making the measure of their true 
activity complicated [144]. Also, due to diurnal, circadian and monthly differences in hormone 
expression, multiple sample collections throughout the day or regular collection at fixed intervals 
may be required, and such collection requirement can be prohibitively expensive or inconvenient 
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with blood [149]. One drawback for utilising saliva as a source of biomarkers is that the 
concentration of biomarkers in saliva is usually lower compared to that in the blood [150]. 
However, with the advent of nanotechnology, novel and highly sensitive techniques could evolve 
that could overcome this limitation. 
In this chapter, the rapid detection and quantification of various small molecules, namely 
ochratoxin A (OTA), cocaine and estradiol, via a versatile and sensitive colorimetric assay utilising 
aptamer-functionalised Au NP was described. The aptamers that bind these targets were developed 
using the SELEX process. Briefly, a random nucleic acid library, consisting ~ 1015 of single-
stranded oligonucleotides, is incubated with the target molecules for aptamer–target binding. 
Unbound oligonucleotide sequences are separated and eluted, leaving only sequences that bind the 
target molecules. Bound oligonucleotides are further amplified using PCR, and the process is 
repeated for the enrichment of binding nucleic acid strands. The OTA aptamer consists of a high 
G content (47%), which indicates that it most likely folds into a G-quadruplex structure [151]. The 
presence of Mg2+ was vital for aptamer–target binding as Mg2+ was thought to mediate aptamer–
target bridging interaction where OTA forms a coordination complex with Mg2+ via the carboxyl 
and 8-hydroxyl groups of OTA [152]. The OTA aptamer has a dissociation constant (Kd) of 96 
nM [153]. For the cocaine aptamer, aptamer–target binding results in a significant change in the 
secondary structure of the aptamer, forming a three-way stem–loop structure with the cocaine 
binding pocket found in a central lipophilic cavity [154]. Binding between the aptamer and cocaine 
occurs without the presence of Mg2+, although lower background signals were obtained with a 
higher salt concentration due to stabilisation of the stem. The cocaine aptamer has a Kd of about 
400 nM [154]. The estradiol aptamer contains several stem regions and the binding buffer required 
for aptamer–target binding contains Mg2+. The estradiol aptamer has a Kd of 130 nM [155].  
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During target detection for our assay, aptamer–target recognition modulated the aptamer coverage 
on aptamer-functionalised Au NP probes, which served as selective and programmable nano-
complexes. Subsequently, signal transduction was achieved via aptamer coverage-mediated 
growth of the Au NP probes (instead of via aggregation of Au NPs), where the morphology of the 
grown Au nanostructure varied in a dose-dependent manner. The morphologically-varied 
nanostructures gave rise to different coloured solutions, which could be observed by the naked 
eye. The assay could detect Ochratoxin A (OTA) from red wine, as well as cocaine and estradiol 
spiked into synthetic urine and saliva, respectively, using minimal sample preparation steps. In 
addition, the sensing mechanism was applicable on a chip-based platform, which could be useful 
for rapid and portable detection of small molecules. 
3.2 Experimental Section 
3.2.1 Materials 
Aptamers were custom synthesized by Integrated DNA Technologies, Inc. (Belgium), (see 
sequences in Table 3.1). Gold nanoparticles (Au NPs) were obtained from BBI Solutions (Cardiff, 
UK). OTA and ochratoxin B (OTB) were obtained from Enzo Life Sciences (UK) Ltd. and Santa 
Cruz Biotechnology, Inc., respectively. Cocaine hydrochloride, 17β-estradiol, L-phenylalanine, 
hydroxylamine, hydrogen tetrachloroaurate (III) (HAuCl4·3H2O) and poly(ethylene glycol) (PEG, 
8 kDa) were obtained from Sigma-Aldrich (UK). Synthetic urine (SurineTM) and saliva (OraFlx), 
and red wine reference material were obtained from LGC Standards (Middlesex, UK). Commercial 
red wine was purchased from a local Sainsbury’s Supermarket (London, UK). OTA immuno-
affinity column (RIDA® OTA) was obtained from R-Biopharm AG (Darmstadt, Germany). 
Sodium dodecyl sulfate (SDS) solution (10% w/v) was obtained from Promega (UK). Nuclease-
free water was obtained from Life Technologies (UK). 
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Table 3.1. Sequences of the aptamers used. 
Name Sequence (5’  3’) 
Ochratoxin A aptamer CGG GTG TGG GTG CCT TGA TCC AGG GAG TCT CTA 
ATC 
Random sequence  
(Negative Control) 
GAT TAG AGA CTC CCT GGA TCA AGG CAC CCA CAC 
CCG 
Cocaine aptamer GGG AGA CAA GGA AAA TCC TTC AAT GAA GTG GGT 
CGA CA 
Estradiol aptamer GCT TCC AGC TTA TTG AAT TAC ACG CAG AGG GTA 
GCG GCT CTG CGC ATT CAA TTG CTG CGC GCT GAA 
GCG CGG AAG C 
 
3.2.2 Preparation of samples for target detection 
For the detection of OTA, OTB, cocaine and estradiol under ideal conditions, targets were prepared 
in methanol. For the extraction of OTA from the commercial red wine and certified reference 
material, the samples were mixed with an equal volume of extraction solution containing 5% (w/v) 
sodium bicarbonate (NaHCO3) and 1% (w/v) PEG. The mixture was shaken thoroughly for 3 min, 
and then filtered through a pleated filter paper (Grade 595 1/2). The pH was brought to ~ 7 using 
PBS, and passed through a syringe filter (0.2 µm) before applying the mixture to the immuno-
affinity column (IAC), following the manufacturer’s protocol. Captured OTA was eluted using 
methanol. 
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For spiking cocaine in synthetic urine, desired concentrations were obtained by 10× dilution of 
prepared cocaine solutions in undiluted synthetic urine. The spiked solution was then diluted 36× 
before addition to the aptamer–Au NP probe. 
For spiking estradiol in synthetic saliva, desired concentrations were obtained by 10× dilution of 
prepared estradiol solutions in undiluted synthetic saliva. Next, methanol (4× the volume of 
synthetic saliva) was added for the precipitation of protein, which was incubated overnight at 4°C. 
The solutions were then centrifuged at 20,800 rcf for 30 min (room temperature). The supernatant 
was collected and added directly to the aptamer-Au NP probe. 
3.2.3 Aptamer–gold nanoparticle adsorption 
The amount of aptamers required for Au NP growth was determined by a calibration experiment 
so that the peak wavelength of grown Au NPs was about 615 nm (see Figure 3.2c, which depicts 
such a calibration curve). Adsorption reactions were conducted overnight at room temperature. 
The amounts of aptamer and magnesium chloride (MgCl2) used for each targets were optimized 
to produce the largest peak shift at the limits of detection. 
The volumes stated here refer to the preparation of aptamer-Au NP probes in a single well (volume 
of 180 µL), and can be scaled up depending on the number of wells required. For OTA detection 
(both in aqueous and in red wine samples), 7.5 µL of OTA aptamer (2 µM) was added to 0.5 µL 
of 5-nm Au NP (83 nM), 20 µL of MgCl2 (1 mM) and 152 µL of water. In the study of probe size 
effect, 11 µL of OTA aptamer (2 µM) was added to 4.4 µL of 10-nm Au NP (9.5 nM), 20 µL of 
MgCl2 (1 mM) and 144.6 µL of water. 
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For cocaine detection (ideal conditions), 18.2 µL of cocaine aptamer (2 µM) was added to 2 µL of 
5-nm Au NP (83 nM), 20 µL of MgCl2 (100 µM) and 139.8 µL of water. For the detection of 
spiked cocaine in synthetic urine, 16.6 µL of cocaine aptamer (2 µM) was added to 10 µL of 5-nm 
Au NP (83 nM), 20 µL of MgCl2 (100 µM), 8 µL of SDS (10% w/v) and 125.4 µL of water.  
For estradiol detection (ideal condition), 16 µL of estradiol aptamer (2 µM) was added to 0.5 µL 
of 5-nm Au NPs (83 nM), 20 µL of MgCl2 (100 µM) and 143.5 µL of water, and for the detection 
of spiked estradiol in synthetic saliva, 45 µL of estradiol aptamer (2 µM) was added to 0.5 µL of 
5-nm Au NPs (83 nM), 20 µL of MgCl2 (100 µM) and 114.5 µL of water. 
3.2.4 Target detection and Au NP growth (signal generation) 
The assays were carried out in clear 96-well plates (tissue culture treated, Corning) at room 
temperature. Target solutions (20 µL) were added to the aptamer-Au NP probe solution (180 µL, 
pH 6.5). This was followed by incubation for 30 min. The presence of divalent cations, such as 
Mg2+, mediated aptamer–target binding by bridging the interaction between the target and aptamer 
[152]. Next, 5 µL of hydroxylamine (130 mM for OTA detection and 400 mM for cocaine and 
estradiol detection) and 10 µL of HAuCl4 (1.9 mM) were sequentially added to the target–probe 
solution (final pH = 3.0). Another 3 aliquots of HAuCl4 (10 µL, 1.9 mM) were then added with a 
5-min incubation between each addition. The solutions were mixed thoroughly using the pipette 
during addition to each well. We found that less aptamer was required for the growth of branched 
Au NPs using a stepwise addition of HAuCl4, compared to a single addition. This enabled the use 
of low quantities of aptamers when preparing the aptamer–Au NP probes, and helped to improve 
the sensitivity of the assay. Photographs showing the colour changes were taken after the last 
HAuCl4 addition. Ultraviolet-visible (UV-vis) spectra were measured with a SpectraMax M5 plate 
reader (Molecular Devices, USA). 
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3.2.5 Transmission electron microscopy (TEM) imaging 
Samples were prepared on copper-supported carbon films by depositing a drop of solution (5 µL) 
on the film and allowing it to dry overnight. TEM imaging was performed by Dr. Yiyang Lin, and 
images were acquired with a JEOL 2000FX, using 200 kV acceleration voltage.  
3.2.6 Dynamic light scattering (DLS) 
Dynamic light scattering measurements were performed at 25ºC on a Malvern Zetasizer Nano ZS 
(Malvern, UK) with a backscattering detection at 173º and a He-Ne laser (λ = 632.8 nm). Each 
sample was incubated at 25ºC for 2 min to reach equilibrium before measurement. 
3.2.7 Aptamer desorption analysis 
The assay for OTA detection was performed as described above, and the zeta potential 
measurement was conducted using a Zetasizer Nano ZS (Malvern, UK). For fluorescence study, 1 
µL of FAM-modified OTA aptamer (2 µM) was added to 50 µL of 40-nm Au NP (0.15 nM), 20 
µL of MgCl2 (1 mM) and 109 µL of water, and then incubated overnight. 40-nm Au NPs were 
used so as to attain sufficient quenching of FAM-modified OTA aptamers. OTA solutions at 
desired concentrations were added and incubated at room temperature for 30 min. The solution 
was centrifuged at 2,300 rcf for 10 min, and fluorescence of the supernatant was measured using 
a SpectraMax M5 plate reader (excitation and emission wavelengths: 495 nm and 530 nm, 
respectively). 
3.2.8 Circularity analysis 
ImageJ v1.48 (http://imagej.nih.gov/ij/) was used for the circularity analysis. TEM images were 
loaded and converted to binary with ‘Watershed’ applied. Next, the ‘Analyze Particle’ function 
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was used to obtain the values for circularity. Circularity values for particles with 2D projection 
area of less than 1000 were omitted. 
3.2.9 Aptamer–Au NP probe immobilisation on aminosilane-coated glass slide 
A 7-µL solution containing 10-nm Au NPs (2.4 nM), OTA aptamers (0.6 µM) and MgCl2 (100 
µM) was applied onto the glass slide, and left to dry overnight at room temperature. The glass slide 
was then washed with water and dried with N2 to remove unbound aptamer–Au NP probes. 
3.2.10 Target detection on aminosilane-coated glass slide 
Target solutions (6 µL) with desired OTA concentrations were added to the immobilized probes 
on the glass slide, and incubated for 30 min at room temperature. Hydroxylamine (2 µL, 50 mM) 
and HAuCl4 (4 µL, 1.2 mM) were added for Au NP growth. Another aliquot of HAuCl4 (4 µL, 1.2 
mM) was added after a 5-min incubation. Photographs showing the color changes were taken after 
the last HAuCl4 addition. 
3.2.11 Red, green, blue (RGB) analysis 
ImageJ v1.48 was used for the RGB analysis of the glass slide photographs. A circular region 
outlining each color spots was selected, and the ‘Histogram’ function was used to obtain the mean 
red and blue intensities within the region. 
3.3 Results and Discussion 
3.3.1 Mechanism for the detection of small molecules 
The principal mechanism for the detection of small molecule targets is depicted in Figure 3.1. 
Aptamer–Au NP probes were formed by interaction between the Au NPs and the amine groups on 
the nucleosides of the aptamer oligonucleotide. Desorption of aptamer strands from the surface of 
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Au NP probes would occur when small molecules were present due to aptamer–target interaction 
and binding. The resultant aptamer coverage after aptamer–target interaction was modulated by 
the concentration of small molecule targets, whereby the higher the concentration of small 
molecules, the lower the resultant aptamer coverage, and vice versa. Following this, Au NP growth 
was achieved by reducing Au3+ using NH2OH in the presence of the aptamer–Au NP probes, which 
served as seed particles. As Au0 atoms were deposited onto the seed particles, the latter would 
grow into morphologically different nanostructures, depending on the concentration of small 
molecules present. In the presence of low target concentration, i.e. high aptamer coverage, the 
isotropic growth of the Au NPs would be disrupted, resulting in the formation of branched 
nanostructures, which produced a blue-coloured solution [156]. Conversely, when the 
concentration of target was high and the aptamer coverage was low, the Au NPs were able to grow 
into nanostructures with a spherical morphology that produced a red-coloured solution. The change 
in morphology would be indicated by a blue shift in the UV-vis spectra of grown Au NPs. 
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Figure 3.1. Schematic illustration of the proposed mechanism for the colourimetric detection of 
small molecule targets. (a) Aptamer–Au NP probes are formed by adsorption of aptamers to Au 
NP surface via Au–nucleoside affinity. (1) In the presence of target small molecules, aptamer–
target interaction results in the desorption of aptamer strands from the Au NP surface. The higher 
the target concentration, the higher the amount of desorption. In the absence of target molecules, 
aptamer strands remain surface-bound. (2) Au NP growth mediated by hydroxylamine (NH2OH) 
and hydrogen tetrachloroaurate (III) (HAuCl4) results in varied morphologies, and consequently 
different colours, of grown Au NPs. Grown Au NPs with low amounts of aptamer adsorbed are 
spherical and red in colour, whereas those with high amounts of adsorbed aptamer have a branched 
morphology and are blue in colour. (b) Increasing target concentration results in a blue shift of the 
UV-vis spectra of grown Au NPs, due to a change in morphology (branched to spherical), and a 
concomitant colour change of the solution from blue to red. 
3.3.2 Effect of aptamer coverage on the growth of Au NPs 
In order to investigate how the amount of aptamer strands present on the surface of Au NPs would 
modulate the growth of Au NPs, the Au NPs were incubated with varying concentration of OTA 
aptamers. A blue-to-red colour change of the grown Au NP solutions was observed when Au NPs 
were incubated with a decreasing concentration of OTA aptamers (Figure 3.2a). This colour 
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change was accompanied by a blue shift (Figure 3.2b) of the UV-vis spectra of grown Au NPs, as 
well as a decreasing SPR peak wavelength (Figure 3.2c). The effect of a decreasing concentration 
of aptamers is akin to an increasing concentration of target small molecules, and the effect on 
grown Au NPs should be similar. This would be corroborated in the detection of OTA targets in 
the next section (Section 3.3.3), where morphological changes of grown Au NPs were studied as 
well. 
 
Figure 3.2. (a) Photographs showing the different colours generated after the growth of 5-nm Au 
NPs with different concentrations of aptamers added. The tonality of the solutions changed from 
blue to purple and then to red, with a decreasing concentration of aptamers. (b) UV-vis spectra of 
Au NP grown with the addition of 125 nM (black), 87.5 nM (blue), 75 nM (purple), 50 nM (green), 
25 nM (gold), 12.5 nM (orange) and 0 nM (red) of OTA aptamers. A blue shift of the LSPR spectra 
was observed as the concentration of aptamers decreased. (c) Corresponding peak shifts in the 
grown Au NP solution with an increasing concentration of aptamers. Error bars represent the 
standard deviation (SD) of the mean, n = 5. 
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3.3.3 Detection of ochratoxin A 
The detection of small molecule OTA served as a proof-of-concept study to validate our detection 
protocol. Procedures for the preparation of aptamer–Au NP probes and detection of OTA targets 
were followed as described in Section 3.2.3 and 3.2.4, respectively. Following the growth of Au 
NPs, a blue–red change in colour of the grown Au NP solutions was observed (Figure 3.3a), where 
there was an obvious blue–purple colour change, beginning at 1 nM of OTA, and turned 
increasingly red as the concentration of target increased. There was a corresponding blue shift in 
the UV-vis spectra of grown Au NPs with an increase in the concentration of OTA targets (Figure 
3.3b). The peak shift–OTA concentration response curve (Figure 3.3c) was obtained by comparing 
the peak shifts of grown Au NPs under different concentrations of OTA to that of the blank, where 
no OTA target was added to the aptamer–Au NP probes. A LOD of 1 nM of OTA was obtained 
from the peak shift measurements. The LOD was determined as the lowest concentration of targets 
that produced a signal that was greater than 3× the standard deviation (SD) of the blank solution. 
Our assay achieved comparable detection sensitivity as the current electrochemical (0.07–0.27 
nM) [157-159], and colorimetric (0.05–20 nM) [160-162] techniques. However, it was able to 
transduce the concentration of target molecules in a semi-quantitative fashion, without the need 
for complex instrumentation. 
The morphologies of the grown Au NPs were studied by TEM (Figures 3.3d–g). TEM showed that 
the blank solution contained nanostructures with a branched morphology (Figure 3.3d). With an 
increase in the concentration of OTA to 10 nM, grown nanostructures appeared less branched 
(Figure 3.3e). In the presence of a high concentration of OTA (10 µM), grown Au NPs evolved 
into increasingly spherical nanostructures (Figure 3.3f). As a reference, growing Au NPs without 
aptamer functionalisation, defined as “Au NP only” in Figure 3.3a, produced spherical Au NPs 
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(Figure 3.3g). The colour, spectral and morphological changes were in tandem with our proposed 
target detection mechanism illustrated in Figure 3.1. 
 
Figure 3.3. (a) Photographs showing the colourimetric detection of OTA with the naked eye, 
whereby grown Au NPs changed from blue to red with an increasing concentration of OTA. “Au 
NP only” refers to Au NPs without OTA aptamer adsorption. (b) UV-vis spectra of grown Au NPs 
corresponding to blank (black), 0.01 nM (blue), 1 nM (purple), 100 nM (green), 1 µM (gold), 10 
µM (orange) of OTA, and Au NPs without OTA aptamer adsorption (red). (c) Peak shifts of 
various OTA concentrations measured with respect to the peak wavelength of the blank. Error bars 
represent the SD of the mean, n = 5. TEM images of grown Au NPs for (d) blank, (e) 10 nM of 
OTA, (f) 10 µM of OTA and (g) Au NPs without OTA aptamer adsorption. Scale bars = 100 nm. 
Particle analysis conducted using ImageJ also revealed significant increase in the circularity of 
grown Au NPs (Figure 3.4a) as the particles transitioned from a branched morphology to a 
spherical one with an increasing OTA concentration. The red shift experienced for branched 
nanostructures, compared to spherical nanostructures, was derived from the low-energy plasmon 
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resonance from the tips of the grown branches, as well as from tip–core interactions [163], instead 
of resulting from aggregation. Dynamic light scattering (DLS) measurements of the grown Au NPs 
(Figure 3.4b) confirmed that there was no aggregation of the Au NPs, as their size was ~ 80 nm, 
which corresponded to the size of single NPs shown in Figures 3.3d–g, and in additional TEM 
micrographs (Figures 3.4c–f), which showed a uniform growth of Au NPs. 
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Figure 3.4. (a) Mean circularity of grown Au NPs, where circularity increased as grown Au NPs 
became more spherical morphologically. Error bars represent the standard error (SE) of the mean 
circularity, n ≥ 250 NPs. Analysis of variance (ANOVA) using the Bonferroni test with pairwise 
comparison; *P < 0.01. (b) DLS measurement of grown Au NPs for the blank (black), 10 nM of 
OTA (blue), 10 µM of OTA (green) and Au NP only (red). TEM images of grown Au NPs for (c) 
blank, (d) 10 nM OTA, (e) 10 µM OTA and (f) Au NP only (without OTA aptamer adsorption). 
Scale bar = 100 nm. 
The formation of branched nanostructures resulting from the growth of aptamer-functionalised Au 
NPs is illustrated in Figure 3.5, where growth reaction conducted in the presence of free aptamers 
only did not produce any observable peaks in the UV-vis spectrum compared to the growth of 
aptamer-functionalised Au NPs. 
 
Figure 3.5. UV-vis spectra of the growth reaction with (black) and without (red) Au NPs, in the 
presence of NH2OH, HAuCl4 and aptamers. 
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3.3.4 Characterising aptamer desorption via zeta potential and fluorescence 
analyses 
To further elucidate if aptamer–target interaction resulted in aptamer desorption from the surface 
of aptamer–Au NP probes, zeta potential of the probe–target solutions was measured after probe–
target incubation for 0.5 h at room temperature (RT) (Figure 3.6a). Comparing Au NPs before 
OTA aptamer functionalisation (Au NP only) with Au NPs after functionalisation (blank), the zeta 
potential decreased from -12.9 to -22.2 mV, signifying that negatively charged aptamer 
oligonucleotides were adsorbed on the Au NP surface. Upon addition of an increasing 
concentration of OTA targets, zeta potential increased to -14.1 mV at 10 µM of OTA. This increase 
in zeta potential could indicate desorption of negatively charged aptamers from the surface of the 
Au NPs. The same phenomenon was verified via fluorescence analysis, where Au NPs were 
functionalised with FAM-conjugated aptamer strands for quenching of the FAM fluorescence 
through FRET. An increase in fluorescence intensity was observed when an increasing 
concentration of OTA targets was added to the aptamer–Au NP probes (Figure 3.6b), which could 
also indicate desorption of FAM-conjugated aptamer strands after probe–target interaction. After 
comparison, the increase of both zeta potential and fluorescence intensity showed similar trends 
(Figure 3.6b). 
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Figure 3.6. (a) Zeta potential of grown Au NPs with the addition of different OTA concentrations. 
(b) Increase in zeta potential and fluorescence response (red) for aptamer desorption analysis after 
incubation with an increasing concentration of OTA targets. Lines have been added to guide the 
eyes. Error bars indicate the standard deviation (SD) of the mean, n = 3. 
3.3.5 Specificity of aptamer–target interaction 
In order to investigate the specificity of aptamer–target interactions, which resulted in target 
concentration-dependent colourimetric and spectral differences, control experiments using OTB 
and L-phenylalanine, which were structurally similar to OTA (Figure 3.7a) were performed. To 
determine if OTA molecules specifically recognised the OTA aptamer, a random oligonucleotide 
sequence was used for Au NP functionalisation instead. Figures 3.7b–c show that there was 
virtually no colourimetric and spectral changes when the random sequence was used for Au NP 
functionalisation, demonstrating that the OTA molecules would only interact specifically with the 
OTA aptamer sequence. The GTGGG region in the OTA aptamer has been identified as a crucial 
segment for OTA binding [151], and that region was absent for the random sequence used. In 
addition, the 23rd and 24th G nucleotides were also vital for binding with OTA, as the substitution 
of those G nucleotides to C nucleotides resulted in the loss of aptamer–OTA binding [164]. 
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Figure 3.7. (a) Structural comparison of OTA, OTB and L-phenylalanine. (b) Photographs of 
grown Au NPs when (top) OTA was added to Au NPs functionalised with the random sequence, 
to determine if OTA bound specifically to its aptamer, and when (middle) L-phenylalanine and 
(bottom) OTB were added to OTA aptamer–Au NP probes, to study cross-reactivity of the OTA 
aptamer with molecules of similar structure. (c) Peak shifts resulting from adding OTA to Au NPs 
adsorbed with the random sequence (red), and from the addition of OTB (blue) and L-
phenylalanine (green) to OTA aptamer–Au NP probes, as compared to the OTA detection (black) 
obtained from Figure 3.3c. Error bars represent the SD of the mean, n = 3. 
Subsequently, non-specific cross-reaction of the OTA aptamer with OTB and L-phenylalanine was 
determined. L-phenylalanine and a low concentration of OTB (≤ 10 nM) did not elicit any 
colourimetric or spectral changes, when they were added to Au NPs functionalised with the OTA 
aptamer (Figures 3.7b–c). However, we observed colour and spectral changes at high OTB 
concentrations (≥ 100 nM). Compared to OTA, OTB is generally present at much lower 
concentrations (< 0.3 to 5 nM) in food products [165, 166], hence, the presence of OTB in food 
samples at those levels should not significantly affect OTA detection. 
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3.3.6 Detection of OTA from red wine samples 
As our assay achieved a LOD that was lower than the maximum limit (~ 5 nM) of OTA allowable 
in wine products as defined by the European Commission (EC 1881/2006), we set out to quantify 
OTA extracted from commercial red wine and a red wine reference material certified to have ~ 1.3 
nM of OTA present. IAC-based extraction of OTA is frequently used in parallel with 
chromatographic methods, such as HPLC, and has enhanced OTA extraction [167, 168]. OTA 
targets were extracted from the red wine samples using an IAC (Section 3.2.2), and the eluted 
solution was incubated with aptamer–Au NP probes for target detection.  
 
Figure 3.8. (a) Photographs of grown Au NPs for OTA detection in commercially purchased red 
wine and certified red wine reference material (containing ~ 1.3 nM of OTA). (b) Comparison of 
peak shift for commercial red wine (blue bar) and reference material (red bar) against the 
calibration curve (orange) obtained earlier (Figure 3.3c). Error bars represent the SD of the mean, 
n = 3. 
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From Figure 3.8, we observed a slight change in colour tonality and peak shift for the commercial 
red wine, while the reference material produced a distinct colour change. When compared to the 
detection of OTA obtained in Figure 3.3c, the reference material elicited a spectral shift, which 
corresponded to an approximate OTA concentration of 3 nM, and has a good correlation with the 
certified concentration of 1.3 nM. 
3.3.7 Detection of spiked cocaine in synthetic urine 
Next, we utilised our assay in the detection of spiked cocaine in synthetic urine to test the versatility 
of our assay in the detection of various small molecule targets, and to investigate the viability of 
target detection in physiologically relevant medium. The composition of the purchased synthetic 
urine, while remained proprietary, closely emulated the salt and protein contents of physiological 
urine. The cocaine aptamer used has been reported in the literature [154]. In the detection of 
cocaine under aqueous conditions, a LOD of 0.1 nM of cocaine was obtained, with a blue to reddish 
purple change in the colour of grown Au NP solutions (Figure 3.9a). SDS-coated aptamer–Au NP 
probes were then used for the detection of spiked cocaine in synthetic urine. The use of SDS-
coated probes enabled direct target detection after diluting the sample 36×, before mixing with the 
probes (Figure 3.9b). Subsequently, a blue to purple colour change was obtained with 1 nM (LOD) 
of cocaine spiked in synthetic urine (Figure 3.9c). The concentration of cocaine present in the urine 
of drug users is in the range of 12 nM–118 µM [169, 170], therefore, with the current detection 
sensitivity, our assay could easily be adopted for the screening of cocaine levels. Furthermore, the 
LOD was similar to that achieved by chromatographic methods (~ 3 nM) [141, 171], but our assay 
could be a more straightforward and cost-effective alternative as high-throughput target detection 
could be achieved in a 96-well plate without the need for complex instrumentation. In general, the 
presence of cocaine can be detected the longest after administration in the hair, followed by urine, 
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saliva and serum [141]. The half-life of cocaine is 1 h, and it should be noted that cocaine is 
metabolised to metabolites, such as benzoyl ecgonine and ecgonine methyl ester, by the time 
cocaine is passed into urine. However, the cocaine aptamer utilised did not demonstrate binding 
to these metabolites [154], therefore, new aptamers targeting such metabolites have to be 
developed in order to supplement aptamer-based detection of cocaine. 
 
Figure 3.9. (a, top) Colourimetric changes of grown Au NPs in the detection of cocaine under 
aqueous conditions, and (bottom) the corresponding peak shift obtained from UV-vis measurement 
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of the grown Au NP solutions. Error bars represent the SD of the mean, n = 3. (b) UV-vis spectra 
of grown Au NP probes (without aptamer adsorbed) with the addition of synthetic urine that was 
diluted by 2× (black), 9× (pink), 18× (blue), and 36× (green), as compared to when no synthetic 
urine was added (red). Diluting the synthetic urine 36× did not cause aggregation or colour change 
of the aptamer–Au NP probes after the growth reaction. (c, top) Photographs of grown Au NPs for 
cocaine detection in spiked synthetic urine. (bottom) Peak shifts of various cocaine concentrations 
measured with respect to the peak wavelength of the blank. Concentrations stated are before 
dilution of spiked synthetic urine samples. Error bars represent the SD of the mean, n = 3. 
3.3.8 Detection of spiked 17-β estradiol in synthetic saliva 
Similarly, the synthetic saliva was formulated such that its salt and biological contents closely 
resemble that of normal physiological saliva. Although the reported estradiol aptamer [155] has 
traditionally been employed to quantify estradiol contamination in water, its application in the 
physiological screening of estradiol is advantageous for monitoring proper functioning of the 
ovaries, as well as to assess the risk of breast cancer [59, 60]. In addition, salivary estradiol is 
found in its active form, and has a good correlation with the expression of estradiol in serum. For 
the initial detection of estradiol under aqueous conditions, we achieved a LOD of 0.1 nM, where 
a blue to purple colour change was observed and continued to become reddish purple as the 
concentration of estradiol increased, producing a concomitant peak shift (Figure 3.10a). 
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Figure 3.10. (a, top) Colourimetric changes of grown Au NPs in the detection of estradiol under 
aqueous conditions, and (bottom) the corresponding peak shift obtained from UV-vis measurement 
of the grown Au NP solutions. Error bars represent the SD of the mean, n = 3. (b, top) Photographs 
of grown Au NPs for estradiol detection in spiked synthetic saliva. (bottom) Peak shifts of various 
estradiol concentrations measured with respect to the peak wavelength of the blank. 
Concentrations stated are spiked synthetic saliva samples before protein precipitation using 
methanol. Error bars represent the SD of the mean, n = 3  
A facile protein precipitation step was required to remove interferences from physiological 
proteins, since saliva constitutes a higher concentration of proteins in comparison to urine [172]. 
Protein precipitation was performed by adding methanol to synthetic saliva samples that were 
spiked with estradiol (Section 3.2.2). Following this, the mixture was centrifuged to pellet the 
protein precipitates, and the supernatant was added directly to aptamer–Au NP probes for the 
detection of spiked estradiol. From Figure 3.10b, we observed a blue-to-purple colour change with 
0.2 nM of estradiol (LOD), which was in the upper biological range of 0.018–0.13 nM for female 
salivary estradiol [173-175]. Being able to detect various hormonal and small molecule targets for 
salivary diagnostics is advantageous; cortisol, which has a normal concentration of 3.2 nM in 
healthy saliva, can be used to detect Cushing’s syndrome, which is characterised by an 
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overexpression of salivary cortisol (44 nM) [57, 58]. Furthermore, tracking changes in hormone 
levels and screening illicit androgenic drugs are potential applications in sports medicine [176]. 
3.3.9 Factors affecting target detection 
The level of peak shift generated from the detection of small molecule targets is derived from the 
amount of aptamer desorption, which is modulated by two competing factors, the binding between 
aptamer and target, as well as the affinity between aptamer and Au NP. The Kd related to a 
particular aptamer–target pair controls how readily they interact, where a lower Kd results in 
greater aptamer–target binding affinity, leading to a greater amount of aptamer desorption. With 
regards to the affinity between aptamer strands and the Au NPs, a shorter aptamer sequence 
produces a weaker adsorption of aptamer strands due to fewer NH2–Au binding sites; thereby 
promoting greater desorption upon aptamer–target interaction. Hence, employing a short aptamer 
sequence, which has a low Kd towards its target would likely result in a large peak shift. This was 
seen in the example of detecting 1 µM of OTA (Figure 3.3c), where a large peak shift (~ 37.8 nm) 
was produced, since the OTA aptamer has a short length of 36 bases and a low Kd of 96 nM [153]. 
In contrast, despite the cocaine aptamer having a similar length (38 bases), its Kd with respect to 
cocaine was ~ 400 nM [154], hence a peak shift of only ~ 11.2 nm was produced for the detection 
of 1 µM of cocaine (Figure 3.9a). On the other hand, although the estradiol aptamer possesses a 
low Kd (130 nM) [155], its long length of 76 bases most likely hindered aptamer desorption, hence 
the peak shift produced for the detection of 1 µM of estradiol was only ~ 9.2 nm (Figure 3.10a). 
Next, the size of Au NP probes and the presence of salt in target samples were investigated as 
probable factors affecting the detection of OTA targets. When aptamer–Au NP probes were 
prepared using 10-nm Au NPs, instead of 5-nm ones, lower peak shifts were produced (Figure 
3.11a). A lower peak shift generation was probably due to more aptamer strands being present on 
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10-nm Au NPs as a result of their greater surface area. Hence, at a given concentration of OTA, 
the change in aptamer coverage was lower, resulting in lower peak shifts.  
 
Figure 3.11. (a) Comparison of peak shifts for OTA detection using aptamer–Au NP probes 
prepared with 5-nm (black) and 10-nm (blue) Au NPs. Error bars represent the SD of the mean, n 
=3. (b) Peak shifts for OTA detection when the target solution contained an additional 10 mM 
(pink) and 50 mM (green) of NaCl, as compared to when no NaCl is added (black). Error bars 
represent the SD of the mean, n =3. 
Salt present in target samples may result from naturally occurring electrolytes in complex samples, 
or exist as residual salt after preparation of sample solutions. In order to investigate the effect salt 
has on the detection of OTA, target solutions were supplemented with 10 and 50 mM of NaCl, and 
detected using aptamer–Au NP probes prepared using 5-nm Au NPs. From Figure 3.11b, we 
observe a decrease in peak shifts as the amount of NaCl increased. The decrease in peak shift 
generated was most likely due to enhanced charge screening by the salt, which strengthened the 
binding between aptamer strands and Au NPs, thereby reducing the amount of aptamer desorption 
and consequently decreased the signal generated. 
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3.3.10 Target detection on aminoalkylsilane-coated glass slide 
Finally, in order to illustrate the versatility of our assay, not only with respect to the ability to 
detect various small molecule targets, but also across various platforms, we adopted our assay from 
solution onto an aminoalkylsilane-coated glass slide for solid substrate-based detection of small 
molecule targets. The principal steps for the detection of target (Figure 3.12a) were similar to 
solution-based target detection. First, aptamer-functionalised Au NPs probes were immobilised on 
the surface of the glass slide. The probes were then incubated with OTA targets, where similarly, 
a high concentration of targets produced spherical NPs (which were red) in the subsequent Au NP 
growth step. A low concentration of targets produced branched NPs, which were blue. Indeed, 
from Figures 3.12b–c, a blue-to-red colour change was observed when immobilised aptamer–Au 
NP probes were incubated with an increasing concentration of OTA. Through image analysis using 
ImageJ, we obtained a dose-dependent increase in red intensity versus blue (Figure 3.12d), 
indicating a colour change from blue to red. 
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Figure 3.12. (a) Schematic illustration of the detection of small molecules on glass slide coated 
with an (3-aminopropyl)triethoxysilane (APTES) layer. (b) Photograph of grown Au NPs for OTA 
detection on an aminosilane-coated glass slide. (c) Enlarged view of grown Au NPs on the glass 
slide, with various OTA target concentrations. Hydrophobic boundaries were created using a black 
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permanent marker for simple patterning of the glass slide. (d) RGB analysis of grown Au NPs, 
whereby the red vs. blue ratio increased as target concentration increased, indicating a blue-to-red 
colour change. Error bars represent the SD of the mean, n = 3. 
3.4 Conclusions and Future Work 
Significant efforts have been devoted towards creating facile, highly sensitive and selective, and 
rapid assays for the detection of small molecule targets. The potential applications for such 
technologies include food, drugs and environmental screening, the diagnosis of infectious and 
genetic diseases via quantification of small molecule biomarkers, as well as sports medicine and 
assessing treatment efficacy by monitoring the level of drugs in the body. This chapter described 
the development of a novel colourimetric biosensor, which utilised a relatively new concept of 
controlled morphological growth of aptamer-functionalised Au NP probes for the detection of 
small molecule targets, instead of relying on the usual method of Au NP aggregation. Integrating 
aptamer–target interaction and binding with aptamer-controlled growth of Au NPs, aptamer–Au 
NP probes either grew into Au NPs with a branched morphology (blue-coloured solution) in the 
presence of low target concentration, or into spherical Au NP (red-coloured solution) at a high 
target concentration. The assay was rapid, requiring only a 0.5-h incubation period for aptamer–
target interaction, and versatile, where the detection of three different small molecule targets could 
be achieved just by interchanging the aptamer sequence used for the preparation of aptamer–Au 
NP probes. In addition, colourimetric changes due to morphological variation could be detected 
by the naked eye, eliminating the need for expensive and complicated instrumentation, as well as 
highly trained personnel. This also enhanced the applicability of our assay in resource-limited 
settings. Furthermore, the assay readily detected target small molecules from complex matrices 
with high sensitivity and selectivity, e.g. OTA (1 nM) from red wine and from physiologically 
relevant fluids, spiked cocaine (1 nM) from synthetic urine, and spiked estradiol (0.2 nM) from 
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synthetic saliva, after simple sample preparation. The LODs achieved were below designated 
maximum food safety levels (EC 1881/2006), and within physiological limits, enabling the 
application of our assay for the high-throughput testing of real world and biological samples in a 
96-well microtiter plate format. The high sensitivity achieved during target detection was enabled 
by the step-wise Au NP growth mechanism, where minute differences in the aptamer coverage on 
the surface of the Au NP probes could be amplified into significant morphological variations, 
which could be detected by the naked eye as a blue-to-red colour change. In addition, our detection 
mechanism was demonstrated to be feasible on a glass slide as well, achieving highly sensitive 
and distinct colourimetric variations in response to an increasing concentration of targets. Such 
chip-based detection allowed miniaturisation of the assay, minimising consumption of reagents 
and cost. It would serve as a ready and portable device for the rapid and sensitive detection of 
targets at the point-of-use or resource-scarce regions. The mechanism described can be adapted 
easily for the detection of other analytes, as long as specific aptamers targeting the analytes are 
available. Since a vast library of aptamer sequences, which can readily and selectively bind to their 
respective targets, is available in the literature, the assay described is potentially a versatile 
methodology for the detection of a wide range of small molecule targets. 
Nonetheless, interferences from complex matrices have rendered sample preparations, such as 
target extraction using IAC, sample dilution and protein precipitation, necessary in order to prevent 
the aggregation of the aptamer–Au NP probes and enable aptamer–target interactions. Although 
the sample preparation steps described in this chapter are relatively simple to conduct, the total 
elimination of any preparation steps would be ideal and ultimately more time- and cost-effective. 
Therefore, in the future, suitable stabilising ligands should be screened and co-functionalised along 
with aptamers on Au NPs. An example of such a ligand is PEG, which is protein-repellent and can 
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minimise interferences from protein molecules present in the sample. The stoichiometric ratio of 
ligands and aptamers will have to be balanced, such that the Au NP probes remain functional, i.e. 
allows aptamer–target interaction and growth into morphologically different nanostructures, while 
maintaining their stability in complex matrices. 
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Chapter 4 : Tunable Growth of Gold Nanorods using Alkaline 
Phosphate and Its Application in a Diagnostic Assay 
4.1 Introduction 
The anisotropic synthesis and growth of metal nanostructures with well-controlled morphology 
and physical properties present an effective avenue to harness their plasmonic properties [177, 
178]; especially for biosensing applications since the high extinction coefficient of Au 
nanostructures enable sensitive target detection. In particular, the seed-mediated synthesis of gold 
nanorods (Au NRs) [179-181] has been widely studied and adopted, due to the ease of control over 
the uniformity, size and shape of synthesised Au NRs. Furthermore, besides physical properties 
such as size, the plasmonic properties of Au NRs can also be modulated by other topological 
properties [182]. For example, Au NRs possess both longitudinal and transverse localised surface 
plasmon resonance (LLSPR and TLSPR) peaks, which is associated with free electrons oscillating 
along the long and short axis of the NRs, respectively. By controlling the aspect ratio (AR) of the 
Au NRs, we are able to tune the LLSPR peak across a broad spectral range, from the visible to 
near-infrared regime, and Au NRs of different ARs can be detected from the different colours that 
they produce. In addition, Au NRs possess a higher absorption coefficient as compared to spherical 
Au NPs [183], and changes in LLSPR peaks from the modulation of their AR (650–1200 nm) is 
greater than that achievable by SPR peak shifts arising from the aggregation of spherical Au NPs 
(520–650 nm), making Au NRs and their asymmetric growth modulation good material candidates 
for use in plasmonic-based biosensors, which have traditionally relied on Au NP aggregation, 
serving as a new assay among other biosensing assays developed in the lab [24, 184, 185]. 
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Furthermore, when the LSPR of Au NRs is excited by an electromagnetic field, the local electric 
field around the Au NRs is significantly enhanced [186], this enhancement can be exploited by 
analytical techniques, such as surface enhanced Raman spectroscopy (SERS), for the 
quantification of analytes bound to the surface of the Au NRs. For example, Au NRs have been 
employed as SERS substrates for highly sensitive detection of pesticides [186] and toxins [187]. 
The charge transfer between adsorbed target molecules and Au NRs enhanced Raman scattering 
intensities, increasing detection sensitivities. Such versatility in the utility of the plasmonic 
properties of Au NRs has enabled the application of Au NRs in bioimaging [31], optoelectronics 
[188], photothermal treatment [189], drug and gene delivery [190, 191] and biosensing [192-195]. 
In a conventional seed-mediated Au NR synthesis, hexadecyltrimethylammonium bromide 
(CTAB)-stabilised gold seeds (typically 1.5–2 nm) [181, 196] are first prepared by reducing gold 
salt (HAuCl4) using a strong reducing agent, such as sodium borohydride (NaBH4), in the presence 
of CTAB. This is followed by the addition of a growth solution, which contains surfactant (CTAB) 
and a weak reducing agent, such as ascorbic acid, for the gradual, anisotropic growth of Au NRs. 
The seeds formed are single crystalline, leading to a high yield of single crystalline Au NRs and 
the wide spread use of seed-mediated Au NR synthesis [197]. The CTAB-seeds act as a catalyst 
and nucleation site for the deposition of reduced Au and growth of Au NRs. Au NRs with ARs of 
~ 1.5–5 can be obtained using this method [181]. By adopting a sequential growth approach where 
initially grown Au NRs are subsequently used as seed particles, Au NRs with ARs of up to ~ 25 
are synthesised [198].  
Traditionally, the size, shape and AR of Au NRs were tuned by adjusting the relative 
concentrations of reagents, i.e. HAuCl4, CTAB, AgNO3 and ascorbic acid, and pH of the growth 
solution. In general, these reagents control the particle growth rate; a slower growth rate promotes 
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the growth of Au NRs, leading to higher ARs. The consensus for the role of CTAB in the synthesis 
of Au NRs is that CTAB binds preferentially to the {110} facets of the seed particles, due to the 
{110} facet possessing higher surface energy as compared to other facets [181, 194, 198], 
preventing the deposition of Au atoms onto this plane. Instead, Au atoms are deposited more 
readily on the {100} facet, thereby promoting a one-dimensional growth into rod-shaped 
nanoparticles [199]. The concentration of CTAB used is above its critical micelle concentration 
(CMC, 1 mM at 25°C), so that CTAB is able to form a bilayer on the surface of the seed particles 
and grown Au NRs to direct NR growth. Below the CMC, only spherical products are formed, 
while the AR of NRs increases with an increasing concentration of CTAB as preferential 
deposition of Au atoms is further confined to the <100> direction. In the growth solution, HAuCl4 
and CTAB form a metallomicelle complex, [CTA]–[AuBr4], which has a lower reduction potential 
of 0.8 V as compared to that of Au3+ (1.4 V). Consequently, ascorbic acid is only able to reduce 
[AuBr4]
– to [AuBr2]
– metallomicelles. The catalytic activity of the seed particles then further 
reduces Au+ in the metallomicelles to Au0 atoms for Au NR growth. With an increased 
concentration of ascorbic acid, the rate of formation of Au0 is enhanced, thereby increasing the 
growth kinetics of Au NRs. Hence, the CTAB-stabilised seeds grow more isotropically and yields 
Au NRs of lower AR. In addition, the formation of the more stable metallomicelle complex also 
serves to reduce the growth rate, promoting the formation of Au NRs [200]. The presence of 
AgNO3 is essential for the formation of anisotropic Au NRs. Various hypotheses have been 
proposed for the role of AgNO3, where AgNO3 complexes with CTAB to form AgBr, which then 
binds preferentially to facets of seed particles and promotes anisotropic rod-shape growth. In 
addition, AgBr can screen charge repulsion between the N+ headgroups of CTAB, promoting 
CTAB templating and formation of Au NR [181]. Furthermore, submonolayers of Ag form more 
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readily on {110} facets compared to {100} or {111} facets in underpotential deposition (UPD) 
[196], leading to confined growth and symmetry breaking. These roles by AgNO3 contribute to 
Au NR formation via reduction in particle growth rate [200]. In order to understand the role of pH 
in affecting the growth of Au NRs, consider the following reduction reaction of the [AuBr4]
– 
metallomicelles in the presence of ascorbic acid: 
2[AuBr4]
– + ascorbic acid + H2O ⇌ 2Au + dehydroascorbic acid + 2H+ + 4Br– 
The addition of acids, such as HNO3 or HCl, shifts the reaction equilibrium to the left, reducing 
the supply of Au0 atoms and growth rate of Au NRs, and leads to the growth of NRs with higher 
AR [201]. In addition, the presence of HNO3 in CTAB increases the viscosity of the solution, 
causing the formation of longer, more flexible worm-like CTAB micelles instead of spherical ones. 
This increased viscosity hampers ionic diffusion of reagents, slowing down the growth rate and 
promoting NR growth [202]. Furthermore, at lower pH, the packing of CTAB bilayers on the NRs 
is tighter, promoting the growth of longer Au NRs [203]. 
Binary surfactant systems [181, 204] have been introduced to grow longer NRs, with ARs of 4.6–
10, and to improve the modulation of NR dimensions and uniformity of grown NRs. Various other 
studies using additives, such as acetone [180], acids [205, 206], halide ions [207-210] and aromatic 
molecules [211, 212] in the growth solution, have also been conducted to control the growth of Au 
NRs. These studies mostly investigate the role of additives in the growth solution, whereas studies 
on the effects of additives on the initial seed particles and how they affect the subsequent 
anisotropic growth of Au NRs are lacking. 
On the other hand, post-synthetic modifications, such as overgrowth of Au, Ag and Pd shells [213-
216], anisotropic oxidation [217] and etching [218] of pre-formed Au NRs for the modulation of 
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their size, shape and spectral properties have been developed in parallel. Several of these methods 
are further adopted in sensitive biosensing applications [216, 218, 219]. Enzyme-linked 
immunosorbent assay (ELISA) is widely used for the detection of protein biomarkers in clinical 
diagnostic due to the high selectivity and specificity afforded by antigen–antibody interactions. 
However, one possible drawback of conventional colourimetric ELISA may be its inability to 
detect targets at the ultralow levels, especially at the early onset of diseases. Application of metal 
nanostructures as a component in the signal transduction process of ELISA has shown to improve 
sensitivity dramatically [78, 220]. 
A common clinical protein marker is the prostate specific antigen (PSA), which is a glycoprotein 
secreted by the prostate and bulbourethral glands, and the urethra lining. Quantification of serum 
PSA is used as a marker for the diagnosis of prostate cancer and for monitoring the efficacy of 
cancer treatment [221]. In the UK, prostate cancer is the 3rd most common cancer (2012), with ~ 
120 new cases daily. It also has the 2nd highest mortality, after lung cancer, with around 30 deaths 
daily [222]. Serum PSA levels were found to increase with age, with maximum PSA levels ranging 
2.4–2.5, 3.5–3.8, 4.5–5.6 and 6.3–6.9 ng/ml for males of 40–49, 50–59, 60–69 and 70–79 years 
old, respectively [221, 223, 224]. For older men (> 50 years old), a digital rectal examination is 
performed along with PSA testing for the early detection of prostate cancer [225]. However, PSA 
tests are prone to providing false-positive and/or false-negative results, where only 25% of men 
with elevated serum PSA (> 4 ng/ml) were confirmed to have prostate cancer after a prostate 
biopsy [226]. Therefore, more has been done to improve the PSA test, including measuring the 
ratio of free PSA in the blood to the total amount of PSA and the rate of change of PSA level over 
time, and using age-specific PSA reference ranges. 
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In this chapter, we describe the novel use of small molecules as additives in the seed solution to 
affect the physical characteristics of the seed particles, and for modulating the size and AR of 
grown Au NRs using the seed-mediated growth approach. The mechanisms of small molecule–
seed interactions were first elucidated, before the strategy was incorporated in an ELISA for the 
detection of PSA from male serum samples. Two structurally-similar small molecules, 4-
aminophenol (AP) and 4-aminophenyl phosphate (APP), were found to elicit completely opposite 
effect on the growth of Au NRs. Incubating seed particles with an increasing concentration of APP 
yielded Au NRs of decreasing AR and a blue shift in the LLSPR of grown NRs, whereas an 
increasing concentration of AP produced Au NRs of increasing AR and a red shift in the LLSPR. 
Interestingly, APP (a non-reducing agent) is the enzymatic substrate of alkaline phosphatase (ALP) 
whereas AP (a reducing agent) is the product of the dephosphorylation reaction. The use of the 
ALP–APP reaction for the generation of AP has been used to modulate the growth of Au NRs, 
with ARs of 2.3–4.5.  
Two mechanisms with regards to the effect of small molecules on the seed particles were 
hypothesised. (i) Capping effect, where amine-containing small molecules, such as APP, bind to 
and cap seed particles via NH2–Au interaction; consequently, the growth of Au NRs is hindered, 
yielding more spherical nanostructures and NRs with lower aspect ratio. (ii) Reduction effect, 
where small molecules that are reducing agents, such as AP, increase the concentration of seed 
particles, leading to the growth of Au NRs with higher AR. To validate our hypothesised 
mechanisms, the growth of Au NRs were modulated using various other structurally-similar small 
molecules. Binding of small molecules to the seed particles was characterised using SERS, 
whereas the reduction effect was determined by the ability of small molecules to deposit Ag on 
the surface of Au NPs via reduction of Ag+, and eliciting the corresponding SPR shift from 520 
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nm (SPR peak of Au) to 400–450 nm (SPR peak of Ag). Furthermore, by capitalising on the 
significant spectral shifts derived from the physical changes of grown Au NRs, we developed a 
highly sensitive ELISA assay to detect PSA in the physiological range. The resulting red shift in 
the LLSPR of grown Au NRs showed good correlation with pre-determined PSA levels present in 
two commercially available male serum samples. 
4.2 Experimental Section 
4.2.1 Materials 
4-aminophenol (≥ 99%, HPLC), 4-nitrophenyl phosphate disodium salt hexahydrate (≥ 99%), 4-
nitrophenol, 4-nitrophenyl phosphate di(tris) salt (NPP), 1,4-dihydroxybenzene (hydroquinone, ≥ 
99.5%), p-phenylenediamine (PDA,  ≥ 99%), L-ascorbic acid (≥ 99%), hydroxylamine 
hydrochloride (99%), gold(III) chloride hydrate (HAuCl4, 99.999%), 
hexadecyltrimethylammonium bromide (CTAB, ≥ 99%), silver nitrate (AgNO3, ≥ 99%), 
hydrochloric acid solution (HCl, 1.0 N), sodium borohydride (NaBH4, 99.99%), 1-dodecanethiol 
(DDT, ≥ 98%), (11-mercaptoundecyl)trimethylammonium bromide (MTAB), phosphate buffered 
saline containing 0.05% w/v Tween 20 (PBS-T, pH 7.4), prostate specific antigen (PSA, ≥ 99%), 
and tissue culture treated and Nunc-ImmunoTM MaxiSorpTM 96-well plates were purchased from 
Sigma-Aldrich (UK). 4-aminophenyl phosphate monosodium salt (APP, > 99%), mouse 
monoclonal antibody to PSA (2 mg/ml), and biotin-conjugated mouse monoclonal antibody to 
PSA (1.2 mg/ml) were obtained from Abcam (UK). HEPES buffer (1 M, pH 8.0) was bought from 
VWR (UK). Nuclease-free water, SuperBlockTM (Tween 20, PBS) blocking buffer, neutravidin-
conjugated alkaline phosphatase (neutravidin-ALP), and phosphate buffered saline (PBS, 1×, pH 
7.2) were acquired from Life Technologies (UK). Dialysis kit (MWCO 1 kDa) was procured from 
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GE Healthcare (UK). Au NPs (5 nm) were obtained from BBI Solutions (UK). Male sera 
containing known concentrations of PSA, and female serum were purchased from Sera 
Laboratories International Ltd. (UK). 
4.2.2 Preparation of seed particles 
The seed solution was prepared by the sequential addition of: 500 µL of HAuCl4 (0.5 mM), 500 
µL of CTAB (200 mM), and 60 µL of NaBH4 (8.4 mM). After the addition of NaBH4, the seed 
solution was vortexed vigorously for 1 min. The seed solution was then kept at room temperature 
(RT) for 1–2 h before use. Also, NaBH4 was freshly prepared for each batch of seed solution. 
4.2.3 Preparation of growth solution 
As the growth of Au NRs is conducted in 96-well plates (tissue culture treated), the volume of 
prepared growth solution described here is sufficient for the growth of Au NRs for ten wells, and 
can be scaled up depending on the number of wells required. The growth solution was prepared 
by the sequential addition of 500 µL of HAuCl4 (2 mM), 500 µL of CTAB (200 mM), 20 µL of 
AgNO3 (4 mM), 102 µL of ascorbic acid (12 mM), and 9 µL of HCl (1 M). 
4.2.4 Growth of Au NRs 
The growth of Au NRs was conducted via the sequential addition of 50 µL of HEPES (5 mM), 1 
µL of the seed solution, and 110 µL of the growth solution. The mixture was stirred after the 
addition of each component, and left to incubate overnight (16–20 h) at RT. Note: HEPES (5 mM) 
that was used as the ALP-APP reaction for the ELISA was optimal in basic pH. 
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4.2.5 Tuning the growth of Au NRs using AP, APP and other small molecules 
A stock solution of 10 mM of small molecules (i.e. AP, APP, nitrophenol, NPP, hydroquinone, 
PDA, hydroxylamine, and ascorbic acid) was prepared in HEPES buffer (5 mM), desired 
concentrations of small molecules were then prepared via serial dilution.  
For tuning the growth of Au NRs, 1 µL of the seed solution was added to 50 µL of the prepared 
small molecule solutions (in 5 mM HEPES), and incubated for 10 min at RT. 110 µL of the growth 
solution was then added, and the growth of Au NRs was incubated overnight (16–20 h) at RT. 
4.2.6 Tuning the growth of Au NRs via ALP-APP generation of AP 
Experiments requiring the immobilisation of antibodies were conducted using the Nunc-
ImmunoTM MaxiSorpTM 96-well plates. 50 µL of biotin-conjugated mouse monoclonal antibody 
to PSA (100× diluted in 1× PBS) was added to each well, and incubated overnight (16–20 h) at 
4°C to immobilise the biotin-conjugated antibody.  
The wells were washed three times with HEPES (5 mM) and then blocked with 150 µL of the pre-
made SuperBlock blocking buffer. The SuperBlock buffer is a protein-based blocking solution 
(which does not contain immunoglobulins, albumin and biotin) for blocking excess binding sites 
in ELISA assays. The wells were washed once with HEPES (5 mM) after blocking to remove 
unbound blocking agents. 
50 µL of neutravidin-ALP of various concentrations was added to the wells, and incubated for 0.5 
h at 37°C with shaking (360 rpm). The wells were washed three times with HEPES (5 mM) to 
remove unbound neutravidin-ALP. 
50 µL of APP (10 µM) was added to the wells, and incubated for 1 h at 37°C with shaking (360 
rpm) to generate AP. 1 µL of the seed solution was then added to the wells and incubated for 10 
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min at RT, before 110 µL of the growth solution was added for overnight (16–20 h) growth of Au 
NRs at RT. 
4.2.7 Application of the tunable growth of Au NRs in an ELISA for the detection 
of PSA in human serum samples 
66 µL of mouse monoclonal antibody to PSA (300× diluted in 1× PBS) was added to each well of 
MaxiSorp plate, and incubated overnight (16–20 h) at 4°C to immobilise the antibody. 
The wells were washed three times using 150 µL of PBS-T, and then blocked with 150 µL of 
SuperBlock. The wells were washed once using 150 µL of PBS-T after blocking to remove 
unbound blocking agents. 
Two male serum samples with pre-determined PSA levels and one female serum sample were used 
in the ELISA. Male serum sample 1 contained 5 ng/ml of PSA, whereas male serum sample 2 
contained 66.6 ng/ml of PSA. According to the manufacturer, PSA levels in the male serum 
samples were quantified using direct chemiluminescence and electrochemiluminescence 
immunoassays, which have a detection limit of 0.008 and 0.01 ng/ml, respectively. 150 µL of the 
serum samples was added to the wells, and incubated for 1 h at 37°C with shaking (360 rpm). 
The wells were washed three times using 150 µL of PBS-T, followed by the addition of 50 µL of 
biotin-conjugated mouse monoclonal antibody to PSA (100× diluted in 1× PBS) in each well. This 
was incubated for 1 h at 37°C with shaking (360 rpm). 
The wells were washed three times using 150 µL of HEPES (5 mM). 50 µL of neutravidin-ALP 
(500× diluted in 5 mM HEPES) was added to the wells, and incubated for 0.5 h at 37°C with 
shaking (360 rpm) for biotin–neutravidin binding. 
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The wells were washed three times using 150 µL of HEPES (5 mM). 50 µL of APP (10 µM) was 
added to the wells, and incubated for 1 h at 37°C with shaking (360 rpm) to generate AP. 1 µL of 
the seed solution was then added to the wells, and incubated for 10 min at RT before 110 µL of 
the growth solution was added for the growth of Au NRs. After 30 min, the growth of Au NRs 
was quenched by adding 5.8 µL of DDT (1% in ethanol), and the ultraviolet-visible (UV-vis) 
spectra of grown Au NRs was obtained. 
4.2.8 Transmission electron microscopy (TEM)  
To prepare Au NR samples for TEM imaging, the NR solutions were centrifuged at 6,000 rcf for 
10 min. The supernatant was discarded and the NRs were resuspended in water. This process was 
conducted twice to remove excess CTAB in the NR solutions. Subsequently, 10 µL of the NR 
solution was deposited on copper-supported carbon films, and dried overnight in air. 
To prepare seed particle samples for TEM imaging, after the 10-min incubation with small 
molecules, MTAB was added via a 100× dilution (e.g. 10 µL of MTAB added to 990 µL of seed–
small molecule solution), so that the final concentration of MTAB was 1 mM. The thiol-containing 
MTAB formed a stable monolayer on the surface of the seed particles via thiol–Au binding, and 
quenched the effect that the small molecules have on the seed particles, preventing further changes 
to the seed particles after the 10-min incubation. In addition, the MTAB contained a quaternary 
ammonium cation, N+ (positively charged), which provided charge stabilisation for the seed 
particles. The seed particles were incubated with MTAB overnight (16–20 h) to ensure complete 
formation of the MTAB monolayer at RT. Following this, the seed solution was dialysed, using a 
membrane with 1 kDa molecular weight cut-off (MWCO), for three days against water; water was 
changed daily to remove excess CTAB in the solution. After dialysis, 10 µL of the seed solution 
was deposited on copper-supported carbon films, and dried overnight in air. 
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Finally, TEM imaging was conducted with a JEOL 2000FX (accelerating voltage = 200 kV) for 
both grown Au NRs and seed particles. TEM imaging was performed by Dr. Yiyang Lin. 
4.2.9 Surface-enhanced Raman spectroscopy (SERS) 
Seed particles were incubated with various small molecules (i.e. AP, APP, NPP and hydroquinone) 
for 10 min at RT, and then grown into Au NRs as outlined in Section 4.2.5. Following this, 10 µL 
of grown Au NR solutions were drop-casted onto MgF2 substrates, and left to dry overnight at RT. 
SERS was then performed with the help of lab member, Charalambos Kallepitis, to determine 
which small molecules demonstrated binding to the seed particles, and consequently, to the grown 
Au NRs. Briefly, a Renishaw InVia Raman microscope (Renishaw, Wotton-under-Edge, UK), 
with a 785-nm diode spot laser excitation source (Toptica Photonics XTRA), was used. Spectra 
were collected with a 10× dry objective (Leica, UK), with an exposure time of 10 s and five 
accumulations for each measurement. The spectra were then processed (normalisation, smoothing 
and baseline correction) using a house-written code in MATLAB. 
4.2.10 Reduction of silver nitrate using small molecules 
10 µL of small molecule solution (220 µM, prepared in 5 mM HEPES) was added to a solution 
containing 35 µL of 5-nm Au NPs (16.6 nM) and 10 µL of AgNO3 (4 mM) for the reduction and 
deposition of a Ag layer onto the surface of the Au NPs. 
4.3 Results and Discussion 
4.3.1 Tuning the growth of Au NRs using AP, APP and other small molecules 
The principal mechanisms for tuning the growth and LLSPR of Au NRs using small molecules is 
illustrated in Figure 4.1a below. We hypothesise that the small molecules studied in this chapter 
modulate the growth of Au NRs via two main effects: capping and reduction effects. These effects 
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were manifested by AP and APP, where interestingly, although both of the small molecules were 
very similar, differing only by a phosphate group, they elicited completely opposite effect in tuning 
the growth of Au NRs. AP, which was a reducing agent, caused a red shift in the LLSPR of grown 
Au NRs, while APP, which was able to bind and cap seed particles via NH2–Au interaction, 
produced a blue shift in the LLSPR of the NRs (Figure 4.1b). The NH2–Au interaction is governed 
by various intermolecular forces, including electrostatic, Van der Waals and metal coordination 
via the lone pair electron on N with Au [227]. Although AP also contained a NH2 group, and was 
able to bind to Au, its effect as a reducing agent was dominant. The binding and reduction effects 
of small molecules are further characterised and discussed in Section 4.3.2. 
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Figure 4.1. (a) Schematic illustrating the mechanisms by which small molecules tune the growth 
of Au NRs. During the 10-min incubation between seed particles and small molecules, the small 
molecules either cap the seed particles via NH2–Au interaction, which results in the synthesis of 
Au NRs with lower aspect ratio, or elicit a reducing effect on the seed particles, which causes the 
production of Au NRs with higher aspect ratio. (b) Effect of (left) AP and (right) APP on the 
spectra of grown Au NRs. AP results in a red shift of the LLSPR of the Au NRs, while APP causes 
a blue shift, as concentrations of both small molecules increased from 0–40 µM. (c) TEM images 
of grown Au NRs after incubating the seed particles with different concentrations of APP and AP. 
Scale bars = 50 nm. (d) Corresponding aspect ratios (ARs) of the grown Au NRs, where APP, 
which produces a capping effect causes the formation of Au NRs with lower aspect ratio, while 
AP, which is a reducing agent, produces Au NRs with higher aspect ratio. 
A red shift in the LLSPR of Au NRs was generally associated with an increase in AR, and from 
the TEM micrographs (Figure 4.1c), incubating seed particles with AP resulted in the growth of 
thinner Au NRs with increased AR as the concentration of AP increased (Figure 4.1d). In contrast, 
incubation with APP yielded thicker Au NRs with lower ARs. 
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In order to elucidate the mechanism through which the growth of Au NRs was modulated, the 
effect of various other small molecules, with similar structures and chemical properties as AP and 
APP, on the growth of Au NR was also investigated (Figure 4.2). NPP and nitrophenol are analogs 
of APP and AP, respectively, where the NH2 group on APP and AP are replaced by NO2 on NPP 
and nitrophenol. Both NPP and nitrophenol were non-reducing agents, and from Figures 4.2a–b, 
incubating the seed particles with NPP and NP (0–40 µM) did not produce any changes to the 
spectra of grown Au NRs. This demonstrated that the presence of the NH2 group produced the blue 
shift, as seen for APP, most likely via NH2–Au binding and capping interaction. Subsequently, 
aromatic reducing agents, hydroquinone and PDA, were incubated with the seed particles, and 
both small molecules resulted in a red shift in the LLSPR of grown Au NRs, with an increase in 
the concentration of the analytes (Figures 4.2c–d). In addition, to ascertain whether any reducing 
agents, even non-aromatic ones, were able to elicit a red shift in the LLSPR of Au NRs, ascorbic 
acid and hydroxylamine, which are common reducing agents used in the synthesis of Au NPs, 
were incubated with the seed particles. Indeed, both small molecules yielded a red shift in the 
LLSPR of grown Au NRs (Figures 4.2e–f), indicating that the reducing effect from these 
molecules (i.e. hydroquinone, PDA, ascorbic acid and hydroxylamine) most probably caused the 
red shift in the LLSPR of Au NRs. 
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Figure 4.2. Effect of increasing concentrations (0–40 µM) of (a) NPP, (b) 4-nitrophenol, (c) 
hydroquinone, (d) PDA, (e) L-ascorbic acid, and (f) hydroxylamine on the UV-vis spectra of grown 
Au NRs. 
4.3.2 Capping and reduction effects of small molecules 
After incubating small molecules with the seed particles and then growing them into Au NRs, the 
binding of small molecules was characterised by analysing grown Au NRs using SERS (Figure 
4.3a). The peak at 1445 cm–1 for all samples (grown in the presence of CTAB) corresponded to 
the CH2 scissors mode along the CTAB chain [228, 229]. Compared to the SERS spectrum of the 
blank (no incubation with any small molecules), both APP and AP showed binding as both small 
molecules contained a NH2 group, which would facilitate the formation of NH2–Au interaction. 
For APP, the peaks at 1300–1200 cm–1 was assigned to P=O stretch in phosphates [230]. For AP, 
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the peaks at 1280–1200 cm–1 corresponded to C–N stretch in aromatic amines, while the peak at 
1150 cm–1 was due to C–C–N bending in amines [230]. On the other hand, NPP and hydroquinone 
did not demonstrate binding as their spectra appeared largely similar to the blank. In addition, for 
NPP, the P=O stretch (present for APP), and NO2 antisymmetric stretch in aromatic nitro 
compounds at around 1550–1490 cm–1, were absent. Also, for hydroquinone, the C–O–H planar 
bend, which was characteristic of alcohols, at 1535 cm–1 [231], was absent. 
 
Figure 4.3. (a) SERS spectra of Au NRs grown from seed particles that were incubated with 
hydroquinone, NPP, AP and APP. Blank refers to Au NRs grown from normal seed particles, 
without incubation with any small molecules. (b) UV-vis spectra of resultant Au@Ag NPs from 
the reduction of AgNO3 in the presence of Au NPs (5 nm), using 40 µM of AP, ascorbic acid, 
hydroquinone, PDA, APP and NPP. Blank refers to the UV-vis spectra of Au NP in the presence 
of AgNO3, without the addition of any small molecules. 
The various small molecules, with a final concentration of 40 µM, were then utilised to reduce 
AgNO3 in the presence of Au NPs (5 nm), and their reducing property was determined by the 
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ability of the small molecule to induce a spectral shift from 520 nm (LSPR of Au NPs) to ~ 400–
450 nm (LSPR of Ag NPs) [232, 233]. From Figure 4.3b, AP, ascorbic acid, hydroquinone and 
PDA were determined to be reducing agents due their ability to cause a spectral shift from 520 nm 
towards 400 nm, when added to a solution containing Au NP and AgNO3. Conversely, APP and 
NPP did not induce a reducing effect as there was virtually no spectral shift when compared to the 
blank (without addition of any small molecules). 
APP, which demonstrated binding but not reducing effect, caused a blue shift in the LLSPR of 
grown Au NRs (Figure 4.1b), whereas NPP, which neither bound nor reduced, did not have any 
effect on the LLSPR of the NRs (Figure 4.2a). On the other hand, hydroquinone, which produced 
a reducing effect but no binding, yielded a red shift (Figure 4.2c). Similarly, AP, which produced 
both binding and reducing effects, yielded a red shift (Figure 4.1b) as its reducing effect was 
dominant, as seen in its ability to bring about a huge peak shift in the reduction of AgNO3 (Figure 
4.3b). These results indicate that the binding effect of small molecules caused a blue shift, while a 
reducing effect caused a red shift in the LLSPR of grown Au NRs. 
4.3.3 Effect of reducing small molecules on seed particles 
In order to further elucidate how the small molecules affect the growth of Au NRs, the seed 
particles were analysed after incubation with small molecules.  
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Figure 4.4. (a) UV-vis spectra of seed particles after a 10-min incubation with an increasing 
concentration of AP (0–40 µM) at RT. (b) The ratio of absorbance at 515 nm to that at 700 nm 
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(black), determined from the UV-vis spectra of the seed particles, and the red shift obtained from 
using these seed particles to grow Au NRs (red). Error bars represent the standard deviation (SD) 
of the mean, n = 3. UV-vis spectra of seed particles after a 10-min incubation with increasing 
concentrations of (c) HQ, (d) PDA, (e) ascorbic acid, (f) APP, (g) NPP, and (h) nitrophenol. 
From the UV-vis spectra of the seed particles in Figure 4.4a above, we see an increased absorbance 
and the formation of a peak at ~ 515 nm, when the seeds were incubated with an increasing 
concentration of AP. The ratio of the absorbance at 515 nm to that at 700 nm (Abs515/Abs700) from 
the UV-vis spectra of the seed particles is shown in Figure 4.4b, where the ratio increased with an 
increasing concentration of AP, and began to plateau at 10–40 µM of AP. When these seed 
particles were subsequently used for the growth of Au NRs, the resulting red shift (Figure 4.4b) 
demonstrated a similar trend as that for Abs515/Abs700, where the magnitude of the red shift became 
saturated when seed particles were incubated with ~ 40 µM of AP. This illustrated that the amount 
of red shift achievable could be correlated to the Abs515/Abs700. A similar increase in the 
Abs515/Abs700 of the seed particles spectra was observed when the seed particles were incubated 
with hydroquinone, PDA and ascorbic acid (Figures 4.4c–e), which are also reducing small 
molecules and able to induce a red shift in the LLSPR of grown Au NRs (Figures 4.2c–e). 
However, when the seed particles were incubated with APP, which did not demonstrate a reducing 
effect at a concentration of 40 µM (Figure 4.3b), the UV-vis spectra of the seed particles remained 
virtually unchanged (Figure 4.4f). For NPP and nitrophenol, which also did not demonstrate a 
reducing effect, incubating seed particles with them did not produce any effect on the UV-vis 
spectra of the seed particles (Figures 4.4g–h). As nitrophenol forms a colourimetric product in 
solution, which has a maximum absorption at ~ 400 nm [234], the increase in absorbance from 
400–475 nm was most likely due to the increase in the concentration of NP present in solution as 
opposed to changes to the gold seed particles. Indeed, there was no peak formation at ~ 515 nm as 
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observed for reducing small molecules (Figures 4.4a, c–e), hence incubation with nitrophenol has 
virtually no effect on the seed particles. 
The relationship between the absorbance of Au seed particles, and their size and concentration, 
can be described by the equation below [235]: 
𝐴𝑏𝑠 × 1014 = 𝑁 ∙ 𝑑2  [−0.295 + 1.36exp (− (
𝑑 − 96.8
78.2
)
2
)] 
Abs refers to the absorbance, N refers to the particle concentration, and d refers to the particle 
diameter. Since the absorbance is directly proportional to the particle concentration and diameter, 
an increase in the absorbance of the seed particles, due to reducing small molecules, could be 
derived from an increase in the size or concentration of the seed particles. TEM imaging (Figure 
4.5) of the seed particles after incubating with different concentrations of AP showed that particle 
size did not change significantly, even when incubated with 10 µM of AP, which has caused the 
Abs515/Abs700 of the seed particles to peak (Figure 4.4b).  
 
Figure 4.5. TEM micrographs of seed particles after incubation with different concentrations of 
AP. The seed particles were subsequently capped with MTAB, and then dialysed before imaging. 
In order to determine which parameter was likely responsible for generating the red shift for the 
LLSPR of grown Au NRs, correlating experiments were performed where seed particles of 
(4.1) 
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different sizes or concentrations were used to grow Au NRs, without incubation with small 
molecules. Figure 4.6a shows the effect of seed concentration on the growth of Au NRs, where an 
increase in the concentration of seed particles resulted in a red shift in the LLSPR of grown Au 
NRs. As the amount of Au3+ was distributed among a larger number of seed particles, the rate of 
growth per seed was likely to decrease, and a reduction in growth rate would tend to promote the 
growth of Au NRs with higher AR, leading to a red shift in the LLSPR peak. 
 
Figure 4.6. (a) UV-vis spectra of Au NRs grown by using different concentrations of the seed 
solution, compared to the usual concentration (1×) used so far. (b) UV-vis spectra of Au NRs 
grown using CTAB-stabilised Au NP seeds of different sizes. 
On the contrary, the use of larger seed particles led to a slight blue shift in the LLSPR peaks of 
grown Au NRs instead (Figure 4.6b). The use of larger seed particles tend to result in the growth 
of Au NRs of lower aspect ratio, and has been observed in the literature as well [236]. This was 
because a larger starting seed would lead to thicker rods with a larger diameter and a lower AR, 
manifested as a blue shift in the LLSPR peaks. Furthermore, when AP was added to a solution of 
HAuCl4, UV-vis spectra (Figure 4.7) showed an increase in the absorbance and formation of a 
peak at ~ 515 nm, similar to the UV-vis response obtained when seed particles were added to AP 
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(Figure 4.4a). This demonstrated that AP was able to cause the nucleation of Au3+ in solution, 
leading to the formation of plasmonic NPs. Taken together, since an increase in the seed 
concentration led to a red shift in the LLSPR peaks (Figure 4.6a), whereas an increase in seed size 
led to a blue shift instead (Figure 4.6b), the red shift produced from incubating seed particles with 
reducing small molecules was likely due to an increase in the concentration of the seed particles. 
 
Figure 4.7. UV-vis spectra of HAuCl4 solutions (0.5 mM) after reduction by different 
concentrations of AP. 
4.3.4 Modulating the growth of Au NRs via ALP–APP generation of AP 
To evaluate how the growth of Au NRs could be modulated by the ALP–APP reaction (for the 
generation of AP) and to test its feasibility in a biosensing assay, 10 µM of APP was added to 
wells containing an increasing concentration of immobilised ALP, so that after the ALP–APP 
dephosphorylation reaction, the wells progressively contained less APP and produced more AP. 
After 1 h of reaction at 37°C, the seed particles were added and incubated for 10 min at RT. The 
growth solution was then added. There was a red shift for the longitudinal peaks of the resulting 
Au NRs (Figures 4.8a–b). The grown Au NRs were next characterized using TEM, and a distinct 
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change in the AR of the NRs was observed (Figure 4.8c). Au NRs grown in the absence of ALP 
were thicker (lower AR), and as the concentration of immobilised ALP increased, the Au NRs 
obtained became much thinner (high AR).  
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Figure 4.8. (a) Effect of an increasing amount of immobilised ALP in the ALP–APP 
dephosphorylation reaction on the spectra of Au NRs grown subsequently, (b) and the 
corresponding red shift for the LLSPR of the Au NRs. Error bars represent the SD of the mean, n 
= 3. (c) TEM micrographs (scale bar = 50 nm) and (d) the ARs of grown Au NRs with an increasing 
concentration of immobilised ALP. 
Image analysis of the TEM micrographs revealed that the aspect ratio of Au NRs increased from 
2.3 to 4.5 when the concentration of immobilised ALP increased from 0 to 2530 mU/ml (Figure 
4.8d).  
The immobilisation of an increasing concentration of ALP simulated an increasing concentration 
of target analytes captured by immobilised capture antibodies in an ELISA assay. This experiment 
suggested that it would be feasible to utilise the modulation of Au NR growth in a well-plate 
immunoassay for the detection of disease biomarkers. Therefore, we proceeded to design an 
experiment for the detection of PSA in an ELISA format. 
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4.3.5 Application of the tunable growth of Au NRs in an ELISA for the detection of 
PSA in human serum samples 
The use of the ALP–APP reaction for the modulation of Au NR growth was applied to a sandwich 
ELISA (Figure 4.9a) for the detection of PSA. PSA is a glycoprotein secreted by the prostate and 
bulbourethral glands, and the urethra lining. Quantification of serum PSA is used as a marker for 
the diagnosis of prostate cancer and for monitoring the efficacy of cancer treatment [221]. In the 
ELISA, the PSA targets were immobilised on a 96-well plate via antigen–antibody interaction. 
Next, detection antibody with biotin, followed by neutravidin-coupled ALP were added, where the 
amount of ALP immobilised was dependent on the amount of bound PSA present. APP was then 
added for the generation of AP. In the signal generation step, pre-formed seed particles were 
incubated with the generated AP for 10 min at room temperature, where a low concentration of 
generated AP resulted in Au NRs with a low AR. Conversely, a high concentration of AP resulted 
in Au NRs with a higher AR. The transition of Au NRs from lower to higher AR, in relation to the 
concentration of PSA targets, was reflected by a red shift in the LLSPR peaks of grown Au NRs. 
This is seen in Figure 4.9b, where the detection of an increasing concentration of PSA targets in 
PBS buffer produced a red shift in the LLSPR peaks, with a corresponding limit of detection 
(LOD) of 0.16 ng/ml of PSA (Figure 4.9c), which was lower than the physiological maximum. 
This could prove useful for the detection of prostate cancer, which is usually associated with an 
overexpression of serum PSA. 
To evaluate the applicability of our assay in physiological samples, two commercially obtained 
male serum samples with known serum PSA levels (5 and 66.6 ng/ml for Male Sample 1 and 2, 
respectively), together with commercially obtained female serum (which should only contain trace 
PSA amount, if at all) were tested. The peak shifts were compared to PBS buffer, which acted as 
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the blank. From Figure 4.9d, the female serum only elicited a small peak shift in the longitudinal 
peak of grown Au NRs, which corroborated with the fact that PSA was expressed at much lower 
levels in women [237]. There were much larger peak shifts for the two male serum samples, where 
the magnitude of the peak shift corresponded well with the PSA levels present (Figure 4.9d), 
confirming the feasibility of applying AP-mediated modulation of Au NR growth in a clinically-
relevant diagnostic assay. Serum PSA levels were found to increase with age, with maximum PSA 
levels ranging 2.4–2.5, 3.5–3.8, 4.5–5.6 and 6.3–6.9 ng/ml for males of 40–49, 50–59, 60–69 and 
70–79 years old, respectively [221, 223, 224]. With the ability to quantitatively reflect PSA levels 
in serum, the ELISA could potentially be used for the diagnosis of prostate cancer. 
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Figure 4.9. (a) Schematic of the sandwich ELISA used for the detection of PSA using the 
modulation of Au NR growth. Immobilised capture antibodies first capture PSA targets, which 
biotin-conjugated detection antibodies can then bind to. Next, neutravidin-conjugated ALP 
(neutravidin-ALP) was added and immobilised via biotin–neutravidin interaction. 10 µM of APP 
was then added and incubated for 1 h at 37°C for the generation of AP. Prepared seed particles 
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were then added and incubated for 10 min, where a low concentration of target, and hence the 
generation of a low concentration of AP, resulted in the growth of Au NRs with a low AR, whereas 
a high concentration of target yielded Au NRs with a higher AR. (b) UV-vis spectra of grown Au 
NR and (c) corresponding red shift obtained for the detection of PSA in buffer. Error bars represent 
the SD of the mean, n = 3. (d) Red shift obtained for the detection of PSA in three commercially 
purchased serum samples: male serum sample 1 and 2 were known to contain 5 and 66.6 ng/ml of 
PSA, respectively, and a female serum. The peak shifts were compared to PBS buffer, which acted 
as the blank. Error bars indicate the SD of the mean, n = 3. 
As part of the future work in further lowering the LOD and making the assay more sensitive, 
different experimental conditions could be further optimised: (i) the concentration of seed particle 
used, where lowering the concentration of seed particles would lead to a higher AP to seed ratio, 
thereby increasing the reducing effect of AP; and (ii) the duration of incubating seed particles with 
AP, where a longer incubation duration could enhance the reducing effect, leading to a greater red 
shift at lower concentrations of AP. 
Figure 4.10 below shows that the red shift obtained increased when a lower volume of the seed 
solution was incubated with 3.33 µM of AP. As the reducing effect of AP was probably enhanced 
per seed particle when there were fewer seeds present, a lower volume of seeds could lead to an 
increased detection sensitivity. Similarly, the red shift obtained increased when the incubation 
duration increased from 10 to 30 min (Figure 4.10b), however, increasing the incubation time may 
increase the ELISA assay duration unnecessarily, considering that statistical analysis (using a two-
sample t-test between the red shift obtained at 10 and 30 min) showed that the increase in red shift 
was insignificant (P = 0.09). 
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Figure 4.10. (a) Red shift obtained when different volumes of the seed solution was incubated for 
10 min with 3.33 µM of AP. Error bars represent the SD of the mean, n = 3. (b) Red shift obtained 
when 1 µL of the seed solution was incubated for various durations with 3.33 µM of AP. Error 
bars represent the SD of the mean, n = 3. 
4.4 Conclusions and Future Work 
ELISA assays take advantage of the high specificity between antibody–antigen binding for the 
detection of protein biomarkers in clinical diagnostics, and is increasingly used in conjunction with 
nanomaterials for highly sensitive target detection. As we gain a greater understanding of 
nanomaterials and exert more control over their synthesis and physical characteristics, we can 
better harness their unique plasmonic properties in the development of biosensors and diagnostic 
assays. In this chapter, we described the use of AP as a small molecule additive to modulate the 
growth of Au NRs. Specifically, AP generated from the dephosphorylation reaction between ALP 
and APP resulted in a distinct red shift of the LLSPR peaks, and an increase in AR, of grown Au 
NRs. We hypothesised that the modulation of Au NR growth by small molecules could occur either 
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via a reducing or capping effect. Reducing small molecules, such as AP, led to an increase in seed 
particle concentration during seed–small molecule incubation, and resulted in a red shift of the 
LLSPR peaks of grown Au NRs. On the other hand, structurally-similar small molecule, APP, 
which did not demonstrate a reducing effect, produced a blue shift instead, due to the capping of 
the seed particles via NH2–Au binding, and prevented the anisotropic growth of Au NRs. As a 
result, Au NRs with lower aspect ratio were produced. The capping effect of small molecules was 
characterised by SERS, where APP and AP showed binding after seeds that were incubated with 
them were grown into Au NRs. Although AP demonstrated binding, its reducing effect was 
dominant. The reducing effect of small molecules were next assessed by the ability of the small 
molecules to reduce Ag+ in the presence of Au NPs (5 nm), thereby inducing a spectral shift of 
520 nm (Au LSPR) to ~ 400–450 (Ag LSPR). Summarising the capping and reducing 
characterisations and correlating it with the observed shifts in the LLSPR peaks of grown Au NRs, 
we found that any reducing small molecule (i.e. AP, hydroquinone, PDA and ascorbic acid) was 
able to cause a red shift in the LLSPR peak, whereas non-reducing small molecules with a capping 
effect (i.e. APP) caused a blue shift instead. Also, small molecules with neither reducing nor 
capping effect (i.e. NPP and nitrophenol) had no apparent effect on the LLSPR peaks of grown Au 
NRs. 
Subsequently, the seed particles, after incubation with small molecules, were characterised by UV-
vis spectroscopy. There was an increase in the absorbance, with the formation of a peak at ~ 515 
nm for seed particles incubated with reducing small molecules, whereas the spectra remained 
virtually unchanged when the seed particles were incubated with non-reducing small molecules. 
Furthermore, the increase in absorbance showed a similar trend in the red shift obtained, which 
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suggested that the extent of red shift achievable was correlated to the increase in absorbance after 
incubating the seed particles with reducing small molecules such as AP. 
Through correlating experiments where seed particles of different sizes and concentrations were 
used to grow Au NRs, it was found that the incubation of seed particles with reducing small 
molecules, such as AP, likely led to an increase in the concentration of the seed particles, which 
resulted in the growth of Au NRs of higher AR and a red shift in the LLSPR peaks. 
After elucidating the likely mechanism through which AP modulated the growth of Au NR, the 
ALP–APP dephosphorylation reaction was calibrated against an increasing concentration of 
immobilised neutravidin-ALP to generate an increasing concentration of AP. The increase in 
neutravidin-ALP led to the growth of Au NRs with higher AR (2.3–4.5), which was reflected by a 
red shift in the LLSPR peaks of the Au NRs. Tuning the growth of nanoparticles, especially 
anisotropic nanostructures such as Au NR, is rare as many immunoassays utilising nanomaterials 
still rely on the aggregation of spherical Au NPs [78, 220, 238-241]. Also, the dynamic range 
associated with the spectral shift of the LLSPR of Au NRs, which can potentially be 650–1200 nm 
depending on synthetic conditions, is larger than that achievable by the aggregation of Au NPs 
(520–650 nm). Moreover, the LLSPR of Au NRs, which is tunable in the NIR region, enables their 
use in conjunction with biological samples.  
The ALP–APP modulation of Au NRs growth was then applied to an ELISA assay, where we 
achieved a LOD of 0.16 ng/ml for the detection of PSA in PBS buffer. Furthermore, when tested 
with human male serum samples of known PSA concentrations, the resulting red shift obtained 
corresponded well with the PSA levels, indicating that our ELISA assay was applicable for the 
detection of serum PSA in the diagnosis of prostate cancer. In addition, as many conventional 
ELISA platforms already utilise ALP for signal transduction, ALP-conjugated enzymes or 
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antibodies are readily available, and our assay can be easily incorporated to current platforms, 
without additional synthetic or conjugation processes. 
In the future, additional optimisation processes, as outlined in Figure 4.10, can be carried out to 
increase the red shift obtained at low concentrations of AP. In particular, using a smaller volume 
of the seed solution and increasing the duration of AP–seed incubation can lead to a greater red 
shift. Furthermore, ALP can be conjugated to magnetic beads, which are able to load as high as 
3.1 × 104 enzymes per bead [241], for additional signal amplification where the binding of one 
target molecule leads to the immobilisation of tens of thousands of ALP, potentially lowering the 
LOD by a few orders of magnitude.  
In addition, as the sensitivity of the assay is in part affected by the enzymatic activity of ALP for 
the generation of AP, the use of an enzyme with higher catalytic activity may help to lower the 
LOD. ALP has a turnover number, Kcat, in the range of 10
2–103 s–1 [242-244], while the current 
neutravidin-ALP used possessed a Kcat of ~ 5 × 10
2 s–1 (according to manufacturer’s information). 
In enzymology, Kcat, refers to the maximum number of substrate conversion per second that each 
enzymatic catalytic site can perform at a given concentration of the enzyme. Much faster enzymes, 
such as acetylcholinesterase (AChE), which has a Kcat in the range of 10
4–107 s–1 [245-247], can 
be a potential candidate to replace ALP to lower the LOD. In this case, 4-aminophenyl acetate 
(APA), can be used as the substrate for AChE in order to generate AP. APA is redox inactive [248, 
249], which is similar to APP, hence the use of AChE–APA reaction should generate the same 
pattern of Au NR modulation obtained by the ALP–APP reaction. However, this would require 
verification. On the other hand, catalase (Kcat ~ 6 × 10
6 s–1), which converts H2O2 to H2O and O2, 
and carbonic anhydrase (Kcat ~ 3.6 × 10
7 s–1), which catalyses the reaction of CO2 and H2O to 
produce H2CO3 (carbonic acid)  [250], are some of the fastest enzymes available, and could be 
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used for highly sensitive signal transduction, although new mechanisms for modulating Au NR 
growth based on these enzymes would have to be further explored. 
Lastly, with the advent of integrated microfluidic immunoassay platforms [251, 252], our assay 
could be translated on a microfluidic chip to leverage the increased surface-to-volume ratio, 
minimised consumption of sample and reagents, ability to separate blood cells, and automated 
assay procedure leading to reduced inter-assay variations, associated with the utility of 
microfluidic devices [253, 254].  
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Chapter 5 : Conclusions and Future Work 
Three main research projects involving the development of highly sensitive and novel diagnostic 
platforms for the detection of several major classes of biomarkers, are described in this thesis. The 
various assays were constructed via integration of biochemistry, material science and molecular 
biology with nanotechnology, and harnessed the unique plasmonic properties of Au nanostructures 
to provide highly sensitive signal transduction. Au NP probes, possessing high refractive index, 
were designed to serve as distinct optical probes for visualising miRNA target–probe hybridisation 
conveniently under an optical microscope through DIC imaging. Aptamer-functionalised Au NPs 
enabled highly sensitive and rapid detection of small molecules in complex matrices via a dose-
dependent change in morphology, which could be detected by the naked eye, without the need for 
complex instrumentation. Enzyme-assisted small molecule-mediated modulation of Au NR 
synthesis enabled sensitive detection of protein biomarkers, where changes in the aspect ratio of 
Au NRs translated to a shift in the LLSPR peaks of grown Au NRs over a broad spectral range. In 
addition, the underlying mechanism for the assay was further elucidated to aid future development, 
as well as improvement, of similar biosensing platforms. 
Chapter 2 demonstrated a microarray platform that utilised anti-fouling surface functionalisation 
and hairpin probe for the highly sensitive and direct assaying of circulating miRNAs in human 
serum. Non-specific adsorption and biofouling by serum or plasma proteins and blood cells have 
plagued the detection of biomarkers directly from blood. Functionalising glass slides using 
carboxylic–PEG minimised non-specific adsorption of such biological materials, enabling direct 
detection of miRNA from unprocessed human serum and eliminating tedious sample preparation 
steps. In addition, the specific detection of miRNAs was an issue due to their short length. Hairpin 
probes, which possessed a stem-loop structure, could improve detection selectivity over their linear 
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counterpart, and provided a good solution to overcome this barrier. They also allowed multiplexed 
target detection where there was virtually no cross-contamination observed, even in the presence 
of a high concentration of non-target miRNAs. Coupled with the use of Au NP-tagged signalling 
probes, which possessed high refractive index, direct imaging of the Au NP probes via DIC 
microscopy was possible using a basic laboratory optical microscope. The combination of the 
various components allowed the detection of miRNA spiked in human serum down to a LOD of 
100 fM, outperforming commercial aldehyde-functionalised glass slides. This also eliminated the 
need for complex target amplification processes such as PCR, which discouraged utility of 
microarrays at the POC, especially in resource-limited areas where expensive equipment and 
trained clinical personnel would be lacking. Without an intrinsic signal amplification process, the 
current platform would be more suitable for up-regulation studies of miRNA. Also, as the assay 
was conducted under static conditions, long hybridisation duration was necessary to ensure 
sufficient probe–target hybridisation occurred, since the diffusion of nucleic acid strands would be 
slow. As such, the integration of a signal amplification process, such as enzymatic target recycling, 
and microfluidic channels to introduce flow-based target detection, might be necessary to 
significantly improve detection sensitivity and result turnaround time. This could promote the 
utility of the platform in a POC setting. 
Chapter 3 described the controlled growth of aptamer-functionalised Au NP probes, where probes 
grew into nanostructures with a branched morphology (blue-coloured solution) with low target 
concentrations, or spherical NPs (red-coloured solution) with high target concentrations. This 
study highlighted the use of morphological evolution of Au NPs in highly sensitive colourimetric 
platforms, which have traditionally relied on the aggregation of Au NPs. The mechanism of the 
assay involved aptamer–target binding and aptamer desorption from Au NP surface, to modulate 
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the resulting aptamer coverage on the surface of Au NP probes. Aptamer-mediated Au NP growth 
would then produce branched NPs when aptamer coverage was high and spherical NPs when 
coverage was low. Target detection was rapid and versatile, where changes in morphology could 
be seen by the naked eye or quantified via a blue shift (branched to spherical) using UV-vis 
spectroscopy. Furthermore, sensitive detection of small molecules from complex matrices was 
achieved: OTA from red wine, cocaine spiked in synthetic urine and estradiol spiked in synthetic 
saliva, which only required facile sample preparation steps. In addition, the assay could be easily 
adapted onto a solid substrate for the sensitive, rapid and portable detection of target in the field. 
Although current sample preparation steps were simple and convenient to perform, complete 
elimination of any sample preparation would be ideal. This would entail stabilisation of the 
aptamer–Au NP probes in complex samples, where charge screening from physiological 
electrolytes and thiol–Au interferences from plasma protein, could cause the probes to aggregate 
and lose their ability to interact with target small molecules. The use of PEG-containing ligands 
could prove useful, however, optimising the conditions under which such ligands could be 
employed would be necessary in order to ensure that the aptamer–Au NP probes could remain 
stable and functional in complex matrices. 
Chapter 4 established the novel use of small molecules, in particular AP, as an additive for the 
seed particles to control the growth of Au NRs via seed-mediated synthesis of Au NRs. Small 
molecules could modulate the growth of Au NRs via one of two pathways: (i) decreasing the 
anisotropicity of grown Au NRs by capping the seed particles via binding such as NH2–Au 
interaction, leading to the growth of Au NRs with lower aspect ratios; and (ii) increasing the 
anisotropicity of NRs via a reducing effect, which increased the concentration of seed particles, 
thereby reducing the rate of growth per seed particle and promoting the growth of Au NRs of 
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higher aspect ratios. The increase in aspect ratio was reflected as a red shift in the LLSPR of grown 
Au NRs. In addition, the mechanism could be developed into a biosensor via ALP–APP generation 
of AP, where Au NRs of diverse aspect ratio (2.3–4.5) were obtained, and the LLSPR peaks could 
be tuned over a broad spectral range. The enzyme-mediated anisotropic growth of Au NRs has 
been relatively less studied as previous work mostly relied on capping or etching of Au NRs to 
reduce anisotropicity. The ALP–APP reaction was subsequently incorporated in an ELISA assay 
for the detection of PSA, which was a biomarker used in diagnosing prostate cancer. Highly 
sensitive detection of PSA was achieved due to the sensitive change of the LLSPR peaks in 
response to changes in the aspect ratio of Au NRs. Further validation of the assay was performed 
using male serum samples of known PSA levels, where red shifts obtained corresponded well with 
the amount of PSA present. Various optimisation steps could be performed to increase the 
sensitivity of the assay and achieve a lower LOD. In particular, the use of a much faster enzyme, 
such as AChE, which has a much higher Kcat as compared to ALP could be very useful. In addition, 
the use of micro-sized magnetic beads, which would be able to hold thousands of enzymes on their 
surfaces, could be a robust methodology for signal amplification by a few orders of magnitude. 
Also, the integration of microfluidic platforms could improve inter-assay reproducibility, and 
reduce the consumption of reagents and samples, leading to cost reduction.  
Table 5.1 below compares the various assays developed in this thesis to current gold standard tests. 
140 
 
 
 
Table 5.1. Summary comparing the various assays developed to gold standard tests. 
Platform 
Analyte & 
Disease 
Limit of 
Detection 
Selectivity 
No. of 
Steps 
& Time 
to 
Result 
 
Immunochemi- 
luminescence 
Cardiac troponin I 
for acute 
myocardial 
infarction 
6 pg/ml Negligible cross reactivity with 
cardiac troponin T, troponin C, 
skeletal troponin I, actin, CK-
MB and myoglobin 
5 steps  
20 min 
Microarray –  
This thesis 
miR-208b for 
acute myocardial 
infarction 
100 fM Discrimination of 1- and 2-base 
mismatches 
4 steps 
12.5 h 
HPLC Ochratoxin A for 
food screening 
0.02 nM OTA detected using a elution 
time of 6 min [167] 
9 steps 
2 h 
Aptamer–Au 
NP – This 
thesis 
Ochratoxin A for 
food screening 
1 nM Negligible cross reactivity with 
similarly structured L-
phenylalanine and low 
concentrations of ochratoxin B 
2 steps 
45 min 
GC-MS Cocaine for drug 
abuse 
3 nM Cocaine detected against 
norcocaine and 
benzoylecgonine using a scan 
time of ~ 7 min [171] 
10 steps 
1.5–2 h 
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Aptamer–Au 
NP – This 
thesis 
Cocaine for drug 
abuse 
1 nM Aptamer did not bind to 
metabolites such as 
benzoylecgonine and ecgonine 
methyl ester [154] 
2 steps 
45 min 
Ultra-HPLC 17β-estradiol for 
assessing ovarian 
function 
0.02 nM Some interferences by related 
compounds such as estriol and 
estrone [255] 
16 steps 
1.5–2 h 
Aptamer–Au 
NP – This 
thesis 
17β-estradiol for 
assessing ovarian 
function 
0.2 nM Aptamer selective for estradiol 
against structurally similar 
compounds such as 2-
methoxynaphthalene and 1-
aminoanthraquinone [155] 
2 steps 
45 min 
ELISA  PSA for prostate 
cancer 
0.5 ng/ml No interferences from high 
concentrations of compounds 
such as ascorbic acid, caffeine 
and hCG [256] 
8 steps 
45 min 
ELISA –  
This thesis  
PSA for prostate 
cancer 
1.6 ng/ml Not measured 10 steps 
4.5 h 
 
Finally, as the studies described here pertained to in vitro diagnostics, advancement towards in 
vivo studies would be a new and interesting direction to explore. Techniques developed could be 
utilised to aid the development of such in vivo biosensors. For example, PEG functionalisation 
could be used for anti-fouling effect to reduce non-specific binding and interferences from 
biomolecules in the blood. Also, nucleic acid probes or aptamers, containing secondary structures 
such as a stem-loop structure, could be employed for highly selective detection of target cells, such 
as circulating tumour cells in the bloodstream. Furthermore, the probes could be functionalised on 
Au NRs, where their LLSPR in the biologically transparent window might be used for direct in 
vivo imaging. Besides moving towards in vivo studies, greater integration of solution-based assays 
142 
 
with solid substrates for the development of portable lateral flow or electrochemical diagnostic 
devices would be of high interest. This could ensure that fundamental science developed on the 
benchtop would be translated to practical devices and applications in the real world. 
In addition, as assays were developed for the detection of targets that were spiked into 
physiological fluids, such as spiking of synthetic miR-208b in human serum (chapter 2) and 
estradiol in synthetic saliva (chapter 3), further work and optimisation could be carried out for the 
development of assays for probing real clinical samples, since synthetic nucleic acid and saliva 
may not behave completely like real samples and matrices. Without advancing towards the testing 
of clinical samples, assays developed would only remain as proof-of-concept prototypes. Further 
development of assays on lateral flow devices would be a good direction since they are able to 
accommodate direct testing of complex samples, such as whole blood, and generate signal readouts 
within minutes, without the need for complex instrumentation. However, lateral flow devices have 
traditionally been used for the detection of protein biomarkers, and tests for nucleic acid detection 
are relatively scarce, possibly due to a lack of feasible amplification method, especially in a field 
setting. Nonetheless, development in isothermal amplification methods has allowed facile 
amplification of nucleic acid targets. Coupled with Au NP-based microfluidics, an integrated and 
automated hybrid device could be developed to achieve a portable, sensitive and reliable diagnostic 
assay. 
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